0001638833-19-000061.txt : 20190809 0001638833-19-000061.hdr.sgml : 20190809 20190809164545 ACCESSION NUMBER: 0001638833-19-000061 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190809 DATE AS OF CHANGE: 20190809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Surgery Partners, Inc. CENTRAL INDEX KEY: 0001638833 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 473620923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37576 FILM NUMBER: 191013523 BUSINESS ADDRESS: STREET 1: 310 SEVEN SPRINGS WAY STREET 2: SUITE 500 CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 615-234-5900 MAIL ADDRESS: STREET 1: 310 SEVEN SPRINGS WAY STREET 2: SUITE 500 CITY: BRENTWOOD STATE: TN ZIP: 37027 10-Q 1 a2q1910-q.htm 10-Q Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________
Form 10-Q
_____________________________________
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2019
or
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number:  001-37576
_____________________________________
Surgery Partners, Inc.
(Exact name of registrant as specified in its charter)
_____________________________________
Delaware
 
47-3620923
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)

310 Seven Springs Way, Suite 500
Brentwood, Tennessee 37027
(Address of principal executive offices and zip code)
(615) 234-5900
(Registrant’s telephone number, including area code)
_____________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, par value $0.01 per share
 
SGRY
 
The Nasdaq Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  x No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. 
Large accelerated filer o
 
Accelerated filer x
Non-accelerated filer o
 
Smaller reporting company o
 
 
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o  No  x
As of August 5, 2019, there were 49,476,880 shares of the registrant’s common stock outstanding.
 


SURGERY PARTNERS, INC.
FORM 10-Q
TABLE OF CONTENTS

 
 
Page
 
 
 
 
 
 
Item 1.
 
 
 
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
 
 
 
Notes to Condensed Consolidated Financial Statements (Unaudited)
 
 
 
Item 2.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Item 4.
 
 
 
 
 
 
Item 1.
Item 1A.
Risk Factors
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
Item 3.
Defaults Upon Senior Securities
Item 4.
Mine Safety Disclosures
Item 5.
Other Information
Item 6.
Exhibits



PART I - FINANCIAL INFORMATION
Item 1.  Financial Statements
SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, dollars in millions, except per share amounts)

 
 
June 30,
2019
 
December 31,
2018
ASSETS
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
117.4

 
$
184.3

Accounts receivable
 
301.9

 
307.6

Inventories
 
44.0

 
43.4

Prepaid expenses and other current assets
 
65.7

 
53.0

Total current assets
 
529.0

 
588.3

Property and equipment, net of accumulated depreciation of $75.1 and $56.1, respectively
 
400.1

 
426.3

Intangible assets, net
 
53.6

 
54.3

Goodwill
 
3,402.3

 
3,382.8

Investments in and advances to affiliates
 
93.4

 
78.5

Long-term deferred tax assets
 
99.5

 
109.2

Other long-term assets
 
313.0

 
36.9

Total assets
 
$
4,890.9

 
$
4,676.3

 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable
 
$
71.7

 
$
83.3

Accrued payroll and benefits
 
45.9

 
55.2

Other current liabilities
 
193.9

 
155.2

Current maturities of long-term debt
 
57.3

 
55.6

Total current liabilities
 
368.8

 
349.3

Long-term debt, less current maturities
 
2,397.4

 
2,270.9

Other long-term liabilities
 
387.1

 
271.3

 
 
 
 
 
Non-controlling interests—redeemable
 
316.0

 
326.6

Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $376.6 and $359.3, respectively
 
376.6

 
359.3

 
 
 
 
 
Stockholders' equity:
 
 
 
 
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none
 
—

 
—

Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 49,502,893 and 48,869,204, respectively
 
0.5

 
0.5

Additional paid-in capital
 
677.8

 
673.5

Accumulated other comprehensive loss
 
(50.7
)
 
(22.4
)
Retained deficit
 
(268.9
)
 
(247.0
)
Total Surgery Partners, Inc. stockholders' equity
 
358.7

 
404.6

Non-controlling interests—non-redeemable
 
686.3

 
694.3

Total stockholders' equity
 
1,045.0

 
1,098.9

Total liabilities and stockholders' equity
 
$
4,890.9

 
$
4,676.3


See notes to unaudited condensed consolidated financial statements.


1

SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, dollars in millions, except per share amounts, shares in thousands)

 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
 
 
 
Revenues
 
$
445.4

 
$
436.6

 
$
862.2

 
$
847.9

Operating expenses:
 
 
 
 
 
 
 
 
Salaries and benefits
 
132.7

 
134.1

 
261.9

 
263.8

Supplies
 
123.4

 
121.2

 
238.4

 
235.6

Professional and medical fees
 
36.4

 
36.7

 
71.5

 
72.4

Lease expense
 
21.0

 
21.8

 
41.6

 
43.2

Other operating expenses
 
26.9

 
26.3

 
53.1

 
52.4

Cost of revenues
 
340.4

 
340.1

 
666.5

 
667.4

General and administrative expenses
 
23.3

 
26.1

 
45.0

 
50.3

Depreciation and amortization
 
19.1

 
16.7

 
37.9

 
32.4

Income from equity investments
 
(2.2
)
 
(2.5
)
 
(4.2
)
 
(4.4
)
(Gain) loss on disposals and deconsolidations, net
 
(8.2
)
 
3.2

 
(7.6
)
 
3.2

Transaction and integration costs
 
6.2

 
11.7

 
8.2

 
16.7

Loss on debt extinguishment
 
11.7

 
—

 
11.7

 
—

Other income
 
(0.4
)
 
(2.2
)
 
(0.4
)
 
(2.4
)
Total operating expenses
 
389.9

 
393.1

 
757.1

 
763.2

Operating income
 
55.5

 
43.5

 
105.1

 
84.7

Tax receivable agreement expense
 
—

 
—

 
(2.4
)
 
—

Interest expense, net
 
(46.4
)
 
(35.9
)
 
(88.4
)
 
(70.2
)
Income before income taxes
 
9.1

 
7.6

 
14.3

 
14.5

Income tax expense
 
1.0

 
3.3

 
2.7

 
5.1

Net income
 
8.1

 
4.3

 
11.6

 
9.4

Less: Net income attributable to non-controlling interests
 
(27.9
)
 
(23.8
)
 
(51.5
)
 
(46.4
)
Net loss attributable to Surgery Partners, Inc.
 
(19.8
)
 
(19.5
)
 
(39.9
)
 
(37.0
)
Less: Amounts attributable to participating securities
 
(8.8
)
 
(7.9
)
 
(17.3
)
 
(15.7
)
Net loss attributable to common stockholders
 
$
(28.6
)
 
$
(27.4
)
 
$
(57.2
)
 
$
(52.7
)
 
 
 
 
 
 
 
 
 
Net loss per share attributable to common stockholders
 
 
 
 
 
 
 


Basic
 
$
(0.59
)
 
$
(0.57
)
 
$
(1.19
)
 
$
(1.10
)
Diluted (1)
 
$
(0.59
)
 
$
(0.57
)
 
$
(1.19
)
 
$
(1.10
)
Weighted average common shares outstanding
 
 
 
 
 
 
 
 
Basic
 
48,291

 
48,016

 
48,241

 
48,012

Diluted (1)
 
48,291

 
48,016

 
48,241

 
48,012

(1) The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.

See notes to unaudited condensed consolidated financial statements.



2

SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited, dollars in millions)

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
 
 
Net income
$
8.1

 
$
4.3

 
$
11.6

 
$
9.4

Other comprehensive income, net of tax:
 
 
 
 
 
 
 
Derivative activity
(16.8
)
 
—

 
(28.3
)
 
—

Comprehensive (loss) income
$
(8.7
)
 
$
4.3

 
$
(16.7
)
 
$
9.4

Less: Comprehensive income attributable to non-controlling interests
(27.9
)
 
(23.8
)
 
(51.5
)
 
(46.4
)
Comprehensive loss attributable to Surgery Partners, Inc.
$
(36.6
)
 
$
(19.5
)
 
$
(68.2
)
 
$
(37.0
)
See notes to unaudited condensed consolidated financial statements.



3

SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited, dollars in millions, shares in thousands)

 
Common Stock
 
Additional
Paid-in Capital
 
Accumulated Other Comprehensive Loss
 
Retained Deficit
 
Non-Controlling Interests—
Non-Redeemable
 
Total
 
Shares
 
Amount
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2017
48,687

 
$
0.5

 
$
695.5

 
$
—

 
$
(41.3
)
 
$
681.9

 
$
1,336.6

Net (loss) income
—

 
—

 
—

 
—

 
(17.5
)
 
15.9

 
(1.6
)
Equity-based compensation
368

 
—

 
1.3

 
—

 
—

 
—

 
1.3

Preferred dividends
—

 
—

 
(7.8
)
 
—

 
—

 
—

 
(7.8
)
Repurchase of shares
(157
)
 
—

 
(2.0
)
 
—

 
—

 
—

 
(2.0
)
Acquisition and disposal of shares of non-controlling interests, net (1)
—

 
—

 
2.0

 
—

 
—

 
(1.2
)
 
0.8

Distributions to non-controlling interests—non-redeemable holders
—

 
—

 
—

 
—

 
—

 
(22.5
)
 
(22.5
)
Balance at March 31, 2018
48,898

 
0.5

 
689.0

 
—

 
(58.8
)
 
674.1

 
1,304.8

Net (loss) income
—

 
—

 
—

 
—

 
(19.5
)
 
16.6

 
(2.9
)
Equity-based compensation
4

 
—

 
2.5

 
—

 
—

 
—

 
2.5

Preferred dividends
—

 
—

 
(7.9
)
 
—

 
—

 
—

 
(7.9
)
Acquisition and disposal of shares of non-controlling interests, net (1)
—

 
—

 
(7.7
)
 
—

 
—

 
(17.5
)
 
(25.2
)
Distributions to non-controlling interests—non-redeemable holders
—

 
—

 
—

 
—

 
—

 
(16.8
)
 
(16.8
)
Balance at June 30, 2018
48,902

 
$
0.5

 
$
675.9

 
$
—

 
$
(78.3
)
 
$
656.4

 
$
1,254.5

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2018
48,869

 
$
0.5

 
$
673.5

 
$
(22.4
)
 
$
(247.0
)
 
$
694.3

 
$
1,098.9

Net (loss) income
—

 
—

 
—

 
—

 
(20.1
)
 
16.0

 
(4.1
)
Equity-based compensation
517

 
—

 
0.9

 
—

 
—

 
—

 
0.9

Preferred dividends
—

 
—

 
(8.5
)
 
—

 
—

 
—

 
(8.5
)
Other comprehensive loss
—

 
—

 
—

 
(11.5
)
 
—

 
—

 
(11.5
)
Net effect of adoption of new accounting standard (see Note 1)
—

 
—

 
—

 
—

 
18.0

 
—

 
18.0

Acquisition and disposal of shares of non-controlling interests, net (1)
—

 
—

 
8.0

 
—

 
—

 
6.1

 
14.1

Distributions to non-controlling interests—non-redeemable holders
—

 
—

 
—

 
—

 
—

 
(23.5
)
 
(23.5
)
Balance at March 31, 2019
49,386

 
0.5

 
673.9

 
(33.9
)
 
(249.1
)
 
692.9

 
1,084.3

Net (loss) income
—

 
—

 
—

 
—

 
(19.8
)
 
18.7

 
(1.1
)
Equity-based compensation
117

 
—

 
3.1

 
—

 
—

 
—

 
3.1

Preferred dividends
—

 
—

 
(8.8
)
 
—

 
—

 
—

 
(8.8
)
Other comprehensive loss
—

 
—

 
—

 
(16.8
)
 
—

 
—

 
(16.8
)
Acquisition and disposal of shares of non-controlling interests, net (1)
—

 
—

 
9.6

 
—

 
—

 
(7.6
)
 
2.0

Distributions to non-controlling interests—non-redeemable holders
—

 
—

 
—

 
—

 
—

 
(17.7
)
 
(17.7
)
Balance at June 30, 2019
49,503

 
$
0.5

 
$
677.8

 
$
(50.7
)
 
$
(268.9
)
 
$
686.3

 
$
1,045.0

(1) 
Includes post acquisition date adjustments.

See notes to unaudited condensed consolidated financial statements.



4

SURGERY PARTNERS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, dollars in millions)

 
 
Six Months Ended June 30,
 
 
2019
 
2018
 
 
 
 
 
Cash flows from operating activities:
 
 
 
 
Net income
 
$
11.6

 
$
9.4

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
Depreciation and amortization
 
37.9

 
32.4

Non-cash interest expense (income), net
 
0.1

 
(0.7
)
Non-cash lease expense
 
19.6

 
—

Equity-based compensation expense
 
4.9

 
4.8

(Gain) loss on disposals and deconsolidations, net
 
(7.6
)
 
3.2

Loss on debt extinguishment
 
11.7

 
—

Deferred income taxes
 
2.0

 
3.8

Income from equity investments, net of distributions received
 
0.1

 
(0.2
)
Changes in operating assets and liabilities, net of acquisitions and divestitures:
 
 
 
 
Accounts receivable
 
6.9

 
12.8

Other operating assets and liabilities
 
(40.0
)
 
4.1

Net cash provided by operating activities
 
47.2

 
69.6

 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
Purchases of property and equipment
 
(31.8
)
 
(15.9
)
Payments for acquisitions, net of cash acquired
 
(13.2
)
 
(47.9
)
Proceeds from disposals of facilities and other assets
 
17.6

 
10.2

Purchases of equity investments
 
(15.2
)
 
—

Other investing activities
 
(0.3
)
 
(1.2
)
Net cash used in investing activities
 
(42.9
)
 
(54.8
)
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
Principal payments on long-term debt
 
(422.8
)
 
(45.4
)
Borrowings of long-term debt
 
438.9

 
21.4

Payments of debt issuance costs
 
(8.8
)
 
—

Payment of premium on debt extinguishment
 
(17.8
)
 
—

Payments of preferred dividends
 
—

 
(7.8
)
Distributions to non-controlling interest holders
 
(60.9
)
 
(55.8
)
Receipts (payments) related to ownership transactions with non-controlling interest holders
 
1.2

 
(0.1
)
Repurchase of shares
 
—

 
(2.0
)
Other financing activities
 
(1.0
)
 
(3.9
)
Net cash used in financing activities
 
(71.2
)
 
(93.6
)
Net decrease in cash, cash equivalents and restricted cash
 
(66.9
)
 
(78.8
)
Cash, cash equivalents and restricted cash at beginning of period
 
184.6

 
175.2

Cash, cash equivalents and restricted cash at end of period
 
$
117.7

 
$
96.4

See notes to unaudited condensed consolidated financial statements.


5
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)


1. Organization and Summary of Accounting Policies
Organization
Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."
As of June 30, 2019, the Company owned or operated a portfolio of 128 surgical facilities, comprised of 113 ASCs and 15 surgical hospitals in 31 states. The Company owns these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves. The Company owned a majority interest in 85 of the surgical facilities and consolidated 107 of these facilities for financial reporting purposes.
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018.
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.
Variable Interest Entities
The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of June 30, 2019, the consolidated VIEs include four surgical facilities, three anesthesia practices and three physician practices.
The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of June 30, 2019 and December 31, 2018, were $24.8 million and $11.2 million, respectively, and the total liabilities of the consolidated VIEs were $17.2 million and $3.6 million, respectively.
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level 1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.


6
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):
 
 
Carrying Amount
 
Fair Value
 
 
June 30,
2019
 
December 31,
2018
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
 
 
 
 
Term Loan
 
$
1,440.8

 
$
1,447.9

 
$
1,386.8

 
$
1,382.8

Senior Unsecured Notes due 2021
 
$
—

 
$
406.7

 
$
—

 
$
407.2

Senior Unsecured Notes due 2025
 
$
370.0

 
$
370.0

 
$
324.7

 
$
320.5

Senior Unsecured Notes due 2027
 
$
430.0

 
$
—

 
$
427.9

 
$
—

The fair values in the table above were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values under Level 3 calculations.
The Company has entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activities"). The fair value of these derivative instruments was $50.7 million and $22.4 million at June 30, 2019 and December 31, 2018, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.
The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP assets and liabilities were based on quoted market prices, or Level 1 computations. As of June 30, 2019 and December 31, 2018, the fair value of both the assets and liabilities in the SERP were $1.0 million and $1.4 million, respectively, and were included in other long-term assets and other long-term liabilities in the condensed consolidated balance sheets.
Revenues
The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
A summary of revenues by service type as a percentage of total revenues follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Patient service revenues:
 
 
 
 
 
 
 
   Surgical facilities revenues
94.1
%
 
92.6
%
 
94.0
%
 
93.0
%
   Ancillary services revenues
4.6
%
 
4.9
%
 
4.7
%
 
4.9
%
 
98.7
%
 
97.5
%
 
98.7
%
 
97.9
%
Other service revenues:
 
 
 
 
 
 
 
   Optical services revenues
0.2
%
 
0.6
%
 
0.2
%
 
0.7
%
   Other revenues
1.1
%
 
1.9
%
 
1.1
%
 
1.4
%
 
1.3
%
 
2.5
%
 
1.3
%
 
2.1
%
Total revenues
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
Patient service revenues. This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary


7
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.
Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change.
Other service revenues. Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.
Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.
The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):
 
 
Three Months Ended June 30,
 
 
2019
 
2018
 
 
Amount
 
%
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
Private insurance
 
$
230.5

 
52.4
%
 
$
227.7

 
53.5
%
Government
 
178.1

 
40.5
%
 
163.9

 
38.6
%
Self-pay
 
9.5

 
2.2
%
 
13.1

 
3.1
%
Other (1)
 
21.4

 
4.9
%
 
20.6

 
4.8
%
Total patient service revenues
 
439.5

 
100.0
%
 
425.3

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
1.0

 
 
 
2.8

 
 
Other revenues
 
4.9

 
 
 
8.5

 
 
Total revenues
 
$
445.4

 
 
 
$
436.6

 
 
 
 
Six Months Ended June 30,
 
 
2019
 
2018
 
 
Amount
 
%
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
Private insurance
 
$
445.8

 
52.4
%
 
$
444.2

 
53.5
%
Government
 
343.0

 
40.3
%
 
321.0

 
38.7
%
Self-pay
 
20.3

 
2.4
%
 
25.9

 
3.1
%
Other (1)
 
41.2

 
4.9
%
 
38.9

 
4.7
%
Total patient service revenues
 
850.3

 
100.0
%
 
830.0

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
2.1

 
 
 
5.8

 
 
Other revenues
 
9.8

 
 
 
12.1

 
 
Total revenues
 
$
862.2

 
 
 
$
847.9

 
 


8
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Cash, Cash Equivalents and Restricted Cash
The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.
Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both June 30, 2019 and December 31, 2018. These restricted investments represent restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities’ cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.
Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of June 30, 2019 and December 31, 2018, the Company had a net third-party Medicaid settlements liability of $7.5 million and $4.8 million, respectively, included in other current liabilities in the condensed consolidated balance sheets.
The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient’s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient’s insurance prior to the patient’s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.
The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.
The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets. Such receivables were $10.0 million and $8.5 million at June 30, 2019 and December 31, 2018, respectively.
Goodwill
Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions for the six months ended June 30, 2019 is included in Note 2. "Acquisitions."
A summary of activity related to goodwill for the six months ended June 30, 2019 is as follows (in millions):
Balance at December 31, 2018
 
$
3,382.8

Acquisitions, including post acquisition adjustments
 
19.5

Balance at June 30, 2019
 
$
3,402.3

Derivative Instruments and Hedging Activities
In accordance with Accounting Standards Codification 815, Derivatives and Hedging, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may


9
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Non-Controlling Interests—Redeemable
Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively. In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners’ or physician minority members’, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The non-controlling interests—redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.
A summary of activity related to the non-controlling interests—redeemable is as follows (in millions):
Balance at December 31, 2018
 
$
326.6

Net income attributable to non-controlling interests—redeemable
 
16.8

Acquisition and disposal of shares of non-controlling interests, net—redeemable (1)
 
(7.7
)
Distributions to non-controlling interest—redeemable holders
 
(19.7
)
Balance at June 30, 2019
 
$
316.0

(1)
Includes post acquisition date adjustments.
Income Taxes
The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in healthcare regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.
The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company’s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases.
The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was $18.0 million reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.
The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company’s financial statements and related footnotes are complete and accurate and are adequately reviewed


10
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.
2. Acquisitions
During the six months ended June 30, 2019, the Company acquired a controlling interest in one surgical facility and a physician practice for a combined cash purchase price of $13.2 million, net of cash acquired. The acquisitions were funded through cash from operations. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):
Cash consideration
 
$
13.4

Fair value of non-controlling interests
 
8.3

Aggregate acquisition date fair value
 
$
21.7

Net assets acquired:
 
 
Current Assets
 
$
1.4

Property and equipment
 
1.0

Goodwill
 
19.9

Current liabilities
 
(0.5
)
Long-term debt, less current maturities
 
(0.1
)
Aggregate acquisition date fair value
 
$
21.7

The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the six months ended June 30, 2019, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2018. The goodwill acquired was primarily allocated to the Company's reportable segments as follows: $11.4 million to surgical facility services and $8.5 million to ancillary services. The results of operations of the acquisitions were included in the Company’s results of operations beginning on the dates of acquisition and were not considered significant for the six months ended June 30, 2019.
Other Acquisitions and Dispositions
During the six months ended June 30, 2019, the Company acquired a non-controlling interest in four surgical facilities for a cash investment of $14.0 million. The non-controlling interest was accounted for as an equity method investment and recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.
During the six months ended June 30, 2019, the Company disposed of previously owned real property associated with one of its existing non-consolidated surgical facilities. In connection with the sale, the Company recognized a $10.9 million pretax gain included in (gain) loss on disposals and deconsolidations, net in the accompanying condensed consolidated statements of operations. The sale did not impact the Company's investment in the surgical facility, which continues to be accounted for as an equity method investment.


11
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

3. Long-Term Debt
A summary of long-term debt is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Term Loan (1)
 
$
1,440.8

 
$
1,447.9

Senior Unsecured Notes due 2021 (2)

—

 
406.7

Senior Unsecured Notes due 2025
 
370.0

 
370.0

Senior Unsecured Notes due 2027
 
430.0

 
—

Notes payable and secured loans
 
75.9

 
79.4

Finance lease obligations (3)
 
149.2

 
25.4

Less: unamortized debt issuance costs
 
(11.2
)
 
(2.9
)
Total debt
 
2,454.7

 
2,326.5

Less: Current maturities
 
57.3

 
55.6

Total long-term debt
 
$
2,397.4

 
$
2,270.9

(1)
Includes unamortized fair value discount of $5.3 million and $5.5 million as of June 30, 2019 and December 31, 2018, respectively.
(2)
Includes unamortized fair value premium of $6.7 million as of December 31, 2018. The premium was written off upon redemption as discussed below.
(3)
In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."
Senior Unsecured Notes due 2027
Effective April 11, 2019, the Company issued an aggregate principal amount of $430.0 million of senior unsecured notes due April 15, 2027 (the "2027 Unsecured Notes"). The 2027 Unsecured Notes bear interest at the rate of 10.000% per annum, payable semi-annually on April 15 and October 15 of each year, beginning on October 15, 2019. The 2027 Unsecured Notes are a senior unsecured obligation of Surgery Center Holdings, Inc. and are guaranteed on a senior unsecured basis by each of Surgery Center Holdings, Inc.'s existing and future domestic wholly-owned restricted subsidiaries that guarantees the 2017 Senior Secured Credit Facilities (subject to certain exceptions).
The Company may redeem up to 40% of the aggregate principal amount of the 2027 Unsecured Notes at any time prior to April 15, 2022, with the net cash proceeds of certain equity issuances at a redemption price equal to 110.000% of the principal amount of notes to be redeemed, plus accrued and unpaid interest to, but excluding, the date of redemption.
The Company may redeem the 2027 Unsecured Notes, in whole or in part, at any time prior to April 15, 2022, at a redemption price equal to 100% of the principal amount of notes to be redeemed plus the applicable premium, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. The Company may redeem the 2027 Unsecured Notes, in whole or in part, at any time on or after April 15, 2022, at the redemption prices set forth below (expressed as a percentage of the principal amount of notes to be redeemed), plus accrued and unpaid interest, if any, to, but excluding, the date of redemption:
April 15, 2022 to April 14, 2023
105.000
%
April 15, 2023 to April 14, 2024
102.500
%
April 15, 2024 and thereafter
100.000
%
If Surgery Center Holdings, Inc. experiences a change of control under certain circumstances, it must offer to purchase the 2027 Unsecured Notes at a purchase price equal to 101.000% of the aggregate principal amount of notes, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.
The indenture governing the 2027 Unsecured Notes contains customary affirmative and negative covenants, which, among other things, limit the Company’s ability to incur additional debt, pay dividends, create or assume liens, effect transactions with its affiliates, guarantee payment of certain debt securities, sell assets, merge, consolidate, enter into acquisitions and effect sale and leaseback transactions.
In connection with the offering of the 2027 Unsecured Notes, the Company recorded debt issuance costs of $8.8 million.
Senior Unsecured Notes due 2021
In connection with issuance of the 2027 Unsecured Notes as discussed above, the Company redeemed all of the then existing senior unsecured notes due 2021 ("2021 Unsecured Notes"). The redemption price was equal to 104.438% of the outstanding principal amount plus


12
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

accrued and unpaid interest. In connection with the redemption, the Company recorded a debt extinguishment loss of $11.7 million, included in loss on debt extinguishment in the condensed consolidated statements of operations for the three and six months ending June 30, 2019. The loss includes the redemption premium paid partially offset by the write-off of the unamortized fair value premium as of the redemption date.
Revolver
In connection with the completion of the issuance of the 2027 Unsecured Notes, the outstanding commitments under the Company's revolving credit facility ("Revolver") were increased by $45.0 million pursuant to an incremental amendment to the credit agreement governing its revolving credit facility. As of both June 30, 2019 and December 31, 2018, the Company had no outstanding borrowing on the Revolver. As of June 30, 2019, the Company's availability on the Revolver was $115.9 million (including outstanding letters of credit of $4.1 million).
4. Leases
On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted.
The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities.
The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.


13
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at June 30, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Balance Sheets
 
June 30, 2019
Assets:
 
 
 
 
Operating lease assets
 
Other long-term assets
 
$
285.0

Finance lease assets
 
Property and equipment, net of accumulated depreciation
 
146.1

Total leased assets
 
 
 
$
431.1

 
 
 
 
 
Liabilities:
 
 
 
 
Operating lease liabilities:
 
 
 
 
Current
 
Other current liabilities
 
$
34.8

Long-term
 
Other long-term liabilities
 
255.1

Total operating lease liabilities
 
 
 
289.9

Finance lease liabilities:
 
 
 
 
Current
 
Current maturities of long-term debt
 
13.1

Long-term
 
Long-term debt, less current maturities
 
136.1

Total finance lease liabilities
 
 
 
149.2

Total lease liabilities
 

 
$
439.1

The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the six months ended June 30, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Statement of Operations
 
June 30, 2019
 
 
 
 
 
Operating lease costs
 
Lease expense and general and administrative expenses
 
$
34.4

Finance lease costs
 
 
 
 
Amortization of leased assets
 
Depreciation and amortization
 
9.3

Interest on lease liabilities
 
Interest expense, net
 
7.3

Total finance lease costs
 
 
 
16.6

Variable and short-term lease costs
 
Lease expense and general and administrative expenses
 
6.0

Total lease costs
 
 
 
$
57.0

During the six months ended June 30, 2019, the Company incurred lease costs of $10.2 million under operating lease agreements with physician investors who are related parties. During the six months ended June 30, 2019, the Company paid rent of $3.2 million under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.


14
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):
 
 
June 30, 2019
Weighted-average remaining lease term (years)
 
 
Operating leases
 
8.5

Finance leases
 
13.1

Weighted-average discount rate
 
 
Operating leases
 
10.3
%
Finance leases
 
10.5
%
 
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Operating cash outflows from operating leases
 
$
32.8

Operating cash outflows from finance leases
 
$
7.3

Financing cash outflows from finance leases
 
$
5.2

 
 
 
Right-of-use assets obtained in exchange for lease obligations:
 
 
Operating leases
 
$
5.0

Finance leases
 
$
5.0

Future maturities of lease liabilities at June 30, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
35.4

 
$
15.2

2020
 
59.7

 
26.3

2021
 
55.1

 
24.4

2022
 
49.9

 
21.4

2023
 
46.6

 
19.1

Thereafter
 
195.8

 
187.6

Total lease payments
 
442.5

 
294.0

Less: imputed interest
 
(152.6
)
 
(144.8
)
Total lease obligations
 
$
289.9

 
$
149.2

Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. As of December 31, 2018, the current portion of the financing


15
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portion of the finance obligations was $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
5. Redeemable Preferred Stock
On August 31, 2017, the Company issued 310,000 shares of Series A Preferred Stock to Bain at a purchase price of $1,000 per share for an aggregate purchase price of $310.0 million (the "Preferred Private Placement").
A summary of activity related to the redeemable preferred stock follows (in millions):
Balance at December 31, 2018
 
$
359.3

Dividends accrued (there were no cash dividends declared)
 
17.3

Balance at June 30, 2019
 
$
376.6

There were no unpaid cash dividends declared at both June 30, 2019 and December 31, 2018. The aggregate and per share amounts of unpaid cumulative preferred dividends as of June 30, 2019 was $51.0 million and $164.64, respectively.
6. Derivatives and Hedging Activities
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During 2019, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.
For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company’s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. Over the next 12 months, the Company estimates that an additional $11.6 million will be reclassified as an increase to interest expense.
As of June 30, 2019, the Company had four interest rate swaps with a current notional amount of $1.2 billion and a termination date of November 30, 2023. The derivatives are recorded at fair value (see Note 1. "Organization and Summary of Accounting Policies") and classified as a long-term liability included in other long-term liabilities in the condensed consolidated balance sheets.
The following table presents the pre-tax effect of the interest rate swaps on the Company's accumulated other comprehensive income ("OCI") and statement of operations for the three and six months ended June 30, 2019 (dollars in millions):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2019
 
2018 (1)
 
2019
 
2018 (1)
Derivatives in Cash Flow Hedging Relationships
 
 
 
 
 
 
 
 
Loss recognized in OCI (effective portion)
 
$
18.3

 
$
—

 
$
31.1

 
$
—

Loss reclassified from accumulated OCI to interest expense (effective portion)
 
$
1.5

 
$
—

 
$
2.8

 
$
—

(1)
There were no derivatives outstanding for the comparative periods in 2018.
7. Earnings Per Share
Basic and diluted earnings per share are calculated in accordance with Accounting Standards Codification 260, Earnings Per Share, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.


16
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Numerator:
 
 
 
 
 
 
 
Net loss attributable to Surgery Partners, Inc.
$
(19.8
)
 
$
(19.5
)
 
$
(39.9
)
 
$
(37.0
)
Less: amounts allocated to participating securities (1)
(8.8
)
 
(7.9
)
 
(17.3
)
 
(15.7
)
Net loss attributable to common stockholders
$
(28.6
)
 
$
(27.4
)
 
$
(57.2
)
 
$
(52.7
)
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding- basic
48,291

 
48,016

 
48,241

 
48,012

Effect of dilutive securities (2)
—

 
—

 
—

 
—

Weighted average shares outstanding- diluted
48,291

 
48,016

 
48,241

 
48,012

 
 
 
 
 
 
 
 
Loss per share:
 
 
 
 
 
 
 
Basic
$
(0.59
)
 
$
(0.57
)
 
$
(1.19
)
 
$
(1.10
)
Diluted (2)
$
(0.59
)
 
$
(0.57
)
 
$
(1.19
)
 
$
(1.10
)
 
 
 
 
 
 
 
 
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
 
 
 
 
 
 
 
Stock options
—

 
161

 
—

 
144

Restricted shares
25

 
86

 
27

 
83

Convertible preferred stock
N/A

 
N/A

 
N/A

 
N/A

(1)
Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.
(2)
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.
Share Repurchase Transactions
On December 15, 2017, the Company's Board of Directors authorized a share repurchase program of up to $50.0 million of the Company's issued and outstanding common stock from time to time. The timing and size of repurchases will be determined based on market conditions and other factors. The authorization does not obligate the repurchase of any shares and the Company may repurchase shares of common stock at any time without prior notice. The share repurchases will be made in accordance with applicable securities laws in open market or privately negotiated transactions. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.
There were no share repurchases under the share repurchase program during the six months ended June 30, 2019. During the six months ended June 30, 2018, the Company repurchased 156,818 shares of its common stock stock at an average price of $12.64 per share through market purchases. At June 30, 2019, the Company had $46.0 million of repurchase authorization available under the December 2017 authorization.
8. Other Assets and Liabilities
Other Long-Term Assets
A summary of other long-term assets is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease assets
 
$
285.0

 
$
—

Other
 
28.0

 
36.9

Total
 
$
313.0

 
$
36.9



17
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Other Current Liabilities
A summary of other current liabilities is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Accrued legal settlement
 
$
42.0

 
$
42.3

Right-of-use operating lease liabilities
 
34.8

 
—

Interest payable
 
22.4

 
20.8

Amounts due to patients and payors
 
17.5

 
20.0

Accrued expenses and other
 
77.2

 
72.1

Total
 
$
193.9

 
$
155.2

Other Long-Term Liabilities
A summary of other long-term liabilities is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease liabilities
 
$
255.1

 
$
—

Facility lease obligations
 
—

 
149.8

Other
 
132.0

 
121.5

Total
 
$
387.1

 
$
271.3

At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.
9. Commitments and Contingencies
Professional, General and Workers' Compensation Liability Risks
The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains general liability and professional liability insurance in excess of self-insured retentions, on a claims-made basis through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. The Company also maintains workers' compensation insurance, subject to a deductible. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity.
Insurance Reserves
The Company expenses the costs under the self-insured retention exposure for general and professional liability and workers' compensation claims which relate to (i) claims made during the policy period, which are offset by insurance recoveries and (ii) an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions are based upon periodic actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Reserves for professional, general and workers' compensation claim liabilities are determined with no regard for expected insurance recoveries and are presented gross on the condensed consolidated balance sheets. Total professional, general and workers' compensation claim liabilities as of June 30, 2019 and December 31, 2018 were $19.4 million and $18.2 million, respectively. The balances include expected insurance recoveries of $12.0 million at each of June 30, 2019 and December 31, 2018.


18
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Laws and Regulations
Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.
On October 23, 2017, the Company received several civil investigative demands (“CIDs”) from the federal government under the False Claims Act (“FCA”) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company’s physicians and submitted to laboratories owned and operated by the Company. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS.
The Company has been providing information to the government in response to the CIDs and currently has a non-binding agreement in principle with the DOJ on the financial terms of a settlement with the goal of resolving these matters. Based on those discussions, which are still ongoing, the Company recorded a litigation-related charge of $46.0 million relating to these matters on the consolidated statements of operations for the year ended December 31, 2018. The Company believes that this reserve is sufficient to cover a potential resolution with the government relating to these matters, including legal expenses relating to the settlement that have not previously been recorded in operating expenses. The ultimate timing, amount and/or final terms of any such resolution may differ materially from those anticipated or the Company may not be able to reach a resolution at all. It is reasonably possible that the Company will incur additional losses above the amount reserved, but the Company is not able to estimate such amounts at this time. See Item 1A “Risk Factors” in the Company's Annual Report on Form 10-K for the period ended December 31, 2018 under the heading “Risk Factors - Risks Related to Government Regulation - Companies within the healthcare industry, including us, continue to be the subject of federal and state audits and investigations, including actions for false and other improper claims.” 
Acquired Facilities
The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.
The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.
Potential Physician Investor Liability
A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.
Tax Receivable Agreement
On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the “TRA”), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company’s projected realized tax savings over the next six years and are not dependent on the Company’s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA and such


19
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

inability is a result of the terms of credit agreements and other debt documents that are materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 500 basis points until paid. If the terms of such credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.
Assuming the Company’s effective tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates that the total remaining amounts payable under the TRA was approximately $68.2 million and $64.6 million as of June 30, 2019 and December 31, 2018, respectively. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company’s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $53.9 million and $48.5 million as of June 30, 2019 and December 31, 2018, respectively. The current portion of the liability was $8.0 million and $7.6 million as of June 30, 2019 and December 31, 2018, respectively, and was included as a component of other current liabilities in the condensed consolidated balance sheet. The long-term portion was included as a component of other long-term liabilities in the condensed consolidated balance sheets.
10. Segment Reporting
The Company operates in three major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities, the operation of ancillary services and the operation of optical services. The surgical facility services segment consists of the operation of ASCs and surgical hospitals and includes anesthesia services. The ancillary services segment consists of a diagnostic laboratory and multi-specialty physician practices. The optical services segment consists of an optical products group purchasing organization. "All other" primarily consists of the Company's corporate general and administrative functions.
The following tables present financial information for each reportable segment (in millions):

Three Months Ended June 30,
 
Six Months Ended June 30,

2019
 
2018
 
2019
 
2018
Revenues:
 
 
 
 
 
 
 
Surgical facility services
$
424.0

 
$
413.0

 
$
819.8

 
$
801.3

Ancillary services
20.4

 
20.8

 
40.3

 
40.8

Optical services
1.0

 
2.8

 
2.1

 
5.8

Total
$
445.4

 
$
436.6

 
$
862.2

 
$
847.9

 
 
 
 
 
 
 
 
Adjusted EBITDA:
 
 
 
 
 
 
 
Surgical facility services
$
78.4

 
$
75.5

 
$
146.8

 
$
142.0

Ancillary services
1.4

 
1.0

 
2.6

 
2.1

Optical services
0.4

 
0.7

 
0.9

 
1.5

All other
(19.0
)
 
(21.8
)
 
(38.3
)
 
(43.1
)
Total
$
61.2

 
$
55.4

 
$
112.0

 
$
102.5

 
 
 
 
 
 
 
 
Adjusted EBITDA:
$
61.2

 
$
55.4

 
$
112.0

 
$
102.5

Net income attributable to non-controlling interests
27.9

 
23.8

 
51.5

 
46.4

Depreciation and amortization
(19.1
)
 
(16.7
)
 
(37.9
)
 
(32.4
)
Interest expense, net
(46.4
)
 
(35.9
)
 
(88.4
)
 
(70.2
)
Equity-based compensation expense
(3.0
)
 
(2.8
)
 
(4.9
)
 
(4.8
)
Contingent acquisition compensation expense
—

 
(0.5
)
 
—

 
(1.0
)
Transaction, integration and acquisition costs (1)
(8.0
)
 
(12.5
)
 
(11.5
)
 
(18.0
)
Reserve adjustments (2)
—

 
—

 
—

 
(4.8
)
Loss on debt extinguishment
(11.7
)
 
—

 
(11.7
)
 
—

Gain (loss) on disposals and deconsolidations, net
8.2

 
(3.2
)
 
7.6

 
(3.2
)
Tax receivable agreement expense
—

 
—

 
(2.4
)
 
—

Income before income taxes
$
9.1

 
$
7.6

 
$
14.3

 
$
14.5

(1)
For the three months ended June 30, 2019 and 2018, this amount includes transaction and integration costs of $6.2 million and $11.7 million, respectively, and acquisition costs of $1.2 million and $0.8 million, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $0.6 million for the three months ended June


20
SURGERY PARTNERS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

30, 2019, with no comparable costs in the 2018 period. For the six months ended June 30, 2019 and 2018, this amount includes transaction and integration costs of $8.2 million and $16.7 million, respectively, and acquisition costs of $1.5 million and $1.3 million, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $1.8 million for the six months ended June 30, 2019, with no comparable costs in the 2018 period.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.
 
 
June 30,
2019
 
December 31,
2018
Assets:
 
 
 
 
Surgical facility services
 
$
4,445.5

 
$
4,204.3

Ancillary services
 
80.1

 
52.7

Optical services
 
21.8

 
20.1

All other
 
343.5

 
399.2

Total assets
 
$
4,890.9

 
$
4,676.3

 
 
Six Months Ended June 30,
 
 
2019
 
2018
Cash purchases of property and equipment, net:
 
 
 
 
Surgical facility services
 
$
25.3

 
$
13.2

Ancillary services
 
0.3

 
0.3

All other
 
6.2

 
2.4

Total cash purchases of property and equipment, net
 
$
31.8

 
$
15.9



21

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report and included in our Annual Report on Form 10-K for the year ended December 31, 2018. Unless the context otherwise indicates, the terms "Surgery Partners," "we," "us," "our" or the "Company," as used herein, refer to Surgery Partners, Inc. and its subsidiaries. Unless the context implies otherwise, the term “affiliates” means direct and indirect subsidiaries of Surgery Partners, Inc., and partnerships and joint ventures in which such subsidiaries are partners. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of Surgery Partners, Inc. and the term “employees” refers to employees of affiliates of Surgery Partners, Inc.
Cautionary Note Regarding Forward-Looking Statements
This report contains forward-looking statements, which are based on our current expectations, estimates and assumptions about future events. All statements other than statements of current or historical fact contained in this report are forward-looking statements. These statements include, but are not limited to, statements regarding our future financial position, business strategy, budgets, effective tax rate, projected costs and plans and objectives of management for future operations. The words "projections," "believe," "continue," "drive," "estimate," "expect," "intend," "may," "plan," "will," "could," "would" and similar expressions are generally intended to identify forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results to differ from the expectations expressed in the statements. Many of these factors are beyond our ability to control or predict. These factors include, without limitation, our ability to execute on our operational and strategic initiatives, the timing and impact of our portfolio optimization efforts, our ability to continue to improve same-facility volume and revenue growth on the timeline anticipated, if at all, our ability to successfully integrate acquisitions, the anticipated impact and timing of our ongoing efficiency efforts, including insurance consolidations and completed headcount actions, as well as our ongoing procurement and revenue cycle efforts, the impact of adverse weather conditions and other events outside of our control, whether or not a settlement is reached with the  government relating to the previously disclosed investigation, the terms of any such settlement and the ongoing cost of complying with the terms of any such settlement, and the risks and uncertainties set forth under the heading "Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 15, 2019 and discussed from time to time in our reports filed with the SEC.
Considering these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report may not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements. When you consider these forward-looking statements, you should keep in mind these risk factors and other cautionary statements in this report.
These forward-looking statements speak only as of the date made. Other than as required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events or otherwise.
Executive Overview
Total revenues for the second quarter of 2019 increased 2.0% to $445.4 million from $436.6 million for the second quarter of 2018. The implementation of a recent accounting standard on revenue recognition lowered total revenues in the second quarter of 2019 and 2018 by $7.4 million and $8.2 million, respectively. Same-facility revenues for the second quarter of 2019 increased 7.9% from the same period last year, with a 5.9% increase in revenue per case and a 2.0% increase in same-facility cases. For the second quarter of 2019, the net loss attributable to common stockholders was $28.6 million compared to $27.4 million for the same period last year. For the second quarter of 2019, Adjusted EBITDA increased 10.5% to $61.2 million compared to $55.4 million for the same period last year. A reconciliation of non-GAAP financial measures appears below under "Certain Non-GAAP Metrics."
We had cash and cash equivalents of $117.4 million and $115.9 million of borrowing capacity under our revolving credit facility at June 30, 2019. Net operating cash outflows, including operating cash flows less distributions to non-controlling interests, were $0.4 million for the second quarter of 2019.
We continue to focus on improving our same-facility performance, selectively acquiring established facilities and developing new facilities. During the six months ended June 30, 2019, we completed the acquisitions of a surgical facility and a physician practice for an investment of $13.4 million. Additionally, during the six months ended June 30, 2019, we acquired a non-controlling interest in four surgical facilities for a cash investment of $14.0 million. The non-controlling interest was accounted for as an equity method investment and recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.
Revenues
Our revenues consist of patient service revenues and other service revenues. Patient service revenues consist of revenue from our surgical facility services and ancillary services segments. Specifically, patient service revenues include fees for surgical or diagnostic procedures performed at surgical facilities that we consolidate for financial reporting purposes, as well as for patient visits to our physician practices, anesthesia services, pharmacy services and diagnostic screens ordered by our physicians. Other service revenues consist of discounts and handling charges billed to the members of our optical products purchasing organization. Other service revenues also include management and administrative service fees derived from our non-consolidated facilities that we account for under the equity method, management of surgical


22

facilities and physician practices in which we do not own an interest and management services we provide to physician practices for which we are not required to provide capital or additional assets.
The following table summarizes our revenues by service type as a percentage of total revenues for the periods indicated:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Patient service revenues:
 
 
 
 
 
 
 
Surgical facilities revenues
94.1
%
 
92.6
%
 
94.0
%
 
93.0
%
Ancillary services revenues
4.6
%
 
4.9
%
 
4.7
%
 
4.9
%
 
98.7
%
 
97.5
%
 
98.7
%
 
97.9
%
Other service revenues:
 
 
 
 
 
 
 
Optical services revenues
0.2
%
 
0.6
%
 
0.2
%
 
0.7
%
Other
1.1
%
 
1.9
%
 
1.1
%
 
1.4
%
 
1.3
%
 
2.5
%
 
1.3
%
 
2.1
%
Total revenues
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
Payor Mix
The following table sets forth by type of payor the percentage of our patient service revenues generated at the surgical facilities which we consolidate for financial reporting purposes in the periods indicated:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
 
 
Private insurance payors
52.4
%
 
53.5
%
 
52.4
%
 
53.5
%
Government payors
40.5
%
 
38.6
%
 
40.3
%
 
38.7
%
Self-pay payors
2.2
%
 
3.1
%
 
2.4
%
 
3.1
%
Other payors (1)
4.9
%
 
4.8
%
 
4.9
%
 
4.7
%
Total
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Surgical Case Mix
We primarily operate multi-specialty surgical facilities where physicians perform a variety of procedures in various specialties. We believe this diversification helps to protect us from adverse pricing and utilization trends in any individual procedure type and results in greater consistency in our case volume.
The following table sets forth the percentage of cases in each specialty performed at the surgical facilities which we consolidate for financial reporting purposes for the periods indicated:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
 
 
Gastrointestinal
21.2
%
 
21.7
%
 
21.2
%
 
21.4
%
General surgery
2.9
%
 
2.9
%
 
3.0
%
 
3.0
%
Ophthalmology
24.8
%
 
25.8
%
 
24.2
%
 
25.8
%
Orthopedic and pain management
36.9
%
 
37.0
%
 
37.2
%
 
37.3
%
Other
14.2
%
 
12.6
%
 
14.4
%
 
12.5
%
Total
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%


23

Case Growth
Same-facility Information
Same-facility information includes cases and revenues from our consolidated and non-consolidated surgical facilities (excluding facilities acquired in new markets or divested during the current and prior period).

Three Months Ended June 30,
 
Six Months Ended June 30,

2019
 
2018
 
2019
 
2018

 
 
 
 
 
 
 
Cases
141,421

 
138,710

 
274,289

 
269,815

Case growth
2.0
%
 
N/A

 
1.7
%
 
N/A

Revenue per case
$
3,166

 
$
2,991

 
$
3,162

 
$
3,020

Revenue per case growth
5.9
%
 
N/A

 
4.7
%
 
N/A

Number of work days in the period
64

 
64

 
127

 
128

Case growth (days adjusted)
2.0
%
 
N/A

 
2.5
%
 
N/A

Revenue growth (days adjusted)
7.9
%
 
N/A

 
7.3
%
 
N/A

Number of facilities
110

 
N/A

 
110

 
N/A

Accounts Receivable
Our patient service revenues and other receivables from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of our surgical facilities’ cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, we expect that any such changes would be minimal and, therefore, would not have a material effect on our financial condition or results of operations.
Our collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage our patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. We analyze accounts receivable at each of our surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required. Our days sales outstanding were 63 days for both the six months ended June 30, 2019 and the year ended December 31, 2018.
Critical Accounting Policies
A summary of significant accounting policies is disclosed in our 2018 Annual Report on Form 10-K under the caption “Critical Accounting Policies” in Management’s Discussion and Analysis of Financial Condition and Results of Operations. There have been no material changes in the nature of our critical accounting policies or the application of those policies since December 31, 2018.


24

Results of Operations
Three Months Ended June 30, 2019 Compared to Three Months Ended June 30, 2018
The following table summarizes certain results from the statements of operations for the three months ended June 30, 2019 and 2018. The table also shows the percentage relationship to revenues for the periods indicated (dollars in millions):
 
 
Three Months Ended June 30,
 
 
2019
 
2018
 
 
 
 
 
Revenues
 
$
445.4

 
$
436.6

Operating expenses:
 
 
 
 
Cost of revenues
 
340.4

 
340.1

General and administrative expenses
 
23.3

 
26.1

Depreciation and amortization
 
19.1

 
16.7

Income from equity investments
 
(2.2
)
 
(2.5
)
(Gain) loss on disposals and deconsolidations, net
 
(8.2
)
 
3.2

Transaction and integration costs
 
6.2

 
11.7

Loss on debt extinguishment
 
11.7

 
—

Other income
 
(0.4
)
 
(2.2
)
Total operating expenses
 
389.9

 
393.1

Operating income
 
55.5

 
43.5

Interest expense, net
 
(46.4
)
 
(35.9
)
Income before income taxes
 
9.1

 
7.6

Income tax expense
 
1.0

 
3.3

Net income
 
8.1

 
4.3

Less: Net income attributable to non-controlling interests
 
(27.9
)
 
(23.8
)
Net loss attributable to Surgery Partners, Inc.
 
$
(19.8
)
 
$
(19.5
)
Overview. During the three months ended June 30, 2019, our revenues increased 2.0% to $445.4 million compared to $436.6 million for the three months ended June 30, 2018. We incurred a net loss attributable to Surgery Partners, Inc. of $19.8 million for the 2019 period, compared to $19.5 million for the 2018 period.
Revenues. Revenues for the three months ended June 30, 2019 compared to the three months ended June 30, 2018 were as follows (dollars in millions):
 
 
Three Months Ended June 30,
 
 
2019
 
2018
 
 
 
 
 
Patient service revenues
 
$
439.5

 
$
425.3

Optical service revenues
 
1.0

 
2.8

Other service revenues
 
4.9

 
8.5

Total revenues
 
$
445.4

 
$
436.6

Patient service revenues increased 3.3% to $439.5 million for the three months ended June 30, 2019 compared to $425.3 million for the three months ended June 30, 2018. The 2018 period includes patient service revenues associated with disposed facilities that are not included in the 2019 period.
Cost of Revenues. Cost of revenues were $340.4 million for the three months ended June 30, 2019 compared to $340.1 million for the three months ended June 30, 2018. As a percentage of revenues, cost of revenues decreased to 76.4% for the 2019 period compared to 77.9% for the 2018 period, partially due to a change in surgical case mix.
General and Administrative Expenses. General and administrative expenses were $23.3 million for the three months ended June 30, 2019 compared to $26.1 million for the three months ended June 30, 2018. The decrease is primarily due to reduced costs upon completion of our planned investment in our corporate infrastructure and integration of corporate office functions related to acquisitions we completed in 2017. As a percentage of revenues, general and administrative expenses decreased to 5.2% for the 2019 period compared to 6.0% for the 2018 period.


25

Depreciation and Amortization. Depreciation and amortization was $19.1 million and $16.7 million for the three months ended June 30, 2019 and 2018, respectively. As a percentage of revenues, depreciation and amortization expenses was 4.3% for the 2019 period compared to 3.8% for the 2018 period. The increase is primarily due to increased capital investments and integration of acquisitions we completed in 2018.
(Gain) Loss on Disposals and Deconsolidations, Net. The net gain on disposals and deconsolidations was $8.2 million for the 2019 period, including a $10.9 million gain on the sale of previously owned real property associated with one of our non-consolidated surgical facility equity method investments, offset by a loss of $2.7 million on disposals of other long-lived assets. The net loss on disposals and deconsolidations was $3.2 million for the 2018 period, including a net loss of $1.5 million on the sale of surgical facilities and $2.8 million on disposals of other long-lived assets, offset by a net gain of $1.1 million on the deconsolidation of a surgical facility.
Transaction and Integration Costs. We incurred $6.2 million of transaction and integration costs for the three months ended June 30, 2019 compared to $11.7 million for the three months ended June 30, 2018. The decrease primarily relates to reduced reorganization costs as we complete our planned investment in our infrastructure and the integration of acquisitions we completed in 2017.
Loss on Debt Extinguishment. We incurred a debt extinguishment loss of $11.7 million in connection with issuance of the 2027 Unsecured Notes (defined in Note 3. "Long-Term Debt" to the Condensed Consolidated Financial Statements elsewhere in this report). The loss includes the redemption premium paid to redeem the 2021 Unsecured Notes partially offset by the write-off of the unamortized fair value premium as of the redemption date.
Interest Expense, Net. Interest expense, net, increased 29.2%, to $46.4 million for the three months ended June 30, 2019 compared to $35.9 million for the three months ended June 30, 2018. The increase primarily relates to the $180.0 million senior secured incremental term loan, which was fully funded on October 23, 2018 and the issuance of $430.0 million in senior unsecured notes effective April 11, 2019. As a percentage of revenues, interest expense, net was 10.4% for the 2019 period compared to 8.2% for the 2018 period.
Income Tax Expense.  The income tax expense was $1.0 million and $3.3 million for the three months ended June 30, 2019 and 2018, respectively. The effective tax rate was 11.0% for the three months ended June 30, 2019 compared to 43.5% for the three months ended June 30, 2018. The effective tax rate for the 2018 period was primarily due to the Tax Act, which implemented an interest expense limitation resulting in a deferred tax asset that required a valuation allowance to be reported at its net realizable value. We recorded additional tax expense in 2018 to account for the gain on divestitures and valuation allowances on state tax attributes resulting from legislative changes enacted during the second quarter of 2018. The effective tax rate was further impacted by the Tax Act as a result of the reduction in the U.S. federal corporate income tax rate from 35% to 21%, effective January 1, 2018. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.
Net Income Attributable to Non-Controlling Interests. Net income attributable to non-controlling interests was $27.9 million for the three months ended June 30, 2019 compared to $23.8 million for the three months ended June 30, 2018. As a percentage of revenues, net income attributable to non-controlling interests was 6.3% in the 2019 period and 5.5% for the 2018 period.


26

Six Months Ended June 30, 2019 Compared to Six Months Ended June 30, 2018
The following table summarizes certain results from the statements of operations for the six months ended June 30, 2019 and 2018. The table also shows the percentage relationship to revenues for the periods indicated (dollars in millions):
 
 
Six Months Ended June 30,
 
 
2019
 
2018
 
 
 
 
 
Revenues
 
$
862.2

 
$
847.9

Operating expenses:
 
 
 
 
Cost of revenues
 
666.5

 
667.4

General and administrative expenses
 
45.0

 
50.3

Depreciation and amortization
 
37.9

 
32.4

Income from equity investments
 
(4.2
)
 
(4.4
)
(Gain) loss on disposals and deconsolidations, net
 
(7.6
)
 
3.2

Transaction and integration costs
 
8.2

 
16.7

Debt extinguishment costs
 
11.7

 
—

Other income
 
(0.4
)
 
(2.4
)
Total operating expenses
 
757.1

 
763.2

Operating income
 
105.1

 
84.7

Tax receivable agreement expense
 
(2.4
)
 
—

Interest expense, net
 
(88.4
)
 
(70.2
)
Income before income taxes
 
14.3

 
14.5

Income tax expense
 
2.7

 
5.1

Net income
 
11.6

 
9.4

Less: Net income attributable to non-controlling interests
 
(51.5
)
 
(46.4
)
Net loss attributable to Surgery Partners, Inc.
 
$
(39.9
)
 
$
(37.0
)
Overview. During the six months ended June 30, 2019, our revenues increased 1.7% to $862.2 million compared to $847.9 million for the six months ended June 30, 2018. We incurred a net loss attributable to Surgery Partners, Inc. of $39.9 million for the 2019 period, compared to $37.0 million for the 2018 period.
Revenues. Revenues for the six months ended June 30, 2019 compared to the six months ended June 30, 2018 were as follows (dollars in millions):
 
 
Six Months Ended June 30,
 
 
2019
 
2018
 
 
 
 
 
Patient service revenues
 
$
850.3

 
$
830.0

Optical service revenues
 
2.1

 
5.8

Other service revenues
 
9.8

 
12.1

Total revenues
 
$
862.2

 
$
847.9

Patient service revenues increased 2.4% to $850.3 million for the six months ended June 30, 2019 compared to $830.0 million for the six months ended June 30, 2018. The 2018 period includes patient service revenues associated with disposed facilities that are not included in the 2019 period.
Cost of Revenues. Cost of revenues were $666.5 million for the six months ended June 30, 2019 compared to $667.4 million for the six months ended June 30, 2018. As a percentage of revenues, cost of revenues were 77.3% for the 2019 period and 78.7% for the 2018 period.
General and Administrative Expenses. General and administrative expenses were $45.0 million for the six months ended June 30, 2019 compared to $50.3 million for the six months ended June 30, 2018. The decrease is primarily due to reduced costs upon completion of our planned investment in our corporate infrastructure and integration of corporate office functions related to acquisitions we completed in 2017. As a percentage of revenues, general and administrative expenses decreased to 5.2% for the 2019 period compared to 5.9% for the 2018 period.


27

Depreciation and Amortization. Depreciation and amortization was $37.9 million and $32.4 million for the six months ended June 30, 2019 and 2018, respectively. As a percentage of revenues, depreciation and amortization expenses was 4.4% for the 2019 period compared to 3.8% for the 2018 period. The increase is primarily due to increased capital investments and integration of acquisitions we completed in 2018.
(Gain) Loss on Disposals and Deconsolidations, Net. The net gain on disposals and deconsolidations was $7.6 million for the 2019 period, including a $10.9 million gain on the sale of previously owned real property associated with one of our non-consolidated surgical facility equity method investments, offset by a loss of $3.3 million on disposals of other long-lived assets. The net loss on disposals and deconsolidations was $3.2 million for the 2018 period, including a net loss of $1.5 million on the sale of surgical facilities and $2.8 million on disposals of other long-lived assets, offset by a net gain of $1.1 million on the deconsolidation of a surgical facility.
Transaction and Integration Costs. We incurred $8.2 million of transaction and integration costs for the six months ended June 30, 2019 compared to $16.7 million for the six months ended June 30, 2018. The decrease primarily relates to reduced reorganization costs as we complete our planned investment in our infrastructure and the integration of acquisitions we completed in 2017.
Loss on Debt Extinguishment. We incurred a debt extinguishment loss of $11.7 million in connection with issuance of the 2027 Unsecured Notes (defined in Note 3. "Long-Term Debt" to the Condensed Consolidated Financial Statements elsewhere in this report). The loss includes the redemption premium paid to redeem the 2021 Unsecured Notes partially offset by the write-off of the unamortized fair value premium as of the redemption date.
Interest Expense, Net. Interest expense, net, increased 25.9%, to $88.4 million for the six months ended June 30, 2019 compared to $70.2 million for the six months ended June 30, 2018. The increase primarily relates to the $180.0 million senior secured incremental term loan, which was fully funded on October 23, 2018 and the issuance of $430.0 million in senior unsecured notes effective April 11, 2019. As a percentage of revenues, interest expense, net increased to 10.3% for the 2019 period compared to 8.3% for the 2018 period.
Income Tax Expense.  The income tax expense was $2.7 million and $5.1 million for the six months ended June 30, 2019 and 2018, respectively. The effective tax rate was 18.9% for the six months ended June 30, 2019 compared to 35.0% for the six months ended June 30, 2018. The effective tax rate for the 2018 period was primarily due to the Tax Act, which implemented an interest expense limitation resulting in a deferred tax asset that required a valuation allowance to be reported at its net realizable value. We recorded additional tax expense in 2018 to account for the gain on divestitures and valuation allowances on state tax attributes resulting from legislative changes enacted during the second quarter of 2018. The effective tax rate was further impacted by the Tax Act as a result of the reduction in the U.S. federal corporate income tax rate from 35% to 21%, effective January 1, 2018. Based upon the application of interim accounting guidance, the tax rate as a percentage of net income after income attributable to non-controlling interests will vary based upon the relative net income from period to period.
Net Income Attributable to Non-Controlling Interests. Net income attributable to non-controlling interests was $51.5 million for the six months ended June 30, 2019 compared to $46.4 million for the six months ended June 30, 2018. As a percentage of revenues, net income attributable to non-controlling interests was 6.0% in the 2019 period and 5.5% for the 2018 period.
Liquidity and Capital Resources
Operating Activities
The primary source of our operating cash flow is the collection of accounts receivable from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and individuals. During the six months ended June 30, 2019, our cash flow provided by operating activities was $47.2 million compared to $69.6 million in the six months ended June 30, 2018 primarily due to the timing of certain payroll and trade payable payments.
Investing Activities
Net cash used in investing activities during the six months ended June 30, 2019 was $42.9 million, which included $31.8 million related to purchases of property and equipment. We paid an additional $13.2 million in cash for acquisitions (net of cash acquired), which primarily included a surgical facility and physician practice. Further, we paid $15.2 million in cash for a non-controlling interest in four surgical facilities accounted for as equity method investments and we received cash proceeds of $17.6 million related to the sale of previously owned real property associated with one of our non-consolidated equity method investments
Net cash used in investing activities during the six months ended June 30, 2018 was $54.8 million, which included $15.9 million related to purchases of property and equipment. We paid $47.9 million in cash for acquisitions (net of cash acquired), which primarily included three surgical facilities, one of which was merged into an existing facility and multiple physician practices. Further, we received cash proceeds of $10.2 million primarily related to the disposal of two surgical facilities.
Financing Activities
Net cash used in financing activities during the six months ended June 30, 2019 was $71.2 million. During this period, we made distributions to non-controlling interest holders of $60.9 million and received cash related to ownership transactions with consolidated affiliates of $1.2 million. Further, we made repayments on our long-term debt of $422.8 million, which was offset by borrowings of $438.9 million. In connection with the issuance of the 2027 Unsecured Notes and redemption of the existing 2021 Unsecured Notes, we paid debt issuance costs of $8.8 million and paid a redemption premium of $17.8 million.


28

Net cash used in financing activities during the six months ended June 30, 2018 was $93.6 million. During this period, we made distributions to non-controlling interest holders of $55.8 million and payments related to ownership transactions with consolidated affiliates of $0.1 million. Further, we made repayments on our long-term debt of $45.4 million offset by borrowings of $21.4 million. In addition, we made preferred dividend payments of $7.8 million and repurchased $2.0 million of our common stock pursuant to our $50 million repurchase program announced on December 15, 2017.
Debt
As of June 30, 2019, the carrying value of our total indebtedness, was $2.455 billion, which includes unamortized fair value discount of $5.3 million and unamortized deferred financing costs of $11.2 million.
Term Loan and Revolving Credit Facility
We have term loan borrowings with a carrying value of $1.441 billion, consisting of outstanding aggregate principal of $1.446 billion and unamortized fair value discount of $5.3 million (the "Term Loan") as of June 30, 2019. The Term Loan matures on August 31, 2024. The Term Loan amortizes in equal quarterly installments of 0.25% of the aggregate original principal amount of the Term Loan.
We have a revolving credit facility providing for revolving borrowings of up to $120.0 million (the "Revolver" and, together with the Term Loan, the "2017 Senior Secured Credit Facilities"). The Revolver will mature on August 31, 2022. As of June 30, 2019, our availability on the Revolver was $115.9 million (including outstanding letters of credit of $4.1 million).
The Revolver may be utilized for working capital, capital expenditures and general corporate purposes. Subject to certain conditions and requirements set forth in the credit agreement, we may request one or more additional incremental term loan facilities or one or more increases in the commitments on the Revolver.
The 2017 Senior Secured Credit Facilities bear interest at a rate per annum equal to (x) LIBOR plus a margin ranging from 3.00% to 3.25% per annum, depending on our first lien net leverage ratio or (y) an alternate base rate (which will be the highest of (i) the prime rate, (ii) 0.5% per annum above the federal funds effective rate and (iii) one-month LIBOR plus 1.00% per annum (solely with respect to the Term Loan, the alternate base rate shall not be less than 2.00% per annum)) plus a margin ranging from 2.00% to 2.25% per annum. In addition, we are required to pay a commitment fee of 0.50% per annum in respect of unused commitments on the Revolver.
Senior Unsecured Notes
On April 11, 2019, we completed the issuance and sale of $430.0 million in gross proceeds of senior unsecured notes due 2027 (the "2027 Unsecured Notes"). The 2027 Unsecured Notes bear interest at the rate of 10.000% per year, payable semi-annually on April 15 and October 15 of each year, beginning on October 15, 2019. In connection with issuance of the 2027 Unsecured Notes, we redeemed in whole the then existing 2021 Unsecured Notes. The redemption price was equal to 104.438% of the outstanding principal amount plus accrued and unpaid interest. Refer to Note 3. "Long-Term Debt" to the Condensed Consolidated Financial Statements elsewhere in this report for further discussion.
We have $370.0 million aggregate principal amount of senior unsecured notes due July 1, 2025 outstanding (the "2025 Unsecured Notes"). The 2025 Unsecured Notes bear interest at the rate of 6.750% per year, payable semi-annually on January 1 and July 1 of each year.
Other Debt
We and certain of our subsidiaries have other debt consisting of outstanding bank indebtedness of $75.9 million, which is collateralized by the real estate and equipment owned by the surgical facilities to which the loans were made, and right-of-use finance lease obligations of $149.2 million for which we are liable to various vendors for several property and equipment leases classified as finance leases.
Summary
Based on our current level of operations, we believe cash flow from operations and available cash, together with available borrowings on the Revolver, will be adequate to meet our short-term (i.e., 12 months) liquidity needs.
Certain Non-GAAP Metrics
Adjusted EBITDA is not a measurement of financial performance under GAAP and should not be considered in isolation or as a substitute for net income, operating income or any other measure calculated in accordance with GAAP. The items excluded from this non-GAAP metric are significant components in understanding and evaluating our financial performance. We believe such adjustments are appropriate, as the magnitude and frequency of such items can vary significantly and are not related to the assessment of normal operating performance. Our calculation of Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.
When we use the term "Adjusted EBITDA," we are referring to income before income taxes, adjusted for net income attributable to non-controlling interests, depreciation and amortization, interest expense, net, equity-based compensation expense, contingent acquisition compensation expense, transaction, integration and acquisition costs, reserve adjustments, net loss on disposals and deconsolidations and tax receivable agreement expense. We use Adjusted EBITDA as a measure of financial performance. Adjusted EBITDA is a key measure used by our management to assess operating performance, make business decisions and allocate resources.


29

The following table reconciles Adjusted EBITDA to income before income taxes, the most directly comparable GAAP financial measure (in millions and unaudited):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Condensed Consolidated Statements of Operations Data:
 
 
 
 
 
 
 
Income before income taxes
$
9.1

 
$
7.6

 
$
14.3

 
$
14.5

Plus (minus):
 
 
 
 
 
 
 
Net income attributable to non-controlling interests
(27.9
)
 
(23.8
)
 
(51.5
)
 
(46.4
)
Depreciation and amortization
19.1

 
16.7

 
37.9

 
32.4

Interest expense, net
46.4

 
35.9

 
88.4

 
70.2

Equity-based compensation expense
3.0

 
2.8

 
4.9

 
4.8

Contingent acquisition compensation expense
—

 
0.5

 
—

 
1.0

Transaction, integration and acquisition costs (1)
8.0

 
12.5

 
11.5

 
18.0

Reserve adjustments (2)
—

 
—

 
—

 
4.8

(Gain) loss on disposals and deconsolidations, net
(8.2
)
 
3.2

 
(7.6
)
 
3.2

Loss on debt extinguishment
11.7

 
—

 
11.7

 
—

Tax receivable agreement expense
—

 
—

 
2.4

 
—

Adjusted EBITDA
$
61.2

 
$
55.4

 
$
112.0

 
$
102.5

(1)
For the three months ended June 30, 2019 and 2018, this amount includes transaction and integration costs of $6.2 million and $11.7 million, respectively, and acquisition costs of $1.2 million and $0.8 million, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $0.6 million for the three months ended June 30, 2019, with no comparable costs in the 2018 period. For the six months ended June 30, 2019 and 2018, this amount includes transaction and integration costs of $8.2 million and $16.7 million, respectively, and acquisition costs of $1.5 million and $1.3 million, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $1.8 million for the six months ended June 30, 2019, with no comparable costs in the 2018 period.
(2)
This amount represents adjustments to revenue in order to apply consistent policies to businesses acquired by Surgery Partners in prior periods.
We use Credit Agreement EBITDA as a measure of liquidity and to determine our compliance under certain covenants pursuant to our credit facilities. Credit Agreement EBITDA is determined on a trailing twelve-month basis. We have included it because we believe that it provides investors with additional information about our ability to incur and service debt and make capital expenditures. Credit Agreement EBITDA is not a measurement of liquidity under GAAP and should not be considered in isolation or as a substitute for any other measure calculated in accordance with GAAP. The items excluded from Credit Agreement EBITDA are significant components in understanding and evaluating our liquidity. Our calculation of Credit Agreement EBITDA may not be comparable to similarly titled measures reported by other companies.
When we use the term “Credit Agreement EBITDA,” we are referring to Adjusted EBITDA, as defined above, further adjusted for other items related to our historical financial performance during the trailing twelve month period, including loss on litigation settlement, reserve adjustments and contingent acquisition compensation expense. Also included are adjustments for acquisitions, which do not relate to our historical financial performance and instead relate to estimates compiled by our management and calculated in conformance with the definition of “Consolidated EBITDA” used in the credit agreements governing our credit facilities.


30

The following table reconciles Credit Agreement EBITDA to cash flows from operating activities, the most directly comparable GAAP financial measure (in millions and unaudited):
 
 
Twelve Months Ended June 30, 2019
 
 
 
Cash flows from operating activities
 
$
122.2

Plus (minus):
 
 
Non-cash interest income, net
 
0.6

Non-cash lease expense
 
(19.6
)
Deferred income taxes
 
(23.5
)
Income from equity investments, net of distributions received
 
(0.5
)
Changes in operating assets and liabilities, net of acquisitions and divestitures
 
16.8

Income tax expense
 
24.1

Net income attributable to non-controlling interests
 
(115.2
)
Interest expense, net
 
165.2

Transaction, integration and acquisition costs
 
27.4

Loss on litigation settlements
 
46.0

Reserve adjustments
 
(2.1
)
Contingent acquisition compensation expense
 
0.5

Tax receivable agreement expense
 
2.4

Acquisitions (1)
 
37.4

Credit Agreement EBITDA
 
$
281.7

(1)
This includes revenue synergies from other business initiatives and an adjustment for the effects of adopting the new lease accounting standard, as defined in the Credit Agreement.
Recent Accounting Pronouncements
Please refer to Note 1. "Organization and Summary of Accounting Policies" to our condensed consolidated financial statements included elsewhere in this report for a discussion of the impact of the adoption of recently issued accounting standards.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We are subject to market risk primarily from exposure to changes in interest rates based on our financing, investing and cash management activities. We utilize a balanced mix of maturities along with both fixed rate and variable rate debt to manage our exposures to changes in interest rates. Additionally, we periodically enter into interest rate swap agreements to manage our exposure to interest rate fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income.
Our variable rate debt instruments are primarily indexed to the prime rate or LIBOR. Interest rate changes would result in gains or losses in the market value of our fixed rate debt portfolio due to differences in market interest rates and the rates at the inception of the debt agreements. Based on our indebtedness and the effect of our interest rate swap agreements at June 30, 2019, a 100 basis point interest rate change would impact our net earnings and cash flow by approximately $2.5 million annually. Although there can be no assurances that interest rates will not change significantly, we do not expect changes in interest rates to have a material effect on our net earnings or cash flows in 2019 based on our indebtedness at June 30, 2019.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
An evaluation was performed under the supervision and with the participation of our management, including the chief executive officer and the chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended) as of June 30, 2019. Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective.


31

Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended June 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


32

PART II - OTHER INFORMATION
Item 1. Legal Proceedings
Stockholder Litigation. On December 4, 2017, a purported Company stockholder filed an action in the Delaware Court of Chancery (the “Delaware Action”). That action is captioned Klein v. H.I.G. Capital, L.L.C., et al., C.A. No. 2017-0862. The plaintiff in the Delaware Action asserted claims against (i) certain current and former members of the Company’s Board of Directors (together, the “Directors”); (ii) H.I.G. Capital, LLC and certain of its affiliates (collectively, “H.I.G.”); and (iii) Bain Capital Private Equity, L.P. and certain of its affiliates (collectively, “Bain Capital” and, together with the Directors and H.I.G., the “Defendants”). The plaintiff asserted derivative claims on behalf of the Company, which is a nominal defendant in the Delaware Action, as well as putatively direct claims on behalf of a purported class of Company stockholders. The plaintiff in the Delaware Action asserted that the Defendants breached their fiduciary duties in connection with the transactions in which (i) the Company acquired National Surgical Healthcare; (ii) Bain Capital acquired preferred equity in the Company; and (iii) Bain Capital acquired H.I.G.’s equity stake in the Company, and that, in the alternative, Bain Capital aided and abetted those purported breaches. The plaintiff also asserted an unjust enrichment claim against Bain Capital.
On January 2, 2018, the Defendants moved to dismiss the plaintiff’s complaint. On December 19, 2018, the Court of Chancery issued a decision on that motion. Following that decision, all of the Directors have been dismissed from the Delaware Action. The Court did not dismiss the plaintiff’s breach of fiduciary duty claim against H.I.G. or the aiding and abetting claim asserted against Bain Capital. However, the Court dismissed the plaintiff’s breach of fiduciary duty and unjust enrichment claims against Bain Capital. In addition, the Court dismissed all of the plaintiff’s claims that were asserted on behalf of a putative class of Company stockholders. Accordingly, all of the plaintiff’s remaining claims in the Delaware Action are asserted derivatively on the Company’s behalf.
Government Investigation. On October 23, 2017, the Company received several civil investigative demands (“CIDs”) from the federal government under the False Claims Act (“FCA”) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company’s physicians and submitted to laboratories owned and operated by the Company. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS.
The Company has been providing information to the government in response to the CIDs and currently has a non-binding agreement in principle with the DOJ on the financial terms of a settlement with the goal of resolving these matters. Based on those discussions, which are still ongoing, we recorded a litigation-related charge of $46.0 million relating to these matters on the consolidated statements of operations for the year ended December 31, 2018. We believe that this reserve is sufficient to cover a potential resolution with the government relating to these matters, including legal expenses relating to the settlement that have not previously been recorded in our operating expenses. The ultimate timing, amount and/or final terms of any such resolution may differ materially from those anticipated or we may not be able to reach a resolution at all. It is reasonably possible that we will incur additional losses above the amount reserved, but we are not able to estimate such amounts at this time. See Item 1A “Risk Factors” in our Annual Report on Form 10-K for the period ended December 31, 2018 under the heading “Risk Factors - Risks Related to Government Regulation - Companies within the healthcare industry, including us, continue to be the subject of federal and state audits and investigations, including actions for false and other improper claims.” 
Other Litigation. In addition, we are, from time to time, subject to claims and suits, or threats of claims or suits, relating to our business, including claims for damages for personal injuries, breach of management contracts and employment related claims. In certain of these actions, plaintiffs request payment for damages, including punitive damages, which may not be covered by insurance or may otherwise have a material adverse effect on our business or results of operations.
See Note 9. "Commitments and Contingencies" for additional information regarding pending legal proceedings, which information is incorporated herein by reference.
Item 1A. Risk Factors
There have been no material changes with respect to the risk factors discussed in the Annual Report on Form 10-K for the period ended December 31, 2018.


33

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information related to our repurchases of common stock for the periods indicated:
 
 
Total Number of Shares Purchased (1)
 
Average Price Paid per Share
 
Total Number of Shares Purchased as Part of Publicly Announced Programs (2)
 
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
(dollars in millions, except per share amounts)
 
 
 
 
 
 
 
 
April 1, 2019 to April 30, 2019
 
1,198

 
$
11.54

 
—

 
$
46.0

May 1, 2019 to May 31, 2019
 
984

 
$
10.78

 
—

 
$
46.0

June 1, 2019 to June 30, 2019
 
—

 
$
—

 
—

 
$
46.0

Total
 
2,182

 
$
11.20

 
—

 
$
46.0

(1) 
Includes shares delivered to or withheld by us in connection with employee payroll tax withholding upon exercise or vesting of stock awards.
(2) 
Made pursuant to the $50 million share repurchase program authorized by our Board of Directors on December 15, 2017. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.




34

Item 6. Exhibits
No.
 
Description
 
 
 
4.1
 
10.1
 
31.1
 
31.2
 
32.1
 
101.INS
 
XBRL Instance Document
101.SCH
 
XBRL Taxonomy Extension Schema Document
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document


35

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SURGERY PARTNERS, INC.
 
 
By:
/s/ Thomas F. Cowhey
Thomas F. Cowhey
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: August 9, 2019


36
 EX-10.1 2 a2019q2exhibit101.htm EXHIBIT 10.1 Exhibit


Exhibit 10.1
First Amendment to the
Surgery Partners, Inc.
2015 Omnibus Incentive Plan

This Amendment to the Surgery Partners, Inc. 2015 Omnibus Incentive Plan (the “Plan”) is adopted by Surgery Partners, Inc. (the “Company”), effective as of May 29, 2019.

WHEREAS, the Company has established the Plan through which the Company may grant awards of stock options, stock appreciation rights, restricted stock and other stock-based awards to directors, officers and other employees of the Company and its subsidiaries, as well as other persons performing consulting or advisory services for the Company; and

WHEREAS, the Company desires to amend the Plan to increase the total number of shares that may be granted pursuant to the Plan by 3,500,000 shares, resulting in a total of 8,315,700 shares that may be granted under the Plan.

NOW, THEREFORE, the Plan is hereby amended by deleting the first sentence of Section 4(a) in its entirety and inserting the following in its place and stead:

“Subject to adjustment as provided in Section 7, the maximum number of shares of Stock that may be delivered in satisfaction of Awards under the Plan is 8,315,700 shares.”

IN WITNESS WHEREOF, this Amendment is hereby executed by the undersigned officer of the Company, to be effective as of the date first written above.

Surgery Partners, Inc.
     

By:      /s/ Jennifer Baldock
Name:     Jennifer Baldock
Title:
EVP & Chief Legal Officer



 EX-31.1 3 a2019q2exhibit311.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1

CERTIFICATIONS

I, Wayne S. DeVeydt, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


By:
/s/ Wayne S. DeVeydt
Wayne S. DeVeydt
Chief Executive Officer
Date: August 9, 2019




EX-31.2 4 a2019q2exhibit312.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2

CERTIFICATIONS

I, Thomas F. Cowhey, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Surgery Partners, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


By:
/s/ Thomas F. Cowhey
Thomas F. Cowhey
Executive Vice President and Chief Financial Officer
Date: August 9, 2019


 EX-32.1 5 a2019q2exhibit321.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Surgery Partners, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certifies, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)
The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

By:
/s/ Wayne S. DeVeydt
Wayne S. DeVeydt
Chief Executive Officer
Date: August 9, 2019

By:
/s/ Thomas F. Cowhey
Thomas F. Cowhey
Executive Vice President and Chief Financial Officer
Date: August 9, 2019





EX-101.INS 6 sgry-20190630.xml XBRL INSTANCE DOCUMENT 0001638833 2019-01-01 2019-06-30 0001638833 2019-08-05 0001638833 2018-12-31 0001638833 2019-06-30 0001638833 2018-04-01 2018-06-30 0001638833 2018-01-01 2018-06-30 0001638833 2019-04-01 2019-06-30 0001638833 2019-01-01 2019-03-31 0001638833 us-gaap:NoncontrollingInterestMember 2018-12-31 0001638833 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001638833 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001638833 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001638833 us-gaap:RetainedEarningsMember 2018-03-31 0001638833 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0001638833 us-gaap:RetainedEarningsMember 2019-06-30 0001638833 us-gaap:RetainedEarningsMember 2017-12-31 0001638833 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001638833 us-gaap:RetainedEarningsMember 2019-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001638833 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-03-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001638833 2017-12-31 0001638833 us-gaap:CommonStockMember 2018-12-31 0001638833 us-gaap:CommonStockMember 2017-12-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001638833 us-gaap:NoncontrollingInterestMember 2018-06-30 0001638833 us-gaap:CommonStockMember 2019-06-30 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001638833 2018-01-01 2018-03-31 0001638833 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001638833 us-gaap:CommonStockMember 2018-06-30 0001638833 2018-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001638833 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001638833 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001638833 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001638833 us-gaap:RetainedEarningsMember 2019-01-01 0001638833 us-gaap:NoncontrollingInterestMember 2019-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001638833 2018-06-30 0001638833 us-gaap:NoncontrollingInterestMember 2017-12-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001638833 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001638833 us-gaap:CommonStockMember 2018-03-31 0001638833 2019-03-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001638833 us-gaap:NoncontrollingInterestMember 2018-04-01 2018-06-30 0001638833 us-gaap:RetainedEarningsMember 2018-12-31 0001638833 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001638833 us-gaap:NoncontrollingInterestMember 2019-06-30 0001638833 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001638833 us-gaap:CommonStockMember 2019-03-31 0001638833 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001638833 us-gaap:RetainedEarningsMember 2018-06-30 0001638833 us-gaap:NoncontrollingInterestMember 2018-03-31 0001638833 2019-01-01 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-04-01 2018-06-30 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-04-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-04-01 2018-06-30 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-06-30 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-06-30 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-04-01 2019-06-30 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-04-01 2018-06-30 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-06-30 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-06-30 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-04-01 2018-06-30 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-06-30 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-06-30 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-04-01 2018-06-30 0001638833 sgry:OtherServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-06-30 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-04-01 2019-06-30 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-06-30 0001638833 sgry:AncillaryServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-04-01 2019-06-30 0001638833 sgry:SurgicalFacilityServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-04-01 2018-06-30 0001638833 sgry:OpticalServicesMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationOtherServiceMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-04-01 2019-06-30 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2018-01-01 2018-06-30 0001638833 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001638833 sgry:OtherServicesMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember 2019-01-01 2019-06-30 0001638833 sgry:OpticalServicesMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember 2018-01-01 2018-06-30 0001638833 sgry:OtherServicesMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember 2018-01-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember 2018-01-01 2018-06-30 0001638833 sgry:OpticalServicesMember 2019-01-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember 2019-01-01 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017TermLoanMaturing2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SeniorNotesMember 2019-06-30 0001638833 us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember 2019-06-30 0001638833 sgry:FacilitiesSurgicalHospitalsMember 2019-06-30 0001638833 us-gaap:FairValueInputsLevel1Member 2019-06-30 0001638833 sgry:FacilitiesAmbulatorySurgeryCentersMember 2019-06-30 0001638833 us-gaap:VariableInterestEntityPrimaryBeneficiaryAggregatedDisclosureMember 2018-12-31 0001638833 us-gaap:FairValueInputsLevel1Member 2018-12-31 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember 2018-04-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember 2018-04-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember 2018-04-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember 2019-04-01 2019-06-30 0001638833 sgry:OtherServicesMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember 2018-04-01 2018-06-30 0001638833 sgry:OtherServicesMember 2018-04-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:GovernmentMember 2018-04-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:GovernmentMember 2018-04-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:OtherPatientServiceRevenueSourcesMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:OtherPatientServiceRevenueSourcesMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember us-gaap:SelfPayMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember sgry:PrivateInsuranceMember 2018-04-01 2018-06-30 0001638833 sgry:OpticalServicesMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SelfPayMember 2018-04-01 2018-06-30 0001638833 sgry:OpticalServicesMember 2018-04-01 2018-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember 2019-04-01 2019-06-30 0001638833 sgry:HealthcareOrganizationPatientServiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember sgry:PrivateInsuranceMember 2018-04-01 2018-06-30 0001638833 sgry:SurgicalFacilityAndPhysicianPracticeMember 2019-06-30 0001638833 sgry:SurgicalFacilityAndPhysicianPracticeMember 2019-01-01 2019-06-30 0001638833 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2019-01-01 2019-06-30 0001638833 sgry:SurgicalFacilityAndPhysicianPracticeMember sgry:AncillaryServicesMember 2019-06-30 0001638833 sgry:SurgicalFacilityMember 2019-01-01 2019-06-30 0001638833 sgry:OtherAcquisitionsNoncontrollingInterestMember 2019-06-30 0001638833 sgry:SurgicalFacilityAndPhysicianPracticeMember sgry:SurgicalFacilityServicesMember 2019-06-30 0001638833 sgry:OtherAcquisitionsNoncontrollingInterestMember 2019-01-01 2019-06-30 0001638833 sgry:PhysicianPracticeMember 2019-01-01 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:DebtInstrumentRedemptionPeriodFourMember us-gaap:SeniorNotesMember 2019-04-11 2019-04-11 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:DebtInstrumentRedemptionPeriodFiveMember us-gaap:SeniorNotesMember 2019-04-11 2019-04-11 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:SeniorNotesMember 2019-04-11 2019-04-11 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:SeniorNotesMember 2019-04-11 2019-04-11 0001638833 us-gaap:LetterOfCreditMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:SecuredDebtMember 2019-06-30 0001638833 sgry:A2017TermLoanMaturing2024Member us-gaap:SecuredDebtMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember 2019-04-01 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:SeniorNotesMember 2019-06-30 0001638833 sgry:A2017TermLoanMaturing2024Member us-gaap:SecuredDebtMember 2018-12-31 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:SecuredDebtMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:SeniorNotesMember 2019-04-11 2019-04-11 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:SecuredDebtMember 2019-04-11 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:SeniorNotesMember 2019-04-11 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:SeniorNotesMember 2019-04-11 2019-04-11 0001638833 sgry:SeniorUnsecuredNotesDue2027Member sgry:DebtInstrumentRedemptionPeriodSixMember us-gaap:SeniorNotesMember 2019-04-11 2019-04-11 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember 2019-04-11 2019-04-11 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:SeniorNotesMember 2019-06-30 0001638833 sgry:NotesPayableAndSecuredLoansMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2027Member us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:NotesPayableAndSecuredLoansMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember 2019-06-30 0001638833 sgry:SeniorUnsecuredNotesDue2025Member us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember 2018-12-31 0001638833 sgry:SeniorUnsecuredNotesDue2021Member us-gaap:SeniorNotesMember 2019-01-01 2019-06-30 0001638833 us-gaap:RevolvingCreditFacilityMember sgry:A2017RevolverLoanMaturing2022Member us-gaap:SecuredDebtMember 2018-12-31 0001638833 srt:MaximumMember 2019-06-30 0001638833 us-gaap:InvestorMember 2019-01-01 2019-06-30 0001638833 srt:MinimumMember 2019-06-30 0001638833 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-06-30 0001638833 us-gaap:SeriesAPreferredStockMember 2019-06-30 0001638833 us-gaap:SeriesAPreferredStockMember 2018-12-31 0001638833 us-gaap:MajorityShareholderMember us-gaap:SeriesAPreferredStockMember 2017-08-31 2017-08-31 0001638833 us-gaap:MajorityShareholderMember us-gaap:SeriesAPreferredStockMember 2017-08-31 0001638833 us-gaap:InterestRateSwapMember 2019-06-30 0001638833 2017-12-15 0001638833 us-gaap:RestrictedStockMember 2019-01-01 2019-06-30 0001638833 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-06-30 0001638833 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001638833 us-gaap:EmployeeStockOptionMember 2018-04-01 2018-06-30 0001638833 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001638833 us-gaap:RestrictedStockMember 2019-04-01 2019-06-30 0001638833 us-gaap:RestrictedStockMember 2018-04-01 2018-06-30 0001638833 us-gaap:RestrictedStockMember 2018-01-01 2018-06-30 0001638833 2018-01-01 2018-12-31 0001638833 sgry:MateriallyMoreRestrictiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-06-30 0001638833 sgry:NotMateriallyMoreRestrictiveMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-01-01 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2019-01-01 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2018-01-01 2018-06-30 0001638833 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2019-01-01 2019-06-30 0001638833 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2018-01-01 2018-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2018-04-01 2018-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2018-04-01 2018-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2018-01-01 2018-06-30 0001638833 us-gaap:CorporateNonSegmentMember 2018-04-01 2018-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2019-04-01 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2019-04-01 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2018-04-01 2018-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2019-01-01 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2019-04-01 2019-06-30 0001638833 us-gaap:CorporateNonSegmentMember 2019-04-01 2019-06-30 0001638833 us-gaap:CorporateNonSegmentMember 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2018-12-31 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2018-12-31 0001638833 us-gaap:OperatingSegmentsMember sgry:SurgicalFacilityServicesMember 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:AncillaryServicesMember 2019-06-30 0001638833 us-gaap:OperatingSegmentsMember sgry:OpticalServicesMember 2018-12-31 0001638833 us-gaap:CorporateNonSegmentMember 2018-12-31 sgry:Anesthesia_Practice sgry:swap sgry:surgical_facility xbrli:pure sgry:physician_practice iso4217:USD xbrli:shares xbrli:shares sgry:option_to_renew sgry:state iso4217:USD sgry:segment false --12-31 Q2 2019 2019-06-30 10-Q 0001638833 49476880 Yes false Accelerated Filer Surgery Partners, Inc. false false 0 1200000000 500000 1000000 0 0 12500000 18000000 8000000 11500000 48500000 53900000 55400000 -21800000 1000000 700000 75500000 102500000 -43100000 2100000 1500000 142000000 61200000 -19000000 1400000 400000 78400000 112000000 -38300000 2600000 900000 146800000 4 16600000 3200000 -3200000 -3200000 8200000 7600000 10900000 439100000 149800000 0 431100000 1 800000 2000000 -1200000 -25200000 -7700000 -17500000 14100000 8000000 6100000 2000000 9600000 -7600000 700000 -100000 128 113 15 107 85 8500000 10000000 19700000 -7700000 0 600000 0 0 0 2400000 4800000 7500000 7900000 15700000 8800000 17300000 3 4 3 20000000 17500000 83300000 71700000 307600000 301900000 56100000 75100000 -22400000 -50700000 673500000 677800000 7800000 7800000 7900000 7900000 8500000 8500000 8800000 8800000 0 19600000 161000 86000 144000 83000 0 25000 0 27000 4676300000 399200000 52700000 20100000 4204300000 4890900000 343500000 80100000 21800000 4445500000 588300000 529000000 8300000 800000 1300000 1200000 1500000 11700000 16700000 6200000 8200000 1400000 500000 100000 1000000 21700000 21700000 28900000 8800000 1500000 2900000 4700000 6700000 4300000 3500000 25400000 184300000 117400000 175200000 96400000 184600000 117700000 -78800000 -66900000 11600000 0.01 0.01 300000000 300000000 48869204 49502893 48687000 48898000 48902000 48869204 48869000 49386000 49502893 49503000 500000 500000 -19500000 -37000000 -36600000 -68200000 23800000 46400000 27900000 51500000 4300000 9400000 -8700000 -16700000 0.049 0.025 1 0.048 0.535 0.386 0.031 0.975 0.006 0.019 0.926 1 0.049 0.021 1 0.047 0.535 0.387 0.031 0.979 0.007 0.014 0.930 1 0.046 0.013 1 0.049 0.524 0.405 0.022 0.987 0.002 0.011 0.941 1 0.047 0.013 1 0.049 0.524 0.403 0.024 0.987 0.002 0.011 0.940 1 340100000 667400000 340400000 666500000 51000000 18000000 18000000 0.05 0.03 430000000.0 0.1 1.04438 1.01 1 1.025 1.1 1.0500 1 0.4 5500000 5300000 2900000 11200000 6700000 1400000 1000000 8800000 3800000 2000000 64600000 68200000 109200000 99500000 7600000 8000000 16700000 32400000 19100000 37900000 0 0 1500000 2800000 22400000 50700000 0 0 -0.57 -1.10 -0.59 -1.19 -0.57 -1.10 -0.59 -1.19 0.24 55200000 45900000 12000000 12000000 7300000 7300000 25400000 149200000 7000000 13100000 149800000 136100000 294000000 187600000 15200000 19100000 21400000 24400000 26300000 144800000 5200000 146100000 9300000 0.105 P13Y0M28D -46000000 0 0 -11700000 -11700000 -11700000 -11700000 26100000 50300000 23300000 45000000 3382800000 3402300000 19900000 8500000 11400000 19500000 7600000 14500000 9100000 14300000 2500000 4400000 2200000 4200000 200000 -100000 3300000 5100000 1000000 2700000 -12800000 -6900000 -4100000 40000000 54300000 53600000 -35900000 -70200000 -46400000 -88400000 20800000 22400000 43400000 44000000 78500000 93400000 134100000 263800000 132700000 261900000 57000000 P7Y P5Y 442500000 195800000 35400000 46600000 49900000 55100000 59700000 152600000 P10Y 4676300000 4890900000 349300000 368800000 0 0 45000000 4100000 115900000 42300000 42000000 1382800000 1447900000 1447900000 407200000 406700000 406700000 320500000 370000000 370000000 0 79400000 1386800000 1440800000 1440800000 0 0 0 324700000 370000000 370000000 427900000 430000000 430000000 75900000 2270900000 2397400000 55600000 57300000 2326500000 2454700000 694300000 686300000 22500000 22500000 16800000 0 16800000 23500000 23500000 17700000 17700000 -93600000 -71200000 -54800000 -42900000 69600000 47200000 -19500000 -37000000 -19800000 -39900000 23800000 46400000 27900000 51500000 16800000 -27400000 -52700000 -28600000 -57200000 -1600000 15900000 -17500000 -2900000 16600000 -19500000 -4100000 16000000 -20100000 -1100000 18700000 -19800000 1000 1 4 3 31 393100000 763200000 389900000 757100000 43500000 84700000 55500000 105100000 34400000 10200000 289900000 0 34800000 0 255100000 32800000 0 285000000 0.103 P8Y5M20D 812500000 81500000 57200000 61300000 66700000 75600000 470200000 21800000 43200000 21000000 41600000 72100000 77200000 36900000 28000000 36900000 313000000 0 0 -11500000 -11500000 -16800000 -16800000 -28300000 26300000 52400000 26900000 53100000 155200000 193900000 271300000 387100000 -2200000 -2400000 -400000 -400000 121500000 132000000 1200000 300000 2000000 0 0 17800000 0 8800000 55800000 60900000 7800000 0 13400000 47900000 13200000 13200000 0 15200000 14000000 15900000 2400000 300000 13200000 31800000 6200000 300000 25300000 0.01 0.01 164.64 20000000 20000000 0 0 0 0 0 0 53000000 65700000 21400000 438900000 -3900000 -1000000 -100000 1200000 10200000 17600000 36700000 72400000 36400000 71500000 4300000 9400000 8100000 11600000 426300000 400100000 326600000 316000000 359300000 376600000 45400000 422800000 300000 300000 -247000000 -268900000 436600000 20800000 2800000 413000000 425300000 20600000 227700000 163900000 13100000 2800000 8500000 847900000 40800000 5800000 801300000 830000000 38900000 444200000 321000000 25900000 5800000 12100000 445400000 20400000 1000000 424000000 439500000 21400000 230500000 178100000 9500000 1000000 4900000 862200000 40300000 2100000 819800000 850300000 41200000 445800000 343000000 20300000 2100000 9800000 5000000 5000000 18200000 19400000 2800000 4800000 3000000 4900000 1000 310000 368000 4000 517000 117000 310000000 1300000 1300000 2500000 2500000 900000 900000 3100000 3100000 50000000.0 46000000 157000 2000000 2000000 404600000 358700000 1336600000 0 695500000 500000 681900000 -41300000 1304800000 0 689000000 500000 674100000 -58800000 1254500000 0 675900000 500000 656400000 -78300000 1098900000 -22400000 673500000 500000 694300000 -247000000 1084300000 -33900000 673900000 500000 692900000 -249100000 1045000000 -50700000 677800000 500000 686300000 -268900000 121200000 235600000 123400000 238400000 17300000 359300000 359300000 376600000 376600000 310000 310000 310000 310000 310000 310000 12.64 156818 0 7900000 15700000 8800000 17300000 0 0 18300000 31100000 0 4800000 0 0 11200000 24800000 3600000 17200000 6000000 0 0 0 0 48016000 48012000 48291000 48241000 48016000 48012000 48291000 48241000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Balance Sheets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">285.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment, net of accumulated depreciation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">146.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total leased assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">431.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">136.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">439.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Non-Controlling Interests&#8212;Redeemable</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#8212;</font><font style="font-family:inherit;font-size:9pt;">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Redeemable Preferred Stock</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On August 31, 2017, the Company issued </font><font style="font-family:inherit;font-size:9pt;">310,000</font><font style="font-family:inherit;font-size:9pt;"> shares of Series A Preferred Stock to Bain at a purchase price of </font><font style="font-family:inherit;font-size:9pt;">$1,000</font><font style="font-family:inherit;font-size:9pt;"> per share for an aggregate purchase price of </font><font style="font-family:inherit;font-size:9pt;">$310.0 million</font><font style="font-family:inherit;font-size:9pt;"> (the "Preferred Private Placement").</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the redeemable preferred stock follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">359.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividends accrued (there were no cash dividends declared)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">376.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">There were </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> unpaid cash dividends declared at both </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">. The aggregate and per share amounts of unpaid cumulative preferred dividends as of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> was </font><font style="font-family:inherit;font-size:9pt;">$51.0 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$164.64</font><font style="font-family:inherit;font-size:9pt;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> Organization and Summary of Accounting Policies</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:12px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">, the Company owned or operated a portfolio of </font><font style="font-family:inherit;font-size:9pt;">128</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, comprised of </font><font style="font-family:inherit;font-size:9pt;">113</font><font style="font-family:inherit;font-size:9pt;"> ASCs and </font><font style="font-family:inherit;font-size:9pt;">15</font><font style="font-family:inherit;font-size:9pt;"> surgical hospitals in </font><font style="font-family:inherit;font-size:9pt;">31</font><font style="font-family:inherit;font-size:9pt;"> states. The Company owns these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves.&#160;The Company owned a majority interest in </font><font style="font-family:inherit;font-size:9pt;">85</font><font style="font-family:inherit;font-size:9pt;"> of the surgical facilities and consolidated </font><font style="font-family:inherit;font-size:9pt;">107</font><font style="font-family:inherit;font-size:9pt;"> of these facilities for financial reporting purposes.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company&#8217;s fiscal year ends on December&#160;31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company&#8217;s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Variable Interest Entities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of June 30, 2019, the consolidated VIEs include </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities, </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> anesthesia practices and </font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;"> physician practices.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, were </font><font style="font-family:inherit;font-size:9pt;">$24.8 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$11.2 million</font><font style="font-family:inherit;font-size:9pt;">, respectively, and the total liabilities of the consolidated VIEs were </font><font style="font-family:inherit;font-size:9pt;">$17.2 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$3.6 million</font><font style="font-family:inherit;font-size:9pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level&#160;1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,440.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,447.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,386.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,382.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">407.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">324.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">320.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2027</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">430.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">427.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair values in the table above were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values under Level 3 calculations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activities"). The fair value of these derivative instruments was </font><font style="font-family:inherit;font-size:9pt;">$50.7 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$22.4 million</font><font style="font-family:inherit;font-size:9pt;"> at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP assets and liabilities were based on quoted market prices, or Level 1 computations. As of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, the fair value of both the assets and liabilities in the SERP were </font><font style="font-family:inherit;font-size:9pt;">$1.0 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$1.4 million</font><font style="font-family:inherit;font-size:9pt;">, respectively, and were included in other long-term assets and other long-term liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of revenues by service type as a percentage of total revenues follows:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Surgical facilities revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">92.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Ancillary services revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">97.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">97.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Other revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Patient service revenues. </font><font style="font-family:inherit;font-size:9pt;">This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Other service revenues.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:9pt;"> Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">230.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">227.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">178.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">163.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">439.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">425.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">436.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">444.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">343.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">321.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">850.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">830.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">862.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">847.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash, Cash Equivalents and Restricted Cash</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes </font><font style="font-family:inherit;font-size:9pt;">$0.3 million</font><font style="font-family:inherit;font-size:9pt;"> of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and December 31, 2018. These restricted investments represent restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities&#8217; cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, the Company had a net third-party Medicaid settlements liability of </font><font style="font-family:inherit;font-size:9pt;">$7.5 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$4.8 million</font><font style="font-family:inherit;font-size:9pt;">, respectively, included in other current liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient&#8217;s insurance prior to the patient&#8217;s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets. Such receivables were </font><font style="font-family:inherit;font-size:9pt;">$10.0 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$8.5 million</font><font style="font-family:inherit;font-size:9pt;"> at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions for the </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> is included in Note 2. "Acquisitions."</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to goodwill for the </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,382.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisitions, including post acquisition adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,402.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative Instruments and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with Accounting Standards Codification 815, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:9pt;">, the Company records all derivatives on the balance sheet at fair value.&#160;The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Non-Controlling Interests&#8212;Redeemable</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively.&#160;In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners&#8217; or physician minority members&#8217;, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility.&#160;The non-controlling interests</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">&#8212;</font><font style="font-family:inherit;font-size:9pt;">redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the non-controlling interests&#8212;redeemable is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">326.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests&#8212;redeemable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition and disposal of shares of non-controlling interests, net&#8212;redeemable </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.7</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Distributions to non-controlling interest&#8212;redeemable holders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">316.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes post acquisition date adjustments.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in healthcare regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company&#8217;s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was </font><font style="font-family:inherit;font-size:9pt;">$18.0 million</font><font style="font-family:inherit;font-size:9pt;"> reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company&#8217;s financial statements and related footnotes are complete and accurate and are adequately reviewed by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Acquisitions</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">, the Company acquired a controlling interest in </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;"> surgical facility and a physician practice for a combined cash purchase price of </font><font style="font-family:inherit;font-size:9pt;">$13.2 million</font><font style="font-family:inherit;font-size:9pt;">, net of cash acquired. The acquisitions were funded through cash from operations. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2018. The goodwill acquired was primarily allocated to the Company's reportable segments as follows: </font><font style="font-family:inherit;font-size:9pt;">$11.4 million</font><font style="font-family:inherit;font-size:9pt;"> to surgical facility services and </font><font style="font-family:inherit;font-size:9pt;">$8.5 million</font><font style="font-family:inherit;font-size:9pt;"> to ancillary services. The results of operations of the acquisitions were included in the Company&#8217;s results of operations beginning on the dates of acquisition and were not considered significant for the </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Acquisitions and Dispositions</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the six months ended June 30, 2019, the Company acquired a non-controlling interest in </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> surgical facilities for a cash investment of </font><font style="font-family:inherit;font-size:9pt;">$14.0 million</font><font style="font-family:inherit;font-size:9pt;">. The non-controlling interest was accounted for as an equity method investment and recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the six months ended June 30, 2019, the Company disposed of previously owned real property associated with one of its existing non-consolidated surgical facilities. In connection with the sale, the Company recognized a </font><font style="font-family:inherit;font-size:9pt;">$10.9 million</font><font style="font-family:inherit;font-size:9pt;"> pretax gain included in (gain) loss on disposals and deconsolidations, net in the accompanying condensed consolidated statements of operations. The sale did not impact the Company's investment in the surgical facility, which continues to be accounted for as an equity method investment.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash, Cash Equivalents and Restricted Cash</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes </font><font style="font-family:inherit;font-size:9pt;">$0.3 million</font><font style="font-family:inherit;font-size:9pt;"> of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and December 31, 2018. These restricted investments represent restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Professional, General and Workers' Compensation Liability Risks</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains general liability and professional liability insurance in excess of self-insured retentions, on a claims-made basis through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. The Company also maintains workers' compensation insurance, subject to a deductible. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Insurance Reserves</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company expenses the costs under the self-insured retention exposure for general and professional liability and workers' compensation claims which relate to (i)&#160;claims made during the policy period, which are offset by insurance recoveries and (ii)&#160;an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions are based upon periodic actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Reserves for professional, general and workers' compensation claim liabilities are determined with no regard for expected insurance recoveries and are presented gross on the condensed consolidated balance sheets. Total professional, general and workers' compensation claim liabilities as of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;"> were </font><font style="font-family:inherit;font-size:9pt;">$19.4 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$18.2 million</font><font style="font-family:inherit;font-size:9pt;">, respectively. The balances include expected insurance recoveries of </font><font style="font-family:inherit;font-size:9pt;">$12.0 million</font><font style="font-family:inherit;font-size:9pt;"> at each of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Laws and Regulations</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On October 23, 2017, the Company received several civil investigative demands (&#8220;CIDs&#8221;) from the federal government under the False Claims Act (&#8220;FCA&#8221;) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company&#8217;s physicians and submitted to laboratories owned and operated by the Company. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has been providing information to the government in response to the CIDs and currently has a non-binding agreement in principle with the DOJ on the financial terms of a settlement with the goal of resolving these matters. Based on those discussions, which are still ongoing, the Company recorded a litigation-related charge of </font><font style="font-family:inherit;font-size:9pt;">$46.0 million</font><font style="font-family:inherit;font-size:9pt;"> relating to these matters on the consolidated statements of operations for the year ended December 31, 2018. The Company believes that this reserve is sufficient to cover a potential resolution with the government relating to these matters, including legal expenses relating to the settlement that have not previously been recorded in operating expenses. The ultimate timing, amount and/or final terms of any such resolution may differ materially from those anticipated or the Company may not be able to reach a resolution at all. It is reasonably possible that the Company will incur additional losses above the amount reserved, but the Company is not able to estimate such amounts at this time. See Item 1A &#8220;Risk Factors&#8221; in the Company's Annual Report on Form 10-K for the period ended December 31, 2018 under the heading &#8220;Risk Factors - Risks Related to Government Regulation -&#160;</font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Companies within the healthcare industry, including us, continue to be the subject of federal and state audits and investigations, including actions for false and other improper claims</font><font style="font-family:inherit;font-size:9pt;">.&#8221;&#160;</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Acquired Facilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Potential Physician Investor Liability</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Tax Receivable Agreement</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September&#160;30, 2015 (as amended, the &#8220;TRA&#8221;), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company&#8217;s projected realized tax savings over the next six years and are not dependent on the Company&#8217;s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA and such inability is a result of the terms of credit agreements and other debt documents that are materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus </font><font style="font-family:inherit;font-size:9pt;">500</font><font style="font-family:inherit;font-size:9pt;"> basis points until paid. If the terms of such credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus </font><font style="font-family:inherit;font-size:9pt;">300</font><font style="font-family:inherit;font-size:9pt;"> basis points until paid.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Assuming the Company&#8217;s effective tax rate is </font><font style="font-family:inherit;font-size:9pt;">24%</font><font style="font-family:inherit;font-size:9pt;">, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates that the total remaining amounts payable under the TRA was approximately </font><font style="font-family:inherit;font-size:9pt;">$68.2 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$64.6 million</font><font style="font-family:inherit;font-size:9pt;"> as of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company&#8217;s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was </font><font style="font-family:inherit;font-size:9pt;">$53.9 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$48.5 million</font><font style="font-family:inherit;font-size:9pt;"> as of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively. The current portion of the liability was </font><font style="font-family:inherit;font-size:9pt;">$8.0 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$7.6 million</font><font style="font-family:inherit;font-size:9pt;"> as of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and December 31, 2018, respectively, and was included as a component of other current liabilities in the condensed consolidated balance sheet. The long-term portion was included as a component of other long-term liabilities in the condensed consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Variable Interest Entities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company may redeem the 2027 Unsecured Notes, in whole or in part, at any time on or after April 15, 2022, at the redemption prices set forth below (expressed as a percentage of the principal amount of notes to be redeemed), plus accrued and unpaid interest, if any, to, but excluding, the date of redemption:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">April 15, 2022 to April 14, 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">105.000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">April 15, 2023 to April 14, 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">102.500</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">April 15, 2024 and thereafter</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivatives and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;">Cash Flow Hedges of Interest Rate Risk</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During </font><font style="font-family:inherit;font-size:9pt;">2019</font><font style="font-family:inherit;font-size:9pt;">, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. Over the next 12 months, the Company estimates that an additional </font><font style="font-family:inherit;font-size:9pt;">$11.6 million</font><font style="font-family:inherit;font-size:9pt;"> will be reclassified as an increase to interest expense.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">As of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">, the Company had </font><font style="font-family:inherit;font-size:9pt;">four</font><font style="font-family:inherit;font-size:9pt;"> interest rate swaps with a current notional amount of </font><font style="font-family:inherit;font-size:9pt;">$1.2 billion</font><font style="font-family:inherit;font-size:9pt;"> and a termination date of November&#160;30, 2023. The derivatives are recorded at fair value (see Note 1. "Organization and Summary of Accounting Policies") and classified as a long-term liability included in other long-term liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the pre-tax effect of the interest rate swaps on the Company's accumulated other comprehensive income ("OCI") and statement of operations for the three and six months ended June 30, 2019 (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivatives in Cash Flow Hedging Relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss recognized in OCI (effective portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss reclassified from accumulated OCI to interest expense (effective portion)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">There were </font><font style="font-family:inherit;font-size:7pt;">no</font><font style="font-family:inherit;font-size:7pt;"> derivatives outstanding for the comparative periods in 2018.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivative Instruments and Hedging Activities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with Accounting Standards Codification 815, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:9pt;">, the Company records all derivatives on the balance sheet at fair value.&#160;The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During </font><font style="font-family:inherit;font-size:9pt;">2019</font><font style="font-family:inherit;font-size:9pt;">, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company&#8217;s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted earnings per share are calculated in accordance with Accounting Standards Codification 260, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Earnings Per Share</font><font style="font-family:inherit;font-size:9pt;">, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic and diluted earnings per share are calculated in accordance with Accounting Standards Codification 260, </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Earnings Per Share</font><font style="font-family:inherit;font-size:9pt;">, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands): </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to Surgery Partners, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(39.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(37.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: amounts allocated to participating securities </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(17.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(57.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding- basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,291</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,241</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Effect of dilutive securities </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding- diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,291</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,241</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,012</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Loss per share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.59</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.57</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.19</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Diluted </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">86</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Convertible preferred stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Share Repurchase Transactions</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On December 15, 2017, the Company's Board of Directors authorized a share repurchase program of up to </font><font style="font-family:inherit;font-size:9pt;">$50.0 million</font><font style="font-family:inherit;font-size:9pt;"> of the Company's issued and outstanding common stock from time to time. The timing and size of repurchases will be determined based on market conditions and other factors. The authorization does not obligate the repurchase of any shares and the Company may repurchase shares of common stock at any time without prior notice. The share repurchases will be made in accordance with applicable securities laws in open market or privately negotiated transactions. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">There were </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> share repurchases under the share repurchase program during the </font><font style="font-family:inherit;font-size:9pt;">six months ended June 30,</font><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:9pt;">2019</font><font style="font-family:inherit;font-size:9pt;">. During the </font><font style="font-family:inherit;font-size:9pt;">six months ended June 30,</font><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:9pt;">2018</font><font style="font-family:inherit;font-size:9pt;">, the Company repurchased </font><font style="font-family:inherit;font-size:9pt;">156,818</font><font style="font-family:inherit;font-size:9pt;"> shares of its common stock stock at an average price of </font><font style="font-family:inherit;font-size:9pt;">$12.64</font><font style="font-family:inherit;font-size:9pt;"> per share through market purchases. At </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;">, the Company had </font><font style="font-family:inherit;font-size:9pt;">$46.0 million</font><font style="font-family:inherit;font-size:9pt;"> of repurchase authorization available under the December 2017 authorization.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level&#160;1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The fair values in the table above were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values under Level 3 calculations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activities"). The fair value of these derivative instruments was </font><font style="font-family:inherit;font-size:9pt;">$50.7 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$22.4 million</font><font style="font-family:inherit;font-size:9pt;"> at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP assets and liabilities were based on quoted market prices, or Level 1 computations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">195.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">442.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">294.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(152.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(144.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average remaining lease term (years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities: </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from operating leases </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use assets obtained in exchange for lease obligations:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"></font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the six months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Statement of Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of leased assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest on lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Variable and short-term lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Leases</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of </font><font style="font-family:inherit;font-size:9pt;">ten years</font><font style="font-family:inherit;font-size:9pt;"> and may include </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;"> or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;"> to </font><font style="font-family:inherit;font-size:9pt;">seven years</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Balance Sheets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">285.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment, net of accumulated depreciation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">146.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total leased assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">431.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">136.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">439.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the six months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Statement of Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of leased assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest on lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Variable and short-term lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the </font><font style="font-family:inherit;font-size:9pt;">six months ended June 30,</font><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:9pt;">2019</font><font style="font-family:inherit;font-size:9pt;">, the Company incurred lease costs of </font><font style="font-family:inherit;font-size:9pt;">$10.2 million</font><font style="font-family:inherit;font-size:9pt;"> under operating lease agreements with physician investors who are related parties. During the </font><font style="font-family:inherit;font-size:9pt;">six months ended June 30,</font><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:9pt;">2019</font><font style="font-family:inherit;font-size:9pt;">, the Company paid rent of </font><font style="font-family:inherit;font-size:9pt;">$3.2 million</font><font style="font-family:inherit;font-size:9pt;"> under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average remaining lease term (years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities: </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from operating leases </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use assets obtained in exchange for lease obligations:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">195.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">442.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">294.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(152.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(144.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">470.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">812.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard.&#160;As of December 31, 2018, the current portion of the financing obligations was </font><font style="font-family:inherit;font-size:7pt;">$7.0 million</font><font style="font-family:inherit;font-size:7pt;"> and was included in other current liabilities in the consolidated balance sheets.&#160;The long-term portion of the finance obligations was </font><font style="font-family:inherit;font-size:7pt;">$149.8 million</font><font style="font-family:inherit;font-size:7pt;"> and was included as other long-term liabilities in the consolidated balance sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of </font><font style="font-family:inherit;font-size:9pt;">ten years</font><font style="font-family:inherit;font-size:9pt;"> and may include </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;"> or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;"> to </font><font style="font-family:inherit;font-size:9pt;">seven years</font><font style="font-family:inherit;font-size:9pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">195.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">442.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">294.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(152.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(144.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Leases</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of </font><font style="font-family:inherit;font-size:9pt;">ten years</font><font style="font-family:inherit;font-size:9pt;"> and may include </font><font style="font-family:inherit;font-size:9pt;">one</font><font style="font-family:inherit;font-size:9pt;"> or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from </font><font style="font-family:inherit;font-size:9pt;">five</font><font style="font-family:inherit;font-size:9pt;"> to </font><font style="font-family:inherit;font-size:9pt;">seven years</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Balance Sheets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">285.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment, net of accumulated depreciation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">146.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total leased assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">431.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">136.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">439.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the six months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Component of Lease Balances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Classification in Condensed Consolidated Statement of Operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortization of leased assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest on lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total finance lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Variable and short-term lease costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Lease expense and general and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">During the </font><font style="font-family:inherit;font-size:9pt;">six months ended June 30,</font><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:9pt;">2019</font><font style="font-family:inherit;font-size:9pt;">, the Company incurred lease costs of </font><font style="font-family:inherit;font-size:9pt;">$10.2 million</font><font style="font-family:inherit;font-size:9pt;"> under operating lease agreements with physician investors who are related parties. During the </font><font style="font-family:inherit;font-size:9pt;">six months ended June 30,</font><font style="font-family:inherit;font-size:9pt;"> </font><font style="font-family:inherit;font-size:9pt;">2019</font><font style="font-family:inherit;font-size:9pt;">, the Company paid rent of </font><font style="font-family:inherit;font-size:9pt;">$3.2 million</font><font style="font-family:inherit;font-size:9pt;"> under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average remaining lease term (years)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted-average discount rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash paid for amounts included in the measurement of lease liabilities: </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from operating leases </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">32.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing cash outflows from finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use assets obtained in exchange for lease obligations:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance leases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:70%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Finance Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">35.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">59.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">26.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">195.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">187.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">442.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">294.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(152.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(144.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">289.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">470.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">812.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard.&#160;As of December 31, 2018, the current portion of the financing obligations was </font><font style="font-family:inherit;font-size:7pt;">$7.0 million</font><font style="font-family:inherit;font-size:7pt;"> and was included in other current liabilities in the consolidated balance sheets.&#160;The long-term portion of the finance obligations was </font><font style="font-family:inherit;font-size:7pt;">$149.8 million</font><font style="font-family:inherit;font-size:7pt;"> and was included as other long-term liabilities in the consolidated balance sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Long-Term Debt</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of long-term debt is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,440.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,447.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2027</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">430.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes payable and secured loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease obligations </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: unamortized debt issuance costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,454.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,326.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: Current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,397.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,270.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes unamortized fair value discount of $</font><font style="font-family:inherit;font-size:7pt;">5.3 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:7pt;">and</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:7pt;">$5.5 million</font><font style="font-family:inherit;font-size:7pt;"> as of </font><font style="font-family:inherit;font-size:7pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:7pt;">and</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:7pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:7pt;">, respectively. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes unamortized fair value premium of </font><font style="font-family:inherit;font-size:7pt;">$6.7 million</font><font style="font-family:inherit;font-size:7pt;"> as of December 31, 2018. The premium was written off upon redemption as discussed below.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Senior Unsecured Notes due 2027</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Effective April 11, 2019, the Company issued an aggregate principal amount of </font><font style="font-family:inherit;font-size:9pt;">$430.0 million</font><font style="font-family:inherit;font-size:9pt;"> of senior unsecured notes due April 15, 2027 (the "2027 Unsecured Notes"). The 2027 Unsecured Notes bear interest at the rate of </font><font style="font-family:inherit;font-size:9pt;">10.000%</font><font style="font-family:inherit;font-size:9pt;"> per annum, payable semi-annually on April 15 and October 15 of each year, beginning on October 15, 2019. The 2027 Unsecured Notes are a senior unsecured obligation of Surgery Center Holdings, Inc. and are guaranteed on a senior unsecured basis by each of Surgery Center Holdings, Inc.'s existing and future domestic wholly-owned restricted subsidiaries that guarantees the 2017 Senior Secured Credit Facilities (subject to certain exceptions).</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company may redeem up to </font><font style="font-family:inherit;font-size:9pt;">40%</font><font style="font-family:inherit;font-size:9pt;"> of the aggregate principal amount of the 2027 Unsecured Notes at any time prior to April 15, 2022, with the net cash proceeds of certain equity issuances at a redemption price equal to </font><font style="font-family:inherit;font-size:9pt;">110.000%</font><font style="font-family:inherit;font-size:9pt;"> of the principal amount of notes to be redeemed, plus accrued and unpaid interest to, but excluding, the date of redemption.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company may redeem the 2027 Unsecured Notes, in whole or in part, at any time prior to April 15, 2022, at a redemption price equal to </font><font style="font-family:inherit;font-size:9pt;">100%</font><font style="font-family:inherit;font-size:9pt;"> of the principal amount of notes to be redeemed plus the applicable premium, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. The Company may redeem the 2027 Unsecured Notes, in whole or in part, at any time on or after April 15, 2022, at the redemption prices set forth below (expressed as a percentage of the principal amount of notes to be redeemed), plus accrued and unpaid interest, if any, to, but excluding, the date of redemption:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">April 15, 2022 to April 14, 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">105.000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">April 15, 2023 to April 14, 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">102.500</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">April 15, 2024 and thereafter</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">If Surgery Center Holdings, Inc. experiences a change of control under certain circumstances, it must offer to purchase the 2027 Unsecured Notes at a purchase price equal to </font><font style="font-family:inherit;font-size:9pt;">101.000%</font><font style="font-family:inherit;font-size:9pt;"> of the aggregate principal amount of notes, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The indenture governing the 2027 Unsecured Notes contains customary affirmative and negative covenants, which, among other things, limit the Company&#8217;s ability to incur additional debt, pay dividends, create or assume liens, effect transactions with its affiliates, guarantee payment of certain debt securities, sell assets, merge, consolidate, enter into acquisitions and effect sale and leaseback transactions.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In connection with the offering of the 2027 Unsecured Notes, the Company recorded debt issuance costs of </font><font style="font-family:inherit;font-size:9pt;">$8.8 million</font><font style="font-family:inherit;font-size:9pt;">.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Senior Unsecured Notes due 2021</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In connection with issuance of the 2027 Unsecured Notes as discussed above, the Company redeemed all of the then existing senior unsecured notes due 2021 ("2021 Unsecured Notes"). The redemption price was equal to </font><font style="font-family:inherit;font-size:9pt;">104.438%</font><font style="font-family:inherit;font-size:9pt;"> of the outstanding principal amount plus accrued and unpaid interest. In connection with the redemption, the Company recorded a debt extinguishment loss of </font><font style="font-family:inherit;font-size:9pt;">$11.7 million</font><font style="font-family:inherit;font-size:9pt;">, included in loss on debt extinguishment in the condensed consolidated statements of operations for the three and six months ending June 30, 2019. The loss includes the redemption premium paid partially offset by the write-off of the unamortized fair value premium as of the redemption date.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Revolver</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In connection with the completion of the issuance of the 2027 Unsecured Notes, the outstanding commitments under the Company's revolving credit facility ("Revolver") were increased by </font><font style="font-family:inherit;font-size:9pt;">$45.0 million</font><font style="font-family:inherit;font-size:9pt;"> pursuant to an incremental amendment to the credit agreement governing its revolving credit facility. As of both June 30, 2019 and December 31, 2018, the Company had </font><font style="font-family:inherit;font-size:9pt;">no</font><font style="font-family:inherit;font-size:9pt;"> outstanding borrowing on the Revolver. As of June 30, 2019, the Company's availability on the Revolver was </font><font style="font-family:inherit;font-size:9pt;">$115.9 million</font><font style="font-family:inherit;font-size:9pt;"> (including outstanding letters of credit of </font><font style="font-family:inherit;font-size:9pt;">$4.1 million</font><font style="font-family:inherit;font-size:9pt;">).</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company&#8217;s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was </font><font style="font-family:inherit;font-size:9pt;">$18.0 million</font><font style="font-family:inherit;font-size:9pt;"> reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company&#8217;s financial statements and related footnotes are complete and accurate and are adequately reviewed by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> Other Assets and Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Long-Term Assets</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term assets is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">285.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">313.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Current Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other current liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued legal settlement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts due to patients and payors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">193.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">155.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Long-Term Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Facility lease obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">387.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">271.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other current liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued legal settlement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts due to patients and payors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">193.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">155.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Assets and Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Long-Term Assets</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term assets is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">285.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">313.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Current Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other current liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued legal settlement</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">42.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amounts due to patients and payors</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">77.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">72.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">193.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">155.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Long-Term Liabilities</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Facility lease obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">387.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">271.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term liabilities is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">255.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Facility lease obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">132.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">387.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">271.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities&#8217; cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:9pt;">, the Company had a net third-party Medicaid settlements liability of </font><font style="font-family:inherit;font-size:9pt;">$7.5 million</font><font style="font-family:inherit;font-size:9pt;"> and </font><font style="font-family:inherit;font-size:9pt;">$4.8 million</font><font style="font-family:inherit;font-size:9pt;">, respectively, included in other current liabilities in the condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient&#8217;s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient&#8217;s insurance prior to the patient&#8217;s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,445.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,204.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">343.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">399.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,890.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,676.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following tables present financial information for each reportable segment (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">424.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">413.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">819.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">801.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">436.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">862.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">847.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">78.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">146.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">142.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(38.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(43.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">112.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">102.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">112.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">102.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(37.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(32.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(46.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(35.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(88.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(70.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity-based compensation expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent acquisition compensation expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction, integration and acquisition costs </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Reserve adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss on debt extinguishment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gain (loss) on disposals and deconsolidations, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Tax receivable agreement expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">For the </font><font style="font-size:7pt;">three</font><font style="font-family:inherit;font-size:7pt;"> months ended </font><font style="font-family:inherit;font-size:7pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">2018</font><font style="font-family:inherit;font-size:7pt;">, this amount includes transaction and integration costs of </font><font style="font-family:inherit;font-size:7pt;">$6.2 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$11.7 million</font><font style="font-family:inherit;font-size:7pt;">, respectively, and acquisition costs of </font><font style="font-family:inherit;font-size:7pt;">$1.2 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$0.8 million</font><font style="font-family:inherit;font-size:7pt;">, respectively. This amount further includes start-up costs related to a de novo surgical hospital of </font><font style="font-family:inherit;font-size:7pt;">$0.6 million</font><font style="font-family:inherit;font-size:7pt;"> for the three months ended June 30, 2019, with </font><font style="font-family:inherit;font-size:7pt;">no</font><font style="font-family:inherit;font-size:7pt;"> comparable costs in the 2018 period. For the six months ended </font><font style="font-family:inherit;font-size:7pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">2018</font><font style="font-family:inherit;font-size:7pt;">, this amount includes transaction and integration costs of </font><font style="font-family:inherit;font-size:7pt;">$8.2 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$16.7 million</font><font style="font-family:inherit;font-size:7pt;">, respectively, and acquisition costs of </font><font style="font-family:inherit;font-size:7pt;">$1.5 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$1.3 million</font><font style="font-family:inherit;font-size:7pt;">, respectively. This amount further includes start-up costs related to a de novo surgical hospital of </font><font style="font-family:inherit;font-size:7pt;">$1.8 million</font><font style="font-family:inherit;font-size:7pt;"> for the six months ended June 30, 2019, with no comparable costs in the 2018 period.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the non-controlling interests&#8212;redeemable is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">326.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests&#8212;redeemable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition and disposal of shares of non-controlling interests, net&#8212;redeemable </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.7</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Distributions to non-controlling interest&#8212;redeemable holders</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">316.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes post acquisition date adjustments.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Patient service revenues. </font><font style="font-family:inherit;font-size:9pt;">This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient&#8217;s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Other service revenues.</font><font style="font-family:inherit;font-size:9pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:9pt;"> Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,440.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,447.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,386.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,382.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">407.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">324.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">320.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2027</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">430.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">427.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of long-term debt is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Term Loan </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,440.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,447.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2021</font><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">406.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">370.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Senior Unsecured Notes due 2027</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">430.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Notes payable and secured loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finance lease obligations </font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: unamortized debt issuance costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,454.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,326.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: Current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,397.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,270.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes unamortized fair value discount of $</font><font style="font-family:inherit;font-size:7pt;">5.3 million</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:7pt;">and</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:7pt;">$5.5 million</font><font style="font-family:inherit;font-size:7pt;"> as of </font><font style="font-family:inherit;font-size:7pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:7pt;">and</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:7pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:7pt;">, respectively. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes unamortized fair value premium of </font><font style="font-family:inherit;font-size:7pt;">$6.7 million</font><font style="font-family:inherit;font-size:7pt;"> as of December 31, 2018. The premium was written off upon redemption as discussed below.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands): </font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to Surgery Partners, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(39.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(37.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: amounts allocated to participating securities </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(17.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss attributable to common stockholders</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(57.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding- basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,291</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,241</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,012</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Effect of dilutive securities </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding- diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,291</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,241</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">48,012</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Loss per share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.59</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.57</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.19</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Diluted </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Stock options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">144</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Restricted shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">86</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Convertible preferred stock</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">N/A</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">470.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">812.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard.&#160;As of December 31, 2018, the current portion of the financing obligations was </font><font style="font-family:inherit;font-size:7pt;">$7.0 million</font><font style="font-family:inherit;font-size:7pt;"> and was included in other current liabilities in the consolidated balance sheets.&#160;The long-term portion of the finance obligations was </font><font style="font-family:inherit;font-size:7pt;">$149.8 million</font><font style="font-family:inherit;font-size:7pt;"> and was included as other long-term liabilities in the consolidated balance sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Operating Leases </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Capital Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">81.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">470.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">812.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: imputed interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Capital lease obligations</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Includes financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard.&#160;As of December 31, 2018, the current portion of the financing obligations was </font><font style="font-family:inherit;font-size:7pt;">$7.0 million</font><font style="font-family:inherit;font-size:7pt;"> and was included in other current liabilities in the consolidated balance sheets.&#160;The long-term portion of the finance obligations was </font><font style="font-family:inherit;font-size:7pt;">$149.8 million</font><font style="font-family:inherit;font-size:7pt;"> and was included as other long-term liabilities in the consolidated balance sheets.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to goodwill for the </font><font style="font-family:inherit;font-size:9pt;">six</font><font style="font-family:inherit;font-size:9pt;"> months ended </font><font style="font-family:inherit;font-size:9pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:9pt;"> is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:85%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December&#160;31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,382.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisitions, including post acquisition adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,402.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table presents the pre-tax effect of the interest rate swaps on the Company's accumulated other comprehensive income ("OCI") and statement of operations for the three and six months ended June 30, 2019 (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018 </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Derivatives in Cash Flow Hedging Relationships</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss recognized in OCI (effective portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Loss reclassified from accumulated OCI to interest expense (effective portion)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">There were </font><font style="font-family:inherit;font-size:7pt;">no</font><font style="font-family:inherit;font-size:7pt;"> derivatives outstanding for the comparative periods in 2018.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of other long-term assets is as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right-of-use operating lease assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">285.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">313.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:84%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value of non-controlling interests</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net assets acquired:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current Assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Property and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term debt, less current maturities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Aggregate acquisition date fair value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">230.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">227.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">178.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">163.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">439.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">425.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">436.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:6%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Private insurance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">444.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">53.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">343.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">321.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Self-pay</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">38.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total patient service revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">850.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">830.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:18px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">862.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">847.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:6px;padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types. </font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash purchases of property and equipment, net:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total cash purchases of property and equipment, net </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of revenues by service type as a percentage of total revenues follows:</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Patient service revenues:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Surgical facilities revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">92.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">94.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">93.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Ancillary services revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">97.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">97.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other service revenues:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Optical services revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;&#160;Other revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Segment Reporting</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The Company operates in&#160;</font><font style="font-family:inherit;font-size:9pt;">three</font><font style="font-family:inherit;font-size:9pt;">&#160;major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities, the operation of ancillary services and the operation of optical services. The surgical facility services segment consists of the operation of ASCs and surgical hospitals and includes anesthesia services. The ancillary services segment consists of a diagnostic laboratory and multi-specialty physician practices. The optical services segment consists of an optical products group purchasing organization. "All other" primarily consists of the Company's corporate general and administrative functions.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The following tables present financial information for each reportable segment (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">424.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">413.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">819.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">801.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">445.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">436.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">862.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">847.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">78.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">75.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">146.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">142.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(21.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(38.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(43.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">112.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">102.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted EBITDA:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">55.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">112.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">102.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net income attributable to non-controlling interests</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(19.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(16.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(37.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(32.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Interest expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(46.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(35.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(88.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(70.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity-based compensation expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Contingent acquisition compensation expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Transaction, integration and acquisition costs </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Reserve adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Loss on debt extinguishment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Gain (loss) on disposals and deconsolidations, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Tax receivable agreement expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">For the </font><font style="font-size:7pt;">three</font><font style="font-family:inherit;font-size:7pt;"> months ended </font><font style="font-family:inherit;font-size:7pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">2018</font><font style="font-family:inherit;font-size:7pt;">, this amount includes transaction and integration costs of </font><font style="font-family:inherit;font-size:7pt;">$6.2 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$11.7 million</font><font style="font-family:inherit;font-size:7pt;">, respectively, and acquisition costs of </font><font style="font-family:inherit;font-size:7pt;">$1.2 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$0.8 million</font><font style="font-family:inherit;font-size:7pt;">, respectively. This amount further includes start-up costs related to a de novo surgical hospital of </font><font style="font-family:inherit;font-size:7pt;">$0.6 million</font><font style="font-family:inherit;font-size:7pt;"> for the three months ended June 30, 2019, with </font><font style="font-family:inherit;font-size:7pt;">no</font><font style="font-family:inherit;font-size:7pt;"> comparable costs in the 2018 period. For the six months ended </font><font style="font-family:inherit;font-size:7pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">2018</font><font style="font-family:inherit;font-size:7pt;">, this amount includes transaction and integration costs of </font><font style="font-family:inherit;font-size:7pt;">$8.2 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$16.7 million</font><font style="font-family:inherit;font-size:7pt;">, respectively, and acquisition costs of </font><font style="font-family:inherit;font-size:7pt;">$1.5 million</font><font style="font-family:inherit;font-size:7pt;"> and </font><font style="font-family:inherit;font-size:7pt;">$1.3 million</font><font style="font-family:inherit;font-size:7pt;">, respectively. This amount further includes start-up costs related to a de novo surgical hospital of </font><font style="font-family:inherit;font-size:7pt;">$1.8 million</font><font style="font-family:inherit;font-size:7pt;"> for the six months ended June 30, 2019, with no comparable costs in the 2018 period.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;padding-bottom:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:18px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:7pt;padding-left:0px;"><font style="font-family:inherit;font-size:7pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">June&#160;30, <br clear="none"/>2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,445.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,204.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">80.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Optical services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">343.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">399.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,890.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,676.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cash purchases of property and equipment, net:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Surgical facility services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ancillary services</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">All other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total cash purchases of property and equipment, net </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">A summary of activity related to the redeemable preferred stock follows (in millions):</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at December 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">359.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Dividends accrued (there were no cash dividends declared)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at June&#160;30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">376.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;text-indent:24px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</font></div></div> The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods. Includes post acquisition date adjustments. EX-101.SCH 7 sgry-20190630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2102100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Acquisitions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2409401 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001001 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1006000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Derivatives and Hedging Activities link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Derivatives and Hedging Activities (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Derivatives and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Leases - Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2404405 - Disclosure - Leases - Maturities of Leases Prior to Adoption of 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 2403404 - Disclosure - Long-Term Debt - Debt Redemption Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 2403406 - Disclosure - Long-Term Debt - Revolver (Details) link:presentationLink link:calculationLink link:definitionLink 2403405 - Disclosure - Long-Term Debt - Senior Unsecured Notes due 2021 (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Long-Term Debt - Senior Unsecured Notes due 2027 (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Long-Term Debt - Summary of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Long-Term Debt - Summary of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Organization and Summary of Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401410 - Disclosure - Organization and Summary of Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 2401405 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2401409 - Disclosure - Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 2401406 - Disclosure - Organization and Summary of Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Organization and Summary of Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2401413 - Disclosure - Organization and Summary of Accounting Policies - Recent Accounting Pronouncements (Details) link:presentationLink link:calculationLink link:definitionLink 2401411 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details) link:presentationLink link:calculationLink link:definitionLink 2401412 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) link:presentationLink link:calculationLink link:definitionLink 2401407 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) link:presentationLink link:calculationLink link:definitionLink 2401408 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Organization and Summary of Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Other Assets and Liabilities link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Other Assets and Liabilities - Other Long-term Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Other Assets and Liabilities - Other Long-Term Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Other Assets and Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Redeemable Preferred Stock link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Redeemable Preferred Stock - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Redeemable Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Segment Reporting - Revenues and Operating Income by Reportable Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 sgry-20190630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 sgry-20190630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 sgry-20190630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Derivative Instruments and Hedging Activities Disclosure [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest Rate Swap One Interest Rate Swap [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Estimated reduction to interest expense Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Number of interest rate swaps Number of Interest Rate Derivatives Held Derivative notional amount Derivative, Notional Amount Loss recognized in OCI (effective portion) Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss) Loss reclassified from accumulated OCI to interest expense (effective portion) Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion Temporary Equity Disclosure [Abstract] Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Majority Shareholder Majority Shareholder [Member] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Series A Preferred Stock Series A Preferred Stock [Member] Temporary Equity [Line Items] Temporary Equity [Line Items] Stock issued during period (shares) Stock Issued During Period, Shares, New Issues Purchase price per share (in USD per share) Shares Issued, Price Per Share Proceeds from issuance of preferred shares Stock Issued During Period, Value, New Issues Dividends payable Dividends Payable Cumulative preferred dividends Cumulative Dividends Preferred dividends payable (in USD per share) Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears Organization, Consolidation and Presentation of Financial Statements [Abstract] Restricted invested assets included in other long-term assets Restricted Cash and Investments, Noncurrent Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Variable Interest Entities [Axis] Variable Interest Entities [Axis] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure [Member] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Number of facilities included in VIE Variable Interest Entity, Number Of Facilities Variable Interest Entity, Number of Facilities Total assets related to VIE Variable Interest Entity, Consolidated, Carrying Amount, Assets Total liabilities related to VIE Variable Interest Entity, Consolidated, Carrying Amount, Liabilities Business Combinations [Abstract] Acquisitions Business Combination Disclosure [Text Block] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Entity Current Reporting Status Entity Current Reporting Status Entity Emerging Growth Company Entity Emerging Growth Company Entity Small Business Entity Small Business Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Shell Company Entity Shell Company Debt Disclosure [Abstract] Long-Term Debt Long-term Debt [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Surgical Facility and Physician Practice Surgical Facility And Physician Practice [Member] Surgical Facility And Physician Practice [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Cash consideration Payments to Acquire Businesses, Gross Fair value of non-controlling interests Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Acquisition date fair value Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Net assets acquired: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract] Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Goodwill Goodwill Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Long-term debt, less current maturities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Aggregate acquisition date fair value Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Income Statement [Abstract] Revenues Revenue from Contract with Customer, Including Assessed Tax Operating expenses: Operating Expenses [Abstract] Salaries and benefits Labor and Related Expense Supplies Supplies Expense Professional and medical fees Professional Fees Lease expense Operating Leases, Rent Expense, Net Other operating expenses Other Cost and Expense, Operating Cost of revenues Cost of Revenue General and administrative expenses General and Administrative Expense Depreciation and amortization Depreciation, Depletion and Amortization Income from equity investments Income (Loss) from Equity Method Investments (Gain) loss on disposals and deconsolidations, net Gain (Loss) On Disposition Of Assets And Deconsolidation Gain (Loss) On Disposition of Assets And Deconsolidation Transaction and integration costs Business Combination, Integration Related Costs Loss on debt extinguishment Gain (Loss) on Extinguishment of Debt Other income Other Nonrecurring (Income) Expense Total operating expenses Operating Expenses Operating income Operating Income (Loss) Tax receivable agreement expense Tax Receivable Agreement Expense (Benefit) Tax Receivable Agreement Expense (Benefit) Interest expense, net Interest Income (Expense), Nonoperating, Net Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Domestic Income tax expense Income Tax Expense (Benefit) Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Less: Net income attributable to non-controlling interests Net Income (Loss) Attributable to Noncontrolling Interest Net loss attributable to Surgery Partners, Inc. Net Income (Loss) Attributable to Parent Less: Amounts attributable to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Net loss per share attributable to common stockholders Earnings Per Share, Basic and Diluted [Abstract] Basic (in USD per share) Earnings Per Share, Basic Diluted (in USD per share) Earnings Per Share, Diluted Weighted average common shares outstanding Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Basic (shares) Weighted Average Number of Shares Outstanding, Basic Diluted (shares) Weighted Average Number of Shares Outstanding, Diluted Statement of Financial Position [Abstract] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Redeemable preferred stock, shares authorized (shares) Temporary Equity, Shares Authorized Redeemable preferred stock, shares issued (shares) Temporary Equity, Shares Issued Redeemable preferred stock, shares outstanding (shares) Temporary Equity, Shares Outstanding Redeemable preferred stock, redemption value Redeemable Noncontrolling Interest, Equity, Preferred, Redemption Value Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (shares) Preferred Stock, Shares Issued Preferred stock, shares outstanding (shares) Preferred Stock, Shares Outstanding Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (shares) Common Stock, Shares Authorized Common stock, shares issued (shares) Common Stock, Shares, Issued Common stock, shares outstanding (shares) Common Stock, Shares, Outstanding Leases [Abstract] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Noncontrolling Interest Noncontrolling Interest [Member] Physician Investors Investor [Member] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Operating lease costs Operating Lease, Cost Finance lease costs Finance Lease, Cost1 [Abstract] Finance Lease, Cost1 [Abstract] Amortization of leased assets Finance Lease, Right-of-Use Asset, Amortization Interest on lease liabilities Finance Lease, Interest Expense Total finance lease costs Finance Lease, Cost Finance Lease, Cost Variable and short-term lease costs Variable Lease, Cost Total lease costs Lease, Cost Rent paid under finance lease agreement, allocated to principal and interest Finance Lease, Principal And Interest Payments Finance Lease, Principal And Interest Payments Weighted-average remaining lease term, operating leases Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term, finance leases Finance Lease, Weighted Average Remaining Lease Term Weighted-average discount rate, operating leases Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate, finance leases Finance Lease, Weighted Average Discount Rate, Percent Operating cash outflows from operating leases Operating Lease, Payments Operating cash outflows from finance leases Finance Lease, Interest Payment on Liability Financing cash outflows from finance leases Finance Lease, Principal Payments Right-of-use assets obtained in exchange for operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right-of-use assets obtained in exchange for finance leases Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Senior Notes Senior Notes [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Senior Unsecured Notes, Due 2027 Senior Unsecured Notes, Due 2027 [Member] Senior Unsecured Notes, Due 2027 [Member] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Redemption Condition One Debt Instrument, Redemption, Period One [Member] Redemption Condition Two Debt Instrument, Redemption, Period Two [Member] Redemption Condition Six Debt Instrument, Redemption, Period Six [Member] Debt Instrument, Redemption, Period Six [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Face value of debt issued Debt Instrument, Face Amount Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Percentage of debt principal redeemable Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed Redemption price of debt Debt Instrument, Redemption Price, Percentage Debt issuance costs Debt Issuance Costs, Net Secured Debt Secured Debt [Member] Notes payable and secured loans Notes Payable and Secured Loans [Member] Notes Payable and Secured Loans [Member] Term Loan 2017 Term Loan, Maturing 2024 [Member] 2017 Term Loan, Maturing 2024 [Member] Senior Unsecured Notes due 2021 Senior Unsecured Notes Due 2021 [Member] Senior Unsecured Notes Due 2021 [Member] Senior Unsecured Notes due 2025 Senior Unsecured Notes Due 2025 [Member] Senior Unsecured Notes Due 2025 [Member] Senior Unsecured Notes due 2027 Long-term debt Long-term Debt Total lease obligations Finance Lease, Liability Less: unamortized debt issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Total debt Long-term Debt and Lease Obligation, Including Current Maturities Less: Current maturities Long-term Debt and Lease Obligation, Current Total long-term debt Long-term Debt and Lease Obligation Unamortized fair value discount Debt Instrument, Unamortized Discount Unamortized fair value premium Debt Instrument, Unamortized Premium Derivatives and Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Disposed of by Sale Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Investments in and Advances to Affiliates Categorization [Axis] Investments in and Advances to Affiliates Categorization [Axis] Investments in and Advances to Affiliates Categorization [Domain] Investments in and Advances to Affiliates Categorization [Domain] Other Acquisitions, Noncontrolling Interest Other Acquisitions, Noncontrolling Interest [Member] Other Acquisitions, Noncontrolling Interest [Member] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Surgical Facility Services Surgical Facility Services [Member] Surgical Facility Services [Member] Ancillary Services Ancillary Services [Member] Ancillary Services [Member] Surgical Facility Surgical Facility [Member] Surgical Facility [Member] Physician Practice Physician Practice [Member] Physician Practice [Member] Number of businesses acquired Number of Businesses Acquired Payments for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Goodwill allocated Number of non-controlling interests acquired Equity Method Investment, Number Of Noncontrolling Interests Acquired Equity Method Investment, Number Of Noncontrolling Interests Acquired Cash investments to acquire non-controlling interests Payments to Acquire Equity Method Investments Pretax gain recognized on sale Organization and Summary of Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Schedule of Revenue Sources, Health Care Organization [Table] Schedule of Revenue Sources, Health Care Organization [Table] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Healthcare Organization, Patient Service Healthcare Organization, Patient Service [Member] Healthcare Organization, Patient Service [Member] Optical Services Optical Services [Member] Optical Services [Member] Other Other Services [Member] Other Services [Member] Health Care Organization, Revenue Sources [Axis] Health Care Organization, Revenue Sources [Axis] Health Care Organization, Revenue Sources [Domain] Health Care Organization, Revenue Sources [Domain] Private insurance Private Insurance [Member] Private Insurance [Member] Government Government [Member] Self-pay Self-Pay [Member] Other Other Patient Service Revenue Sources [Member] Other Patient Service Revenue Sources [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Customer Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Revenue Revenue Benchmark [Member] Health Care Organization, Receivable and Revenue Disclosures [Line Items] Health Care Organization, Receivable and Revenue Disclosures [Line Items] Total revenues Service revenues as a percentage of total revenues Concentration Risk, Percentage Balance Sheet Related Disclosures [Abstract] Schedule of Other Long-term Assets Schedule of Other Assets, Noncurrent [Table Text Block] Summary of Other Current Liabilities Other Current Liabilities [Table Text Block] Summary of Other Long-term Liabilities Other Noncurrent Liabilities [Table Text Block] Operating Leases (1) Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2019 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2020 Operating Leases, Future Minimum Payments, Due in Two Years 2021 Operating Leases, Future Minimum Payments, Due in Three Years 2022 Operating Leases, Future Minimum Payments, Due in Four Years 2023 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total lease payments Operating Leases, Future Minimum Payments Due Capital Leases Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] 2019 Capital Leases, Future Minimum Payments Due, Next Twelve Months 2020 Capital Leases, Future Minimum Payments Due in Two Years 2021 Capital Leases, Future Minimum Payments Due in Three Years 2022 Capital Leases, Future Minimum Payments Due in Four Years 2023 Capital Leases, Future Minimum Payments Due in Five Years Thereafter Capital Leases, Future Minimum Payments Due Thereafter Total lease payments Capital Leases, Future Minimum Payments Due Less: imputed interest Capital Leases, Future Minimum Payments, Interest Included in Payments Capital lease obligations Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments Current portion of finance lease Finance Lease, Liability, Current Noncurrent portion of finance lease Finance Lease, Liability, Noncurrent Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Adjustments to reconcile net income to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Non-cash interest expense (income), net Noncash Interest Income (Expense), Net Noncash Interest Income (Expense), Net Non-cash lease expense Amortization of Leased Asset Equity-based compensation expense Share-based Payment Arrangement, Noncash Expense Deferred income taxes Deferred Income Tax Expense (Benefit) Income from equity investments, net of distributions received Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Changes in operating assets and liabilities, net of acquisitions and divestitures: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Other operating assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Payments for acquisitions, net of cash acquired Proceeds from disposals of facilities and other assets Proceeds from Sale of Productive Assets Purchases of equity investments Other investing activities Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Principal payments on long-term debt Repayments of Long-term Debt Borrowings of long-term debt Proceeds from Issuance of Long-term Debt Payments of debt issuance costs Payments of Debt Issuance Costs Payment of premium on debt extinguishment Payment for Debt Extinguishment or Debt Prepayment Cost Payments of preferred dividends Payments of Ordinary Dividends, Preferred Stock and Preference Stock Distributions to non-controlling interest holders Payments of Ordinary Dividends, Noncontrolling Interest Receipts (payments) related to ownership transactions with non-controlling interest holders Proceeds from (Payments to) Noncontrolling Interests Repurchase of shares Payments for Repurchase of Equity Other financing activities Proceeds from (Payments for) Other Financing Activities Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of period Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Earnings Per Share [Abstract] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] April 15, 2022 to April 14, 2023 Debt Instrument, Redemption, Period Three [Member] April 15, 2023 to April 14, 2024 Debt Instrument, Redemption, Period Four [Member] April 15, 2024 and thereafter Debt Instrument, Redemption, Period Five [Member] ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Inventories Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net of accumulated depreciation of $75.1 and $56.1, respectively Property, Plant and Equipment, Net, Excluding Capital Leased Assets Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Investments in and advances to affiliates Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Long-term deferred tax assets Deferred Tax Assets, Net, Noncurrent Other long-term assets Other Assets, Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued payroll and benefits Employee-related Liabilities, Current Other current liabilities Other Liabilities, Current Current maturities of long-term debt Total current liabilities Liabilities, Current Long-term debt, less current maturities Other long-term liabilities Other Liabilities, Noncurrent Non-controlling interests—redeemable Redeemable Noncontrolling Interest, Equity, Carrying Amount Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $376.6 and $359.3, respectively Temporary Equity, Carrying Amount, Attributable to Parent Stockholders' equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none Preferred Stock, Value, Issued Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 49,502,893 and 48,869,204, respectively Common Stock, Value, Outstanding Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Retained deficit Retained Earnings (Accumulated Deficit) Total Surgery Partners, Inc. stockholders' equity Stockholders' Equity Attributable to Parent Non-controlling interests—non-redeemable Stockholders' Equity Attributable to Noncontrolling Interest Total stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and stockholders' equity Liabilities and Equity Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Letter of Credit Letter of Credit [Member] 2017 Revolver Loan, Maturing 2022 2017 Revolver Loan, Maturing 2022 [Member] 2017 Revolver Loan, Maturing 2022 [Member] Amount of line of credit outstanding Long-term Line of Credit Availability on line of credit instrument Line of Credit Facility, Remaining Borrowing Capacity Operating Leases Lessee, Operating Lease, Liability, Payment, Due [Abstract] 2019 Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months 2020 Lessee, Operating Lease, Liability, Payments, Due Year Two 2021 Lessee, Operating Lease, Liability, Payments, Due Year Three 2022 Lessee, Operating Lease, Liability, Payments, Due Year Four 2023 Lessee, Operating Lease, Liability, Payments, Due Year Five Thereafter Lessee, Operating Lease, Liability, Payments, Due after Year Five Total lease payments Lessee, Operating Lease, Liability, Payments, Due Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Total lease obligations Operating Lease, Liability Finance Leases Finance Lease, Liability, Payment, Due [Abstract] 2019 Finance Lease, Liability, Payments, Due Next Twelve Months 2020 Finance Lease, Liability, Payments, Due Year Two 2021 Finance Lease, Liability, Payments, Due Year Three 2022 Finance Lease, Liability, Payments, Due Year Four 2023 Finance Lease, Liability, Payments, Due Year Five Thereafter Finance Lease, Liability, Payments, Due after Year Five Total lease payments Finance Lease, Liability, Payment, Due Less: imputed interest Finance Lease, Liability, Undiscounted Excess Amount Goodwill [Roll Forward] Goodwill [Roll Forward] Goodwill, beginning of period Acquisitions, including post acquisition adjustments Goodwill, Acquired During Period Goodwill, end of period Non-Controlling Interests - Redeemable [Roll Forward] Redeemable Noncontrolling Interest [Roll Forward] Redeemable Noncontrolling Interest [Roll Forward] Beginning balance Net income attributable to non-controlling interests—redeemable Net Income (Loss) Attributable to Redeemable Noncontrolling Interest Acquisition and disposal of shares of non-controlling interests, net—redeemable Redeemable Noncontrolling Interest, Increase (Decrease) From Redemptions Or Purchase Of Interests Redeemable Noncontrolling Interest, Increase (Decrease) from Redemptions or Purchase of Interests Distributions to non-controlling interest—redeemable holders Redeemable Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders Redeemable Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Ending balance Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Interest rate swap agreement Derivative Liability, Noncurrent Assets of SERP Deferred Compensation Plan Assets Senior Unsecured Notes, Due 2021 Products and Services [Table] Products and Services [Table] Facilities, Ambulatory Surgery Centers Facilities, Ambulatory Surgery Centers [Member] Facilities, Ambulatory Surgery Centers [Member] Facilities, Surgical Hospitals Facilities, Surgical Hospitals [Member] Facilities, Surgical Hospitals [Member] Products And Services [Line Items] Products And Services [Line Items] Products And Services [Line Items] Number of surgical facilities owned Number of Surgical Facilities Owned Number of Surgical Facilities Owned Number of states in which entity operates Number of States in which Entity Operates Number of surgical facilities owned, majority interest Number Of Surgical Facilities Owned, Majority Interest Number of Surgical Facilities Owned, Majority Interest Number of surgical facilities owned, consolidated Number Of Surgical Facilities Owned, Consolidated Number of Surgical Facilities Owned, Consolidated Right-of-use operating lease liabilities Operating Lease, Liability, Noncurrent Facility lease obligations Lease Obligation, Noncurrent Lease Obligation, Noncurrent Other Other Sundry Liabilities, Noncurrent Total Other Assets and Liabilities Other Assets Disclosure [Text Block] Other Assets and Liabilities Other Liabilities Disclosure [Text Block] Activity Related to Redeemable Preferred Stock Temporary Equity [Table Text Block] Right-of-use operating lease assets Operating Lease, Right-of-Use Asset Other Other Assets, Miscellaneous, Noncurrent Total Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] All Other Corporate, Non-Segment [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Assets Purchases of property and equipment, net Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Initial term of operating leases Lessor, Operating Lease, Term of Contract Number of options to renew operating leases Lessee, Operating Lease, Option To Extend, Number Of Options To Renew Lessee, Operating Lease, Option To Extend, Number Of Options To Renew Typical term of finance leases Lessee, Finance Lease, Term of Contract Assets: Operating lease assets Finance lease assets Finance Lease, Right-of-Use Asset Total leased assets Lease, Right-Of-Use Asset Lease, Right-of-Use Asset Liabilities: Liabilities [Abstract] Operating lease liabilities: Operating Lease, Liability [Abstract] Operating Lease, Liability [Abstract] Current Operating Lease, Liability, Current Long-term Total operating lease liabilities Finance lease liabilities: Finance Lease, Liability [Abstract] Finance Lease, Liability [Abstract] Current Long-term Total finance lease liabilities Total lease liabilities Lease, Liability Lease, Liability Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Beginning balance Dividends accrued (there were no cash dividends declared) Temporary Equity, Accretion of Dividends Ending balance Schedule of Components of Right-of-use Assets and Liabilities Related to Leases Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee [Table Text Block] Schedule of Lease Expense and Cash Flow Information Lease, Cost [Table Text Block] Maturity of Operating Leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Maturity of Finance Leases Finance Lease, Liability, Maturity [Table Text Block] Maturity of Leases Prior to Adoption of 842 Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Maturity of Leases Prior to Adoption of 842 Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block] Cumulative effect of accounting change, adjustment to retained deficit Cumulative Effect of New Accounting Principle in Period of Adoption Summary of Long-term Debt Schedule of Debt [Table Text Block] Summary of Debt Instrument Redemption Debt Instrument Redemption [Table Text Block] Number of operating segments Number of Operating Segments Adjusted EBITDA Earnings Before Interest Taxes Depreciation And Amortization Earnings Before Interest Taxes Depreciation And Amortization Net income attributable to non-controlling interests Depreciation and amortization Equity-based compensation expense Contingent acquisition compensation expense Business Combination, Contingent Acquisition Expense Business Combination, Contingent Acquisition Expense Transaction, integration and practice acquisition costs Business Combination, Integration Related Costs, And Merger Costs Business Combination, Integration Related Costs, And Merger Costs Reserve adjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Business Acquired Loss on debt extinguishment Gain (loss) on disposals and deconsolidations, net Income before income taxes Acquisition costs Business Combination, Acquisition Related Costs Start-up costs related to de novo surgical hospital Start-Up Activities, Start-Up Costs Start-Up Activities, Start-Up Costs Segment Reporting Segment Reporting Disclosure [Text Block] Accrued legal settlement Estimated Litigation Liability, Current Right-of-use operating lease liabilities Interest payable Interest Payable, Current Amounts due to patients and payors Broker-Dealer, Payable to Customer Accrued expenses and other Other Accrued Liabilities, Current Total Schedule of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock options Share-based Payment Arrangement, Option [Member] Restricted shares Restricted Stock [Member] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Net loss attributable to Surgery Partners, Inc. Less: amounts allocated to participating securities Undistributed Earnings (Loss) Allocated To Participating Securities, Basic, Net Of Temporary Equity Adjustments Undistributed Earnings (Loss) Allocated To Participating Securities, Basic, Net Of Temporary Equity Adjustments Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average shares outstanding- basic (shares) Effect of dilutive securities (shares) Weighted Average Number Diluted Shares Outstanding Adjustment Weighted average shares outstanding- diluted (shares) Loss per share: Antidilutive securities excluded from computation of (loss) per share (shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Authorized share repurchase amount Stock Repurchase Program, Authorized Amount Stock repurchased (shares) Treasury Stock, Shares, Acquired Average repurchase cost (in USD per share) Treasury Stock Acquired, Average Cost Per Share Remaining repurchase authorization available Stock Repurchase Program, Remaining Authorized Repurchase Amount Schedule of Carrying Amounts and Fair Values of Long-Term Debt Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Schedule of Revenues by Service Type Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Schedule of Revenue Sources for Patient Service Revenues Schedule of Revenue Sources, Health Care Organization [Table Text Block] Schedule of Rollforward of Goodwill Schedule of Goodwill [Table Text Block] Schedule of Rollforward of Noncontrolling Interest - Redeemable Redeemable Noncontrolling Interest [Table Text Block] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Carrying Amount Reported Value Measurement [Member] Fair Value Estimate of Fair Value Measurement [Member] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Retained Deficit Retained Earnings [Member] Non-Controlling Interests— Non-Redeemable Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning Balance, stockholders' equity (shares) Beginning Balance, stockholders' equity Net (loss) income Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Equity-based compensation (shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Equity-based compensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Preferred dividends Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings Repurchase of shares (shares) Stock Repurchased and Retired During Period, Shares Repurchase of shares Stock Repurchased and Retired During Period, Value Other comprehensive loss Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Net effect of adoption of new accounting standard (see Note 1) Acquisition and disposal of shares of non-controlling interests, net Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net Non-Controlling Interest, Acquisitions And Disposals Of Interests Held By Non-Controlling Interest Holders, Net Distributions to non-controlling interests—non-redeemable holders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Ending Balance, stockholders' equity (shares) Ending Balance, stockholders' equity Statement of Comprehensive Income [Abstract] Other comprehensive income, net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Derivative activity Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: Comprehensive income attributable to non-controlling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive loss attributable to Surgery Partners, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Segment Revenue and Operating Income Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Reconciliation of Assets from Segment to Consolidated Reconciliation of Assets from Segment to Consolidated [Table Text Block] Schedule of Financial Information by Reportable Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Leases Lessee, Finance Leases [Text Block] Leases Lessee, Operating Leases [Text Block] Third-Party Medicaid settlement liability Third-Party Settlements Payable, Current Third-Party Settlements Payable, Current Optical products receivable Optical Products Receivable Optical Products Receivable Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Variable Interest Entities Consolidation, Variable Interest Entity, Policy [Policy Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Revenues Revenue from Contract with Customer [Policy Text Block] Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts Receivable [Policy Text Block] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Derivative Instruments and Hedging Activities Derivatives, Policy [Policy Text Block] Non-Controlling Interests—Redeemable Redeemable Noncontrolling Interest [Policy Text Block] Redeemable Noncontrolling Interest [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Leases Lessee, Leases [Policy Text Block] Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Guarantor Obligations [Table] Schedule of Guarantor Obligations [Table] Unusual Risk or Uncertainty, Nature [Axis] Unusual Risk or Uncertainty, Nature [Axis] Unusual Risk or Uncertainty, Nature [Domain] Unusual Risk or Uncertainty, Nature [Domain] Materially More Restrictive Materially More Restrictive [Member] Materially More Restrictive [Member] Not Materially More Restrictive Not Materially More Restrictive [Member] Not Materially More Restrictive [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] LIBOR London Interbank Offered Rate (LIBOR) [Member] Guarantor Obligations [Line Items] Guarantor Obligations [Line Items] Professional, general and workers' compensation insurance reserve Self Insurance Reserve Expected insurance recoveries Estimated Insurance Recoveries Litigation related charge Gain (Loss) Related to Litigation Settlement Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Federal effective tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Long-term tax receivable agreement liability Deferred Income Tax Liabilities, Net Net long-term tax receivable agreement liability Deferred Income Tax Liabilities, Net Of Discount Deferred Income Tax Liabilities, Net Of Discount Current portion of tax liability Deferred Tax Liabilities, Net, Current Redeemable Preferred Stock Redeemable Preferred Stock [Text Block] Redeemable Preferred Stock [Text Block] Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Revenue Source Product Concentration Risk [Member] Healthcare Organization, Other Service Healthcare Organization, Other Service [Member] Healthcare Organization, Other Service [Member] Optical Services Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Schedule of Effect of Interest Rate Swaps Schedule of Interest Rate Derivatives [Table Text Block] Earnings Per Share Earnings Per Share [Text Block] EX-101.PRE 11 sgry-20190630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Document and Entity Information - shares
 6 Months Ended
Jun. 30, 2019
Aug. 05, 2019
Document and Entity Information [Abstract]    
Entity Registrant Name Surgery Partners, Inc.  
Entity Central Index Key 0001638833  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Document Type 10-Q  
Document Period End Date Jun. 30, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Entity Current Reporting Status Yes  
Entity Emerging Growth Company false  
Entity Small Business false  
Entity Common Stock, Shares Outstanding   49,476,880
Entity Shell Company false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 117.4 $ 184.3
Accounts receivable 301.9 307.6
Inventories 44.0 43.4
Prepaid expenses and other current assets 65.7 53.0
Total current assets 529.0 588.3
Property and equipment, net of accumulated depreciation of $75.1 and $56.1, respectively 400.1 426.3
Intangible assets, net 53.6 54.3
Goodwill 3,402.3 3,382.8
Investments in and advances to affiliates 93.4 78.5
Long-term deferred tax assets 99.5 109.2
Other long-term assets 313.0 36.9
Total assets 4,890.9 4,676.3
Current liabilities:    
Accounts payable 71.7 83.3
Accrued payroll and benefits 45.9 55.2
Other current liabilities 193.9 155.2
Current maturities of long-term debt 57.3 55.6
Total current liabilities 368.8 349.3
Long-term debt, less current maturities 2,397.4 2,270.9
Other long-term liabilities 387.1 271.3
Non-controlling interests—redeemable 316.0 326.6
Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $376.6 and $359.3, respectively 376.6 359.3
Stockholders' equity:    
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none 0.0 0.0
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 49,502,893 and 48,869,204, respectively 0.5 0.5
Additional paid-in capital 677.8 673.5
Accumulated other comprehensive loss (50.7) (22.4)
Retained deficit (268.9) (247.0)
Total Surgery Partners, Inc. stockholders' equity 358.7 404.6
Non-controlling interests—non-redeemable 686.3 694.3
Total stockholders' equity 1,045.0 1,098.9
Total liabilities and stockholders' equity $ 4,890.9 $ 4,676.3
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Accumulated depreciation $ 75.1 $ 56.1
Redeemable preferred stock, shares authorized (shares) 310,000 310,000
Redeemable preferred stock, shares issued (shares) 310,000 310,000
Redeemable preferred stock, shares outstanding (shares) 310,000 310,000
Redeemable preferred stock, redemption value $ 376.6 $ 359.3
Preferred stock, par value (in USD per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (shares) 20,000,000 20,000,000
Preferred stock, shares issued (shares) 0 0
Preferred stock, shares outstanding (shares) 0 0
Common stock, par value (in USD per share) $ 0.01 $ 0.01
Common stock, shares authorized (shares) 300,000,000 300,000,000
Common stock, shares issued (shares) 49,502,893 48,869,204
Common stock, shares outstanding (shares) 49,502,893 48,869,204
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Revenues $ 445.4 $ 436.6 $ 862.2 $ 847.9
Operating expenses:        
Salaries and benefits 132.7 134.1 261.9 263.8
Supplies 123.4 121.2 238.4 235.6
Professional and medical fees 36.4 36.7 71.5 72.4
Lease expense 21.0 21.8 41.6 43.2
Other operating expenses 26.9 26.3 53.1 52.4
Cost of revenues 340.4 340.1 666.5 667.4
General and administrative expenses 23.3 26.1 45.0 50.3
Depreciation and amortization 19.1 16.7 37.9 32.4
Income from equity investments (2.2) (2.5) (4.2) (4.4)
(Gain) loss on disposals and deconsolidations, net (8.2) 3.2 (7.6) 3.2
Transaction and integration costs 6.2 11.7 8.2 16.7
Loss on debt extinguishment 11.7 0.0 11.7 0.0
Other income (0.4) (2.2) (0.4) (2.4)
Total operating expenses 389.9 393.1 757.1 763.2
Operating income 55.5 43.5 105.1 84.7
Tax receivable agreement expense 0.0 0.0 (2.4) 0.0
Interest expense, net (46.4) (35.9) (88.4) (70.2)
Income before income taxes 9.1 7.6 14.3 14.5
Income tax expense 1.0 3.3 2.7 5.1
Net income 8.1 4.3 11.6 9.4
Less: Net income attributable to non-controlling interests (27.9) (23.8) (51.5) (46.4)
Net loss attributable to Surgery Partners, Inc. (19.8) (19.5) (39.9) (37.0)
Less: Amounts attributable to participating securities (8.8) (7.9) (17.3) (15.7)
Net loss attributable to common stockholders $ (28.6) $ (27.4) $ (57.2) $ (52.7)
Net loss per share attributable to common stockholders        
Basic (in USD per share) $ (0.59) $ (0.57) $ (1.19) $ (1.10)
Diluted (in USD per share) [1] $ (0.59) $ (0.57) $ (1.19) $ (1.10)
Weighted average common shares outstanding        
Basic (shares) 48,291 48,016 48,241 48,012
Diluted (shares) [1] 48,291 48,016 48,241 48,012
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Statement of Comprehensive Income [Abstract]        
Net income $ 8.1 $ 4.3 $ 11.6 $ 9.4
Other comprehensive income, net of tax:        
Derivative activity (16.8) 0.0 (28.3) 0.0
Comprehensive (loss) income (8.7) 4.3 (16.7) 9.4
Less: Comprehensive income attributable to non-controlling interests (27.9) (23.8) (51.5) (46.4)
Comprehensive loss attributable to Surgery Partners, Inc. $ (36.6) $ (19.5) $ (68.2) $ (37.0)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Deficit
Non-Controlling Interests— Non-Redeemable
Beginning Balance, stockholders' equity (shares) at Dec. 31, 2017   48,687,000        
Beginning Balance, stockholders' equity at Dec. 31, 2017 $ 1,336.6 $ 0.5 $ 695.5 $ 0.0 $ (41.3) $ 681.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (1.6)       (17.5) 15.9
Equity-based compensation (shares)   368,000        
Equity-based compensation 1.3   1.3      
Preferred dividends (7.8)   (7.8)      
Repurchase of shares (shares)   (157,000)        
Repurchase of shares (2.0)   (2.0)      
Acquisition and disposal of shares of non-controlling interests, net [1] 0.8   2.0     (1.2)
Distributions to non-controlling interests—non-redeemable holders (22.5)         (22.5)
Ending Balance, stockholders' equity (shares) at Mar. 31, 2018   48,898,000        
Ending Balance, stockholders' equity at Mar. 31, 2018 1,304.8 $ 0.5 689.0 0.0 (58.8) 674.1
Beginning Balance, stockholders' equity (shares) at Dec. 31, 2017   48,687,000        
Beginning Balance, stockholders' equity at Dec. 31, 2017 1,336.6 $ 0.5 695.5 0.0 (41.3) 681.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive loss 0.0          
Ending Balance, stockholders' equity (shares) at Jun. 30, 2018   48,902,000        
Ending Balance, stockholders' equity at Jun. 30, 2018 1,254.5 $ 0.5 675.9 0.0 (78.3) 656.4
Beginning Balance, stockholders' equity (shares) at Mar. 31, 2018   48,898,000        
Beginning Balance, stockholders' equity at Mar. 31, 2018 1,304.8 $ 0.5 689.0 0.0 (58.8) 674.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (2.9)       (19.5) 16.6
Equity-based compensation (shares)   4,000        
Equity-based compensation 2.5   2.5      
Preferred dividends (7.9)   (7.9)      
Other comprehensive loss 0.0          
Acquisition and disposal of shares of non-controlling interests, net [1] (25.2)   (7.7)     (17.5)
Distributions to non-controlling interests—non-redeemable holders (16.8)   0.0     (16.8)
Ending Balance, stockholders' equity (shares) at Jun. 30, 2018   48,902,000        
Ending Balance, stockholders' equity at Jun. 30, 2018 $ 1,254.5 $ 0.5 675.9 0.0 (78.3) 656.4
Beginning Balance, stockholders' equity (shares) at Dec. 31, 2018 48,869,204 48,869,000        
Beginning Balance, stockholders' equity at Dec. 31, 2018 $ 1,098.9 $ 0.5 673.5 (22.4) (247.0) 694.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (4.1)       (20.1) 16.0
Equity-based compensation (shares)   517,000        
Equity-based compensation 0.9   0.9      
Preferred dividends (8.5)   (8.5)      
Other comprehensive loss (11.5)     (11.5)    
Acquisition and disposal of shares of non-controlling interests, net [1] 14.1   8.0     6.1
Distributions to non-controlling interests—non-redeemable holders (23.5)         (23.5)
Ending Balance, stockholders' equity (shares) at Mar. 31, 2019   49,386,000        
Ending Balance, stockholders' equity at Mar. 31, 2019 $ 1,084.3 $ 0.5 673.9 (33.9) (249.1) 692.9
Beginning Balance, stockholders' equity (shares) at Dec. 31, 2018 48,869,204 48,869,000        
Beginning Balance, stockholders' equity at Dec. 31, 2018 $ 1,098.9 $ 0.5 673.5 (22.4) (247.0) 694.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive loss $ (28.3)          
Ending Balance, stockholders' equity (shares) at Jun. 30, 2019 49,502,893 49,503,000        
Ending Balance, stockholders' equity at Jun. 30, 2019 $ 1,045.0 $ 0.5 677.8 (50.7) (268.9) 686.3
Beginning Balance, stockholders' equity (shares) at Mar. 31, 2019   49,386,000        
Beginning Balance, stockholders' equity at Mar. 31, 2019 1,084.3 $ 0.5 673.9 (33.9) (249.1) 692.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (1.1)       (19.8) 18.7
Equity-based compensation (shares)   117,000        
Equity-based compensation 3.1   3.1      
Preferred dividends (8.8)   (8.8)      
Other comprehensive loss (16.8)     (16.8)    
Acquisition and disposal of shares of non-controlling interests, net [1] 2.0   9.6     (7.6)
Distributions to non-controlling interests—non-redeemable holders $ (17.7)         (17.7)
Ending Balance, stockholders' equity (shares) at Jun. 30, 2019 49,502,893 49,503,000        
Ending Balance, stockholders' equity at Jun. 30, 2019 $ 1,045.0 $ 0.5 $ 677.8 $ (50.7) $ (268.9) $ 686.3
[1] Includes post acquisition date adjustments.
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net income $ 11.6 $ 9.4
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 37.9 32.4
Non-cash interest expense (income), net 0.1 (0.7)
Non-cash lease expense 19.6 0.0
Equity-based compensation expense 4.9 4.8
(Gain) loss on disposals and deconsolidations, net (7.6) 3.2
Loss on debt extinguishment 11.7 0.0
Deferred income taxes 2.0 3.8
Income from equity investments, net of distributions received 0.1 (0.2)
Changes in operating assets and liabilities, net of acquisitions and divestitures:    
Accounts receivable 6.9 12.8
Other operating assets and liabilities (40.0) 4.1
Net cash provided by operating activities 47.2 69.6
Cash flows from investing activities:    
Purchases of property and equipment (31.8) (15.9)
Payments for acquisitions, net of cash acquired (13.2) (47.9)
Proceeds from disposals of facilities and other assets 17.6 10.2
Purchases of equity investments (15.2) 0.0
Other investing activities (0.3) (1.2)
Net cash used in investing activities (42.9) (54.8)
Cash flows from financing activities:    
Principal payments on long-term debt (422.8) (45.4)
Borrowings of long-term debt 438.9 21.4
Payments of debt issuance costs (8.8) 0.0
Payment of premium on debt extinguishment (17.8) 0.0
Payments of preferred dividends 0.0 (7.8)
Distributions to non-controlling interest holders (60.9) (55.8)
Receipts (payments) related to ownership transactions with non-controlling interest holders 1.2 (0.1)
Repurchase of shares 0.0 (2.0)
Other financing activities (1.0) (3.9)
Net cash used in financing activities (71.2) (93.6)
Net decrease in cash, cash equivalents and restricted cash (66.9) (78.8)
Cash, cash equivalents and restricted cash at beginning of period 184.6 175.2
Cash, cash equivalents and restricted cash at end of period $ 117.7 $ 96.4
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies
 6 Months Ended
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Summary of Accounting Policies
Organization and Summary of Accounting Policies
Organization
Surgery Partners, Inc., a Delaware corporation, acting through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The surgical facilities, which include ambulatory surgery centers ("ASCs") and surgical hospitals, primarily provide non-emergency surgical procedures across many specialties, including, among others, gastroenterology, general surgery, ophthalmology, orthopedics and pain management. The Company's surgical hospitals also provide services such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy and wound care. Ancillary services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services and optical services. Unless the context otherwise indicates, Surgery Partners, Inc. and its subsidiaries are referred to herein as "Surgery Partners," "we," "us," "our" or the "Company."
As of June 30, 2019, the Company owned or operated a portfolio of 128 surgical facilities, comprised of 113 ASCs and 15 surgical hospitals in 31 states. The Company owns these facilities in partnership with physicians and, in some cases, healthcare systems in the markets and communities it serves. The Company owned a majority interest in 85 of the surgical facilities and consolidated 107 of these facilities for financial reporting purposes.
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018.
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.
Variable Interest Entities
The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur. As of June 30, 2019, the consolidated VIEs include four surgical facilities, three anesthesia practices and three physician practices.
The total assets (excluding goodwill and intangible assets, net) of the consolidated VIEs included in the accompanying condensed consolidated balance sheets as of June 30, 2019 and December 31, 2018, were $24.8 million and $11.2 million, respectively, and the total liabilities of the consolidated VIEs were $17.2 million and $3.6 million, respectively.
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level 1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.
A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):
 
 
Carrying Amount
 
Fair Value
 
 
June 30,
2019
 
December 31,
2018
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
 
 
 
 
Term Loan
 
$
1,440.8

 
$
1,447.9

 
$
1,386.8

 
$
1,382.8

Senior Unsecured Notes due 2021
 
$
—

 
$
406.7

 
$
—

 
$
407.2

Senior Unsecured Notes due 2025
 
$
370.0

 
$
370.0

 
$
324.7

 
$
320.5

Senior Unsecured Notes due 2027
 
$
430.0

 
$
—

 
$
427.9

 
$
—


The fair values in the table above were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values under Level 3 calculations.
The Company has entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activities"). The fair value of these derivative instruments was $50.7 million and $22.4 million at June 30, 2019 and December 31, 2018, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.
The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP assets and liabilities were based on quoted market prices, or Level 1 computations. As of June 30, 2019 and December 31, 2018, the fair value of both the assets and liabilities in the SERP were $1.0 million and $1.4 million, respectively, and were included in other long-term assets and other long-term liabilities in the condensed consolidated balance sheets.
Revenues
The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
A summary of revenues by service type as a percentage of total revenues follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Patient service revenues:
 
 
 
 
 
 
 
   Surgical facilities revenues
94.1
%
 
92.6
%
 
94.0
%
 
93.0
%
   Ancillary services revenues
4.6
%
 
4.9
%
 
4.7
%
 
4.9
%
 
98.7
%
 
97.5
%
 
98.7
%
 
97.9
%
Other service revenues:
 
 
 
 
 
 
 
   Optical services revenues
0.2
%
 
0.6
%
 
0.2
%
 
0.7
%
   Other revenues
1.1
%
 
1.9
%
 
1.1
%
 
1.4
%
 
1.3
%
 
2.5
%
 
1.3
%
 
2.1
%
Total revenues
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%

Patient service revenues. This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.
Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change.
Other service revenues. Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.
Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.
The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):
 
 
Three Months Ended June 30,
 
 
2019
 
2018
 
 
Amount
 
%
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
Private insurance
 
$
230.5

 
52.4
%
 
$
227.7

 
53.5
%
Government
 
178.1

 
40.5
%
 
163.9

 
38.6
%
Self-pay
 
9.5

 
2.2
%
 
13.1

 
3.1
%
Other (1)
 
21.4

 
4.9
%
 
20.6

 
4.8
%
Total patient service revenues
 
439.5

 
100.0
%
 
425.3

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
1.0

 
 
 
2.8

 
 
Other revenues
 
4.9

 
 
 
8.5

 
 
Total revenues
 
$
445.4

 
 
 
$
436.6

 
 
 
 
Six Months Ended June 30,
 
 
2019
 
2018
 
 
Amount
 
%
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
Private insurance
 
$
445.8

 
52.4
%
 
$
444.2

 
53.5
%
Government
 
343.0

 
40.3
%
 
321.0

 
38.7
%
Self-pay
 
20.3

 
2.4
%
 
25.9

 
3.1
%
Other (1)
 
41.2

 
4.9
%
 
38.9

 
4.7
%
Total patient service revenues
 
850.3

 
100.0
%
 
830.0

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
2.1

 
 
 
5.8

 
 
Other revenues
 
9.8

 
 
 
12.1

 
 
Total revenues
 
$
862.2

 
 
 
$
847.9

 
 
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Cash, Cash Equivalents and Restricted Cash
The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.
Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both June 30, 2019 and December 31, 2018. These restricted investments represent restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities’ cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.
Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of June 30, 2019 and December 31, 2018, the Company had a net third-party Medicaid settlements liability of $7.5 million and $4.8 million, respectively, included in other current liabilities in the condensed consolidated balance sheets.
The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient’s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient’s insurance prior to the patient’s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.
The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.
The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets. Such receivables were $10.0 million and $8.5 million at June 30, 2019 and December 31, 2018, respectively.
Goodwill
Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries. A summary of the Company's acquisitions for the six months ended June 30, 2019 is included in Note 2. "Acquisitions."
A summary of activity related to goodwill for the six months ended June 30, 2019 is as follows (in millions):
Balance at December 31, 2018
 
$
3,382.8

Acquisitions, including post acquisition adjustments
 
19.5

Balance at June 30, 2019
 
$
3,402.3


Derivative Instruments and Hedging Activities
In accordance with Accounting Standards Codification 815, Derivatives and Hedging, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Non-Controlling Interests—Redeemable
Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively. In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners’ or physician minority members’, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The non-controlling interests—redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.
A summary of activity related to the non-controlling interests—redeemable is as follows (in millions):
Balance at December 31, 2018
 
$
326.6

Net income attributable to non-controlling interests—redeemable
 
16.8

Acquisition and disposal of shares of non-controlling interests, net—redeemable (1)
 
(7.7
)
Distributions to non-controlling interest—redeemable holders
 
(19.7
)
Balance at June 30, 2019
 
$
316.0

(1)
Includes post acquisition date adjustments.
Income Taxes
The Company uses the asset and liability method to account for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. If a carryforward exists, the Company makes a determination as to whether the carryforward will be utilized in the future. A valuation allowance is established for certain carryforwards when their recoverability is deemed to be uncertain. The carrying value of the net deferred tax assets assumes that the Company will be able to generate sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions. If our expectations for future operating results on a consolidated basis or at the state jurisdiction level vary from actual results due to changes in healthcare regulations, general economic conditions, or other factors, we may need to adjust the valuation allowance, for all or a portion of our deferred tax assets. Our income tax expense in future periods will be reduced or increased to the extent of offsetting decreases or increases, respectively, in our valuation allowance in the period when the change in circumstances occurs. These changes could have a significant impact on our future earnings.
The Company and certain of its subsidiaries file a consolidated federal income tax return. The partnerships, limited liability companies, and certain non-consolidated physician practice corporations also file separate income tax returns. The Company's allocable portion of each partnership's and limited liability company's income or loss is included in taxable income of the Company. The remaining income or loss of each partnership and limited liability company is allocated to the other owners.
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company’s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases.
The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was $18.0 million reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.
The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company’s financial statements and related footnotes are complete and accurate and are adequately reviewed by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.2
Acquisitions
 6 Months Ended
Jun. 30, 2019
Business Combinations [Abstract]  
Acquisitions
Acquisitions
During the six months ended June 30, 2019, the Company acquired a controlling interest in one surgical facility and a physician practice for a combined cash purchase price of $13.2 million, net of cash acquired. The acquisitions were funded through cash from operations. The total consideration was allocated to the assets acquired and liabilities assumed based upon the respective acquisition date fair values. The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):
Cash consideration
 
$
13.4

Fair value of non-controlling interests
 
8.3

Aggregate acquisition date fair value
 
$
21.7

Net assets acquired:
 
 
Current Assets
 
$
1.4

Property and equipment
 
1.0

Goodwill
 
19.9

Current liabilities
 
(0.5
)
Long-term debt, less current maturities
 
(0.1
)
Aggregate acquisition date fair value
 
$
21.7


The fair values assigned to certain assets acquired and liabilities assumed by the Company have been estimated on a preliminary basis and are subject to change as new facts and circumstances emerge that were present at the date of acquisition. During the six months ended June 30, 2019, no significant changes were made to the purchase price allocation of assets and liabilities, existing at the date of acquisition, related to individual acquisitions completed in 2018. The goodwill acquired was primarily allocated to the Company's reportable segments as follows: $11.4 million to surgical facility services and $8.5 million to ancillary services. The results of operations of the acquisitions were included in the Company’s results of operations beginning on the dates of acquisition and were not considered significant for the six months ended June 30, 2019.
Other Acquisitions and Dispositions
During the six months ended June 30, 2019, the Company acquired a non-controlling interest in four surgical facilities for a cash investment of $14.0 million. The non-controlling interest was accounted for as an equity method investment and recorded as a component of investments in and advances to affiliates in the accompanying condensed consolidated balance sheets.
During the six months ended June 30, 2019, the Company disposed of previously owned real property associated with one of its existing non-consolidated surgical facilities. In connection with the sale, the Company recognized a $10.9 million pretax gain included in (gain) loss on disposals and deconsolidations, net in the accompanying condensed consolidated statements of operations. The sale did not impact the Company's investment in the surgical facility, which continues to be accounted for as an equity method investment.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Debt
 6 Months Ended
Jun. 30, 2019
Debt Disclosure [Abstract]  
Long-Term Debt
Long-Term Debt
A summary of long-term debt is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Term Loan (1)
 
$
1,440.8

 
$
1,447.9

Senior Unsecured Notes due 2021 (2)

—

 
406.7

Senior Unsecured Notes due 2025
 
370.0

 
370.0

Senior Unsecured Notes due 2027
 
430.0

 
—

Notes payable and secured loans
 
75.9

 
79.4

Finance lease obligations (3)
 
149.2

 
25.4

Less: unamortized debt issuance costs
 
(11.2
)
 
(2.9
)
Total debt
 
2,454.7

 
2,326.5

Less: Current maturities
 
57.3

 
55.6

Total long-term debt
 
$
2,397.4

 
$
2,270.9


(1)
Includes unamortized fair value discount of $5.3 million and $5.5 million as of June 30, 2019 and December 31, 2018, respectively.
(2)
Includes unamortized fair value premium of $6.7 million as of December 31, 2018. The premium was written off upon redemption as discussed below.
(3)
In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."
Senior Unsecured Notes due 2027
Effective April 11, 2019, the Company issued an aggregate principal amount of $430.0 million of senior unsecured notes due April 15, 2027 (the "2027 Unsecured Notes"). The 2027 Unsecured Notes bear interest at the rate of 10.000% per annum, payable semi-annually on April 15 and October 15 of each year, beginning on October 15, 2019. The 2027 Unsecured Notes are a senior unsecured obligation of Surgery Center Holdings, Inc. and are guaranteed on a senior unsecured basis by each of Surgery Center Holdings, Inc.'s existing and future domestic wholly-owned restricted subsidiaries that guarantees the 2017 Senior Secured Credit Facilities (subject to certain exceptions).
The Company may redeem up to 40% of the aggregate principal amount of the 2027 Unsecured Notes at any time prior to April 15, 2022, with the net cash proceeds of certain equity issuances at a redemption price equal to 110.000% of the principal amount of notes to be redeemed, plus accrued and unpaid interest to, but excluding, the date of redemption.
The Company may redeem the 2027 Unsecured Notes, in whole or in part, at any time prior to April 15, 2022, at a redemption price equal to 100% of the principal amount of notes to be redeemed plus the applicable premium, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. The Company may redeem the 2027 Unsecured Notes, in whole or in part, at any time on or after April 15, 2022, at the redemption prices set forth below (expressed as a percentage of the principal amount of notes to be redeemed), plus accrued and unpaid interest, if any, to, but excluding, the date of redemption:
April 15, 2022 to April 14, 2023
105.000
%
April 15, 2023 to April 14, 2024
102.500
%
April 15, 2024 and thereafter
100.000
%

If Surgery Center Holdings, Inc. experiences a change of control under certain circumstances, it must offer to purchase the 2027 Unsecured Notes at a purchase price equal to 101.000% of the aggregate principal amount of notes, plus accrued and unpaid interest, if any, to, but excluding, the date of repurchase.
The indenture governing the 2027 Unsecured Notes contains customary affirmative and negative covenants, which, among other things, limit the Company’s ability to incur additional debt, pay dividends, create or assume liens, effect transactions with its affiliates, guarantee payment of certain debt securities, sell assets, merge, consolidate, enter into acquisitions and effect sale and leaseback transactions.
In connection with the offering of the 2027 Unsecured Notes, the Company recorded debt issuance costs of $8.8 million.
Senior Unsecured Notes due 2021
In connection with issuance of the 2027 Unsecured Notes as discussed above, the Company redeemed all of the then existing senior unsecured notes due 2021 ("2021 Unsecured Notes"). The redemption price was equal to 104.438% of the outstanding principal amount plus accrued and unpaid interest. In connection with the redemption, the Company recorded a debt extinguishment loss of $11.7 million, included in loss on debt extinguishment in the condensed consolidated statements of operations for the three and six months ending June 30, 2019. The loss includes the redemption premium paid partially offset by the write-off of the unamortized fair value premium as of the redemption date.
Revolver
In connection with the completion of the issuance of the 2027 Unsecured Notes, the outstanding commitments under the Company's revolving credit facility ("Revolver") were increased by $45.0 million pursuant to an incremental amendment to the credit agreement governing its revolving credit facility. As of both June 30, 2019 and December 31, 2018, the Company had no outstanding borrowing on the Revolver. As of June 30, 2019, the Company's availability on the Revolver was $115.9 million (including outstanding letters of credit of $4.1 million).
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.2
Leases
 6 Months Ended
Jun. 30, 2019
Leases [Abstract]  
Leases
Leases
On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted.
The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities.
The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.
The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at June 30, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Balance Sheets
 
June 30, 2019
Assets:
 
 
 
 
Operating lease assets
 
Other long-term assets
 
$
285.0

Finance lease assets
 
Property and equipment, net of accumulated depreciation
 
146.1

Total leased assets
 
 
 
$
431.1

 
 
 
 
 
Liabilities:
 
 
 
 
Operating lease liabilities:
 
 
 
 
Current
 
Other current liabilities
 
$
34.8

Long-term
 
Other long-term liabilities
 
255.1

Total operating lease liabilities
 
 
 
289.9

Finance lease liabilities:
 
 
 
 
Current
 
Current maturities of long-term debt
 
13.1

Long-term
 
Long-term debt, less current maturities
 
136.1

Total finance lease liabilities
 
 
 
149.2

Total lease liabilities
 

 
$
439.1


The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the six months ended June 30, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Statement of Operations
 
June 30, 2019
 
 
 
 
 
Operating lease costs
 
Lease expense and general and administrative expenses
 
$
34.4

Finance lease costs
 
 
 
 
Amortization of leased assets
 
Depreciation and amortization
 
9.3

Interest on lease liabilities
 
Interest expense, net
 
7.3

Total finance lease costs
 
 
 
16.6

Variable and short-term lease costs
 
Lease expense and general and administrative expenses
 
6.0

Total lease costs
 
 
 
$
57.0


During the six months ended June 30, 2019, the Company incurred lease costs of $10.2 million under operating lease agreements with physician investors who are related parties. During the six months ended June 30, 2019, the Company paid rent of $3.2 million under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.
The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):
 
 
June 30, 2019
Weighted-average remaining lease term (years)
 
 
Operating leases
 
8.5

Finance leases
 
13.1

Weighted-average discount rate
 
 
Operating leases
 
10.3
%
Finance leases
 
10.5
%
 
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Operating cash outflows from operating leases
 
$
32.8

Operating cash outflows from finance leases
 
$
7.3

Financing cash outflows from finance leases
 
$
5.2

 
 
 
Right-of-use assets obtained in exchange for lease obligations:
 
 
Operating leases
 
$
5.0

Finance leases
 
$
5.0


Future maturities of lease liabilities at June 30, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
35.4

 
$
15.2

2020
 
59.7

 
26.3

2021
 
55.1

 
24.4

2022
 
49.9

 
21.4

2023
 
46.6

 
19.1

Thereafter
 
195.8

 
187.6

Total lease payments
 
442.5

 
294.0

Less: imputed interest
 
(152.6
)
 
(144.8
)
Total lease obligations
 
$
289.9

 
$
149.2


Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. As of December 31, 2018, the current portion of the financing obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portion of the finance obligations was $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
Leases
Leases
On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted.
The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities.
The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.
The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at June 30, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Balance Sheets
 
June 30, 2019
Assets:
 
 
 
 
Operating lease assets
 
Other long-term assets
 
$
285.0

Finance lease assets
 
Property and equipment, net of accumulated depreciation
 
146.1

Total leased assets
 
 
 
$
431.1

 
 
 
 
 
Liabilities:
 
 
 
 
Operating lease liabilities:
 
 
 
 
Current
 
Other current liabilities
 
$
34.8

Long-term
 
Other long-term liabilities
 
255.1

Total operating lease liabilities
 
 
 
289.9

Finance lease liabilities:
 
 
 
 
Current
 
Current maturities of long-term debt
 
13.1

Long-term
 
Long-term debt, less current maturities
 
136.1

Total finance lease liabilities
 
 
 
149.2

Total lease liabilities
 

 
$
439.1


The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the six months ended June 30, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Statement of Operations
 
June 30, 2019
 
 
 
 
 
Operating lease costs
 
Lease expense and general and administrative expenses
 
$
34.4

Finance lease costs
 
 
 
 
Amortization of leased assets
 
Depreciation and amortization
 
9.3

Interest on lease liabilities
 
Interest expense, net
 
7.3

Total finance lease costs
 
 
 
16.6

Variable and short-term lease costs
 
Lease expense and general and administrative expenses
 
6.0

Total lease costs
 
 
 
$
57.0


During the six months ended June 30, 2019, the Company incurred lease costs of $10.2 million under operating lease agreements with physician investors who are related parties. During the six months ended June 30, 2019, the Company paid rent of $3.2 million under a finance lease agreement with a lessor who is a related party. One of the Company's surgical facilities has a non-controlling ownership interest in the lessor. Payments are allocated to principal adjustments of the finance lease liability and interest expense.
The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):
 
 
June 30, 2019
Weighted-average remaining lease term (years)
 
 
Operating leases
 
8.5

Finance leases
 
13.1

Weighted-average discount rate
 
 
Operating leases
 
10.3
%
Finance leases
 
10.5
%
 
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Operating cash outflows from operating leases
 
$
32.8

Operating cash outflows from finance leases
 
$
7.3

Financing cash outflows from finance leases
 
$
5.2

 
 
 
Right-of-use assets obtained in exchange for lease obligations:
 
 
Operating leases
 
$
5.0

Finance leases
 
$
5.0


Future maturities of lease liabilities at June 30, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
35.4

 
$
15.2

2020
 
59.7

 
26.3

2021
 
55.1

 
24.4

2022
 
49.9

 
21.4

2023
 
46.6

 
19.1

Thereafter
 
195.8

 
187.6

Total lease payments
 
442.5

 
294.0

Less: imputed interest
 
(152.6
)
 
(144.8
)
Total lease obligations
 
$
289.9

 
$
149.2


Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. As of December 31, 2018, the current portion of the financing obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portion of the finance obligations was $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.2
Redeemable Preferred Stock
 6 Months Ended
Jun. 30, 2019
Temporary Equity Disclosure [Abstract]  
Redeemable Preferred Stock
Redeemable Preferred Stock
On August 31, 2017, the Company issued 310,000 shares of Series A Preferred Stock to Bain at a purchase price of $1,000 per share for an aggregate purchase price of $310.0 million (the "Preferred Private Placement").
A summary of activity related to the redeemable preferred stock follows (in millions):
Balance at December 31, 2018
 
$
359.3

Dividends accrued (there were no cash dividends declared)
 
17.3

Balance at June 30, 2019
 
$
376.6


There were no unpaid cash dividends declared at both June 30, 2019 and December 31, 2018. The aggregate and per share amounts of unpaid cumulative preferred dividends as of June 30, 2019 was $51.0 million and $164.64, respectively.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.19.2
Derivatives and Hedging Activities
 6 Months Ended
Jun. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives and Hedging Activities
Derivatives and Hedging Activities
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During 2019, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.
For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company’s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. Over the next 12 months, the Company estimates that an additional $11.6 million will be reclassified as an increase to interest expense.
As of June 30, 2019, the Company had four interest rate swaps with a current notional amount of $1.2 billion and a termination date of November 30, 2023. The derivatives are recorded at fair value (see Note 1. "Organization and Summary of Accounting Policies") and classified as a long-term liability included in other long-term liabilities in the condensed consolidated balance sheets.
The following table presents the pre-tax effect of the interest rate swaps on the Company's accumulated other comprehensive income ("OCI") and statement of operations for the three and six months ended June 30, 2019 (dollars in millions):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2019
 
2018 (1)
 
2019
 
2018 (1)
Derivatives in Cash Flow Hedging Relationships
 
 
 
 
 
 
 
 
Loss recognized in OCI (effective portion)
 
$
18.3

 
$
—

 
$
31.1

 
$
—

Loss reclassified from accumulated OCI to interest expense (effective portion)
 
$
1.5

 
$
—

 
$
2.8

 
$
—

(1)
There were no derivatives outstanding for the comparative periods in 2018.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.2
Earnings Per Share
 6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Earnings Per Share
Earnings Per Share
Basic and diluted earnings per share are calculated in accordance with Accounting Standards Codification 260, Earnings Per Share, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.
A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Numerator:
 
 
 
 
 
 
 
Net loss attributable to Surgery Partners, Inc.
$
(19.8
)
 
$
(19.5
)
 
$
(39.9
)
 
$
(37.0
)
Less: amounts allocated to participating securities (1)
(8.8
)
 
(7.9
)
 
(17.3
)
 
(15.7
)
Net loss attributable to common stockholders
$
(28.6
)
 
$
(27.4
)
 
$
(57.2
)
 
$
(52.7
)
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding- basic
48,291

 
48,016

 
48,241

 
48,012

Effect of dilutive securities (2)
—

 
—

 
—

 
—

Weighted average shares outstanding- diluted
48,291

 
48,016

 
48,241

 
48,012

 
 
 
 
 
 
 
 
Loss per share:
 
 
 
 
 
 
 
Basic
$
(0.59
)
 
$
(0.57
)
 
$
(1.19
)
 
$
(1.10
)
Diluted (2)
$
(0.59
)
 
$
(0.57
)
 
$
(1.19
)
 
$
(1.10
)
 
 
 
 
 
 
 
 
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
 
 
 
 
 
 
 
Stock options
—

 
161

 
—

 
144

Restricted shares
25

 
86

 
27

 
83

Convertible preferred stock
N/A

 
N/A

 
N/A

 
N/A

(1)
Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.
(2)
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.
Share Repurchase Transactions
On December 15, 2017, the Company's Board of Directors authorized a share repurchase program of up to $50.0 million of the Company's issued and outstanding common stock from time to time. The timing and size of repurchases will be determined based on market conditions and other factors. The authorization does not obligate the repurchase of any shares and the Company may repurchase shares of common stock at any time without prior notice. The share repurchases will be made in accordance with applicable securities laws in open market or privately negotiated transactions. The authorization does not have a specified expiration date, and the share repurchase program may be suspended, recommenced or discontinued at any time or from time to time without prior notice.
There were no share repurchases under the share repurchase program during the six months ended June 30, 2019. During the six months ended June 30, 2018, the Company repurchased 156,818 shares of its common stock stock at an average price of $12.64 per share through market purchases. At June 30, 2019, the Company had $46.0 million of repurchase authorization available under the December 2017 authorization.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.19.2
Other Assets and Liabilities
 6 Months Ended
Jun. 30, 2019
Balance Sheet Related Disclosures [Abstract]  
Other Assets and Liabilities
Other Assets and Liabilities
Other Long-Term Assets
A summary of other long-term assets is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease assets
 
$
285.0

 
$
—

Other
 
28.0

 
36.9

Total
 
$
313.0

 
$
36.9


Other Current Liabilities
A summary of other current liabilities is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Accrued legal settlement
 
$
42.0

 
$
42.3

Right-of-use operating lease liabilities
 
34.8

 
—

Interest payable
 
22.4

 
20.8

Amounts due to patients and payors
 
17.5

 
20.0

Accrued expenses and other
 
77.2

 
72.1

Total
 
$
193.9

 
$
155.2


Other Long-Term Liabilities
A summary of other long-term liabilities is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease liabilities
 
$
255.1

 
$
—

Facility lease obligations
 
—

 
149.8

Other
 
132.0

 
121.5

Total
 
$
387.1

 
$
271.3


At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.
Other Assets and Liabilities
Other Assets and Liabilities
Other Long-Term Assets
A summary of other long-term assets is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease assets
 
$
285.0

 
$
—

Other
 
28.0

 
36.9

Total
 
$
313.0

 
$
36.9


Other Current Liabilities
A summary of other current liabilities is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Accrued legal settlement
 
$
42.0

 
$
42.3

Right-of-use operating lease liabilities
 
34.8

 
—

Interest payable
 
22.4

 
20.8

Amounts due to patients and payors
 
17.5

 
20.0

Accrued expenses and other
 
77.2

 
72.1

Total
 
$
193.9

 
$
155.2


Other Long-Term Liabilities
A summary of other long-term liabilities is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease liabilities
 
$
255.1

 
$
—

Facility lease obligations
 
—

 
149.8

Other
 
132.0

 
121.5

Total
 
$
387.1

 
$
271.3


At December 31, 2018, the Company had financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. These obligations were included as facility lease obligations in other long-term liabilities at December 31, 2018 in the table above. Upon adoption of the Lease Accounting Standard on January 1, 2019, the Company reevaluated the classification of these financing arrangements utilizing the new accounting requirements for sale-leasebacks, and concluded that each of these financing arrangements continue to not qualify for sale treatment and therefore should continue to be recognized on the balance sheet as finance leases under the new guidance. Further, the Company has an ongoing development agreement to construct a new hospital, which costs were recognized as incurred as a deferred financing obligation included in facility lease obligations at December 31, 2018. Upon reevaluation, the Company concluded that it does not control the assets under construction and therefore the obligation and related asset were derecognized from the balance sheets upon adoption of the Lease Accounting Standard. The lease related to this new hospital is expected to commence in late 2019 when construction is completed.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.2
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies
Professional, General and Workers' Compensation Liability Risks
The Company is subject to claims and legal actions in the ordinary course of business, including claims relating to patient treatment, employment practices and personal injuries. The Company maintains general liability and professional liability insurance in excess of self-insured retentions, on a claims-made basis through third party commercial insurance carriers. Although management believes the coverage is sufficient for the Company's operations, some claims may potentially exceed the scope of coverage in effect. The Company also maintains workers' compensation insurance, subject to a deductible. Plaintiffs in these matters may request punitive or other damages that may not be covered by insurance. The Company is not aware of any such proceedings that are reasonably possible to have a material adverse effect on the Company's business, financial position, results of operations or liquidity.
Insurance Reserves
The Company expenses the costs under the self-insured retention exposure for general and professional liability and workers' compensation claims which relate to (i) claims made during the policy period, which are offset by insurance recoveries and (ii) an estimate of claims incurred but not yet reported that are expected to be reported after the policy period expires. Reserves and provisions are based upon periodic actuarially determined estimates. The reserves are estimated using individual case-basis valuations and actuarial analysis. Reserves for professional, general and workers' compensation claim liabilities are determined with no regard for expected insurance recoveries and are presented gross on the condensed consolidated balance sheets. Total professional, general and workers' compensation claim liabilities as of June 30, 2019 and December 31, 2018 were $19.4 million and $18.2 million, respectively. The balances include expected insurance recoveries of $12.0 million at each of June 30, 2019 and December 31, 2018.
Laws and Regulations
Laws and regulations governing the Company's business, including those relating to the Medicare and Medicaid programs, are complex and subject to interpretation. These laws and regulations govern every aspect of how the Company's surgical facilities conduct their operations, from licensing requirements to how and whether the Company's facilities may receive payments pursuant to the Medicare and Medicaid programs. Compliance with such laws and regulations can be subject to future government agency review and interpretation as well as legislative changes to such laws. Noncompliance with such laws and regulations may subject the Company to significant regulatory action including fines, penalties, and exclusion from the Medicare, Medicaid and other federal healthcare programs. From time to time, governmental regulatory agencies will conduct inquiries of the Company's practices, including, but not limited to, the Company's compliance with federal and state fraud and abuse laws, billing practices and relationships with physicians.
On October 23, 2017, the Company received several civil investigative demands (“CIDs”) from the federal government under the False Claims Act (“FCA”) for documents and information dating back to January 1, 2010 relating to the medical necessity of certain drug tests conducted by the Company’s physicians and submitted to laboratories owned and operated by the Company. In addition, the Company has been informed by CMS that payments to its diagnostic laboratory, Logan Laboratories, have been suspended pending further investigation by CMS.
The Company has been providing information to the government in response to the CIDs and currently has a non-binding agreement in principle with the DOJ on the financial terms of a settlement with the goal of resolving these matters. Based on those discussions, which are still ongoing, the Company recorded a litigation-related charge of $46.0 million relating to these matters on the consolidated statements of operations for the year ended December 31, 2018. The Company believes that this reserve is sufficient to cover a potential resolution with the government relating to these matters, including legal expenses relating to the settlement that have not previously been recorded in operating expenses. The ultimate timing, amount and/or final terms of any such resolution may differ materially from those anticipated or the Company may not be able to reach a resolution at all. It is reasonably possible that the Company will incur additional losses above the amount reserved, but the Company is not able to estimate such amounts at this time. See Item 1A “Risk Factors” in the Company's Annual Report on Form 10-K for the period ended December 31, 2018 under the heading “Risk Factors - Risks Related to Government Regulation - Companies within the healthcare industry, including us, continue to be the subject of federal and state audits and investigations, including actions for false and other improper claims.” 
Acquired Facilities
The Company, through its wholly-owned subsidiaries or controlled partnerships and limited liability companies, has acquired and will continue to acquire surgical facilities with prior operating histories. Such facilities may have unknown or contingent liabilities, including liabilities for failure to comply with healthcare laws and regulations, such as billing and reimbursement, fraud and abuse and similar anti-referral laws. Although the Company attempts to assure that no such liabilities exist, obtain indemnification from prospective sellers covering such matters and institute policies designed to conform centers to its standards following completion of acquisitions, there can be no assurance that the Company will not become liable for past activities that may later be asserted to be improper by private plaintiffs or government agencies. There can be no assurance that any such matter will be covered by indemnification or, if covered, that the liability sustained will not exceed contractual limits or the financial capacity of the indemnifying party.
The Company cannot predict whether federal or state statutory or regulatory provisions will be enacted that would prohibit or otherwise regulate relationships which the Company has established or may establish with other healthcare providers or have materially adverse effects on its business or revenues arising from such future actions. Management believes, however, that it will be able to adjust the Company's operations so as to be in compliance with any statutory or regulatory provision as may be applicable.
Potential Physician Investor Liability
A majority of the physician investors in the partnerships and limited liability companies which operate the Company's surgical facilities carry general and professional liability insurance on a claims-made basis. Each partnership or limited liability company may, however, be liable for damages to persons or property arising from occurrences at the surgical facilities. Although the various physician investors and other surgeons generally are required to obtain general and professional liability insurance with tail coverage that extends beyond the period of any claims-made policies, such individuals may not be able to obtain coverage in amounts sufficient to cover all potential liability. Since most insurance policies contain exclusions, the physician investors will not be insured against all possible occurrences. In the event of an uninsured or underinsured loss, the value of an investment in the partnership interests or limited liability company membership units and the amount of distributions could be adversely affected.
Tax Receivable Agreement
On May 9, 2017, the Company entered into an agreement to amend that certain Income Tax Receivable Agreement, dated September 30, 2015 (as amended, the “TRA”), by and between the Company, and the other parties referred to therein, which amendment became effective on August 31, 2017. Pursuant to the amendment to the TRA, the Company agreed to make payments to H.I.G., the Company's former controlling shareholder, in its capacity as the stockholders representative pursuant to a fixed payment schedule. The amounts payable under the TRA are calculated as the product of (i) an annual base amount and (ii) the maximum corporate federal income tax rate for the applicable year plus three percent. The amounts payable under the TRA are related to the Company’s projected realized tax savings over the next six years and are not dependent on the Company’s actual tax savings over such period. The calculation of amounts payable pursuant to the TRA is thus dependent on the maximum corporate federal income tax rate. To the extent that the Company is unable to make payments under the TRA and such inability is a result of the terms of credit agreements and other debt documents that are materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 500 basis points until paid. If the terms of such credit agreements and other debt documents cause the Company to be unable to make payments under the TRA and such terms are not materially more restrictive than those existing as of September 30, 2015, such payments will be deferred and will accrue interest at a rate of LIBOR plus 300 basis points until paid.
Assuming the Company’s effective tax rate is 24%, calculated as the maximum corporate federal tax rate plus three percent, throughout the remaining term of the TRA, the Company estimates that the total remaining amounts payable under the TRA was approximately $68.2 million and $64.6 million as of June 30, 2019 and December 31, 2018, respectively. As a result of the amendment to the TRA, the Company was required to value the liability under the TRA by discounting the fixed payment schedule using the Company’s incremental borrowing rate. The carrying value of the liability under the TRA, reflecting the discount, was $53.9 million and $48.5 million as of June 30, 2019 and December 31, 2018, respectively. The current portion of the liability was $8.0 million and $7.6 million as of June 30, 2019 and December 31, 2018, respectively, and was included as a component of other current liabilities in the condensed consolidated balance sheet. The long-term portion was included as a component of other long-term liabilities in the condensed consolidated balance sheets.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.2
Segment Reporting
 6 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting
The Company operates in three major lines of business that are also the Company's reportable operating segments - the operation of surgical facilities, the operation of ancillary services and the operation of optical services. The surgical facility services segment consists of the operation of ASCs and surgical hospitals and includes anesthesia services. The ancillary services segment consists of a diagnostic laboratory and multi-specialty physician practices. The optical services segment consists of an optical products group purchasing organization. "All other" primarily consists of the Company's corporate general and administrative functions.
The following tables present financial information for each reportable segment (in millions):

Three Months Ended June 30,
 
Six Months Ended June 30,

2019
 
2018
 
2019
 
2018
Revenues:
 
 
 
 
 
 
 
Surgical facility services
$
424.0

 
$
413.0

 
$
819.8

 
$
801.3

Ancillary services
20.4

 
20.8

 
40.3

 
40.8

Optical services
1.0

 
2.8

 
2.1

 
5.8

Total
$
445.4

 
$
436.6

 
$
862.2

 
$
847.9

 
 
 
 
 
 
 
 
Adjusted EBITDA:
 
 
 
 
 
 
 
Surgical facility services
$
78.4

 
$
75.5

 
$
146.8

 
$
142.0

Ancillary services
1.4

 
1.0

 
2.6

 
2.1

Optical services
0.4

 
0.7

 
0.9

 
1.5

All other
(19.0
)
 
(21.8
)
 
(38.3
)
 
(43.1
)
Total
$
61.2

 
$
55.4

 
$
112.0

 
$
102.5

 
 
 
 
 
 
 
 
Adjusted EBITDA:
$
61.2

 
$
55.4

 
$
112.0

 
$
102.5

Net income attributable to non-controlling interests
27.9

 
23.8

 
51.5

 
46.4

Depreciation and amortization
(19.1
)
 
(16.7
)
 
(37.9
)
 
(32.4
)
Interest expense, net
(46.4
)
 
(35.9
)
 
(88.4
)
 
(70.2
)
Equity-based compensation expense
(3.0
)
 
(2.8
)
 
(4.9
)
 
(4.8
)
Contingent acquisition compensation expense
—

 
(0.5
)
 
—

 
(1.0
)
Transaction, integration and acquisition costs (1)
(8.0
)
 
(12.5
)
 
(11.5
)
 
(18.0
)
Reserve adjustments (2)
—

 
—

 
—

 
(4.8
)
Loss on debt extinguishment
(11.7
)
 
—

 
(11.7
)
 
—

Gain (loss) on disposals and deconsolidations, net
8.2

 
(3.2
)
 
7.6

 
(3.2
)
Tax receivable agreement expense
—

 
—

 
(2.4
)
 
—

Income before income taxes
$
9.1

 
$
7.6

 
$
14.3

 
$
14.5


(1)
For the three months ended June 30, 2019 and 2018, this amount includes transaction and integration costs of $6.2 million and $11.7 million, respectively, and acquisition costs of $1.2 million and $0.8 million, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $0.6 million for the three months ended June 30, 2019, with no comparable costs in the 2018 period. For the six months ended June 30, 2019 and 2018, this amount includes transaction and integration costs of $8.2 million and $16.7 million, respectively, and acquisition costs of $1.5 million and $1.3 million, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $1.8 million for the six months ended June 30, 2019, with no comparable costs in the 2018 period.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.
 
 
June 30,
2019
 
December 31,
2018
Assets:
 
 
 
 
Surgical facility services
 
$
4,445.5

 
$
4,204.3

Ancillary services
 
80.1

 
52.7

Optical services
 
21.8

 
20.1

All other
 
343.5

 
399.2

Total assets
 
$
4,890.9

 
$
4,676.3


 
 
Six Months Ended June 30,
 
 
2019
 
2018
Cash purchases of property and equipment, net:
 
 
 
 
Surgical facility services
 
$
25.3

 
$
13.2

Ancillary services
 
0.3

 
0.3

All other
 
6.2

 
2.4

Total cash purchases of property and equipment, net
 
$
31.8

 
$
15.9
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation of the Company's financial position and results of operations have been included. The Company’s fiscal year ends on December 31 and interim results are not necessarily indicative of results for a full year or any other interim period. The information contained in these condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2018.
Principles of Consolidation
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, as well as interests in partnerships and limited liability companies controlled by the Company through its ownership of a majority voting interest or other rights granted to the Company by contract to manage and control the affiliate's business. All significant intercompany balances and transactions are eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.
Variable Interest Entities
Variable Interest Entities
The condensed consolidated financial statements include the accounts of variable interest entities ("VIE") in which the Company is the primary beneficiary under the provisions of the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification 810, Consolidation. The Company has the power to direct the activities that most significantly impact a VIEs economic performance. Additionally, the Company would absorb the majority of the expected losses from any of these entities should such expected losses occur.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of a financial instrument is the amount at which the instrument could be exchanged in an orderly transaction between market participants to sell the asset or transfer the liability. The Company uses fair value measurements based on quoted prices in active markets for identical assets or liabilities (Level 1), inputs other than quoted prices in active markets that are either directly or indirectly observable (Level 2), or unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions (Level 3), depending on the nature of the item being valued.
The carrying amounts reported in the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, restricted invested assets and accounts payable approximate their fair values under Level 3 calculations.
The fair values in the table above were based on a Level 2 inputs using quoted prices for identical liabilities in inactive markets. The carrying amounts related to the Company's other long-term debt obligations, including finance lease obligations, approximate their fair values under Level 3 calculations.
The Company has entered into certain interest rate swap agreements (see Note 6. "Derivatives and Hedging Activities"). The fair value of these derivative instruments was $50.7 million and $22.4 million at June 30, 2019 and December 31, 2018, respectively, and was included in other long-term liabilities in the condensed consolidated balance sheets. The fair value of these derivative financial instruments was based on a quoted market price, or a Level 2 computation.
The Company maintains a supplemental executive retirement savings plan (the "SERP") for certain executive officers. The SERP is a non-qualified deferred compensation plan for eligible executive officers and other key employees of the Company that allows participants to defer portions of their compensation. The fair value of the SERP assets and liabilities were based on quoted market prices, or Level 1 computations.
Revenues
Revenues
The Company's revenues generally relate to contracts with patients in which the performance obligations are to provide healthcare services. The Company recognizes revenues in the period in which our obligations to provide health care services are satisfied and reports the amount that reflects the consideration the Company expects to be entitled to. The Company's performance obligations are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (e.g., Medicare, Medicaid, managed care health plans, employers and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by or negotiated with the third-party payors. The payment arrangements with third-party payors for the services provided to the related patients typically specify payments at amounts less than the Company's standard charges. The Company continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
Patient service revenues. This includes revenue related to charging facility fees in exchange for providing patient care. The fee charged for healthcare procedures performed in surgical facilities varies depending on the type of service provided, but usually includes all charges for usage of an operating room, a recovery room, special equipment, medical supplies, nursing staff and medications. The fee does not normally include professional fees charged by the patient’s surgeon, anesthesiologist or other attending physician, which are billed directly by such physicians to the patient or third-party payor. However, in several surgical facilities, the Company charges for anesthesia services. Ancillary service revenues include fees for patient visits to the Company's physician practices, pharmacy services and diagnostic tests ordered by physicians.
Patient service revenues are recognized as performance obligations are satisfied. Performance obligations are based on the nature of services provided. Typically, the Company recognizes revenue at a point in time in which services are rendered and the Company has no obligation to provide further patient services. As the Company primarily performs outpatient procedures, performance obligations are generally satisfied same day and revenue is recognized on the date of service.
The Company determines the transaction price based on gross charges for services provided, net of estimated contractual adjustments and discounts from third-party payors. The Company estimates its contractual adjustments and discounts based on contractual agreements, its discount policies and historical experience. Changes in estimated contractual adjustments and discounts are recorded in the period of change.
Other service revenues. Optical service revenues consist of handling charges billed to the members of the Company's optical products purchasing organization. The Company's optical products purchasing organization negotiates volume buying discounts with optical products manufacturers. The buying discounts and any handling charges billed to the members of the buying group represent the revenue recognized for financial reporting purposes. The Company satisfies the performance obligation and recognizes revenue when the orders are shipped to members. The Company bases its estimates for sales returns and discounts on historical experience and has not experienced significant fluctuations between estimated and actual return activity and discounts given.
Other revenues include management and administrative service fees derived from the non-consolidated facilities that the Company accounts for under the equity method, management of surgical facilities in which it does not own an interest, and management services provided to physician practices for which the Company is not required to provide capital or additional assets. These agreements typically require the Company to provide recurring management services over a multi-year period which are billed and collected on a monthly basis. The fees derived from these management arrangements are based on a predetermined percentage of the revenues of each facility or practice and are recognized in the period in which management services are rendered and billed.
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents and Restricted Cash
The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. The Company maintains its cash and cash equivalent balances at high credit quality financial institutions.
Cash, cash equivalents and restricted cash reported within the consolidated statement of cash flows includes $0.3 million of restricted investments, which are reflected in other long-term assets in the consolidated balance sheet at both June 30, 2019 and December 31, 2018. These restricted investments represent restricted cash held in accordance with the provisions of a long-term operating lease agreement held as security for performance under the Company's covenants and obligations within the agreement through January 2024.
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts
Accounts receivable from third-party payors are recorded net of estimated implicit price concessions which are estimated based on the historical trend of the Company's surgical facilities’ cash collections and contractual write-offs, established fee schedules, relationships with payors and procedure statistics. While changes in estimated reimbursement from third-party payors remain a possibility, the Company expects that any such changes would be minimal and, therefore, would not have a material effect on its financial condition or results of operations.
Accounts receivable consists of receivables from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. Management recognizes that revenues and receivables from government agencies are significant to the Company's operations, but it does not believe that there is significant credit risk associated with these government agencies. Concentration of credit risk with respect to other payors is limited because of the large number of such payors. As of June 30, 2019 and December 31, 2018, the Company had a net third-party Medicaid settlements liability of $7.5 million and $4.8 million, respectively, included in other current liabilities in the condensed consolidated balance sheets.
The Company recognizes that final reimbursement of accounts receivable is subject to final approval by each third-party payor. However, because the Company has contracts with its third-party payors and also verifies insurance coverage of the patient before medical services are rendered, the amounts that are pending approval from third-party payors are not considered significant. Amounts are classified outside of self-pay if the Company has an agreement with the third-party payor or has verified a patient’s coverage prior to services rendered. The Company's policy is to collect co-payments and deductibles prior to providing medical services. It is also the Company's policy to verify a patient’s insurance prior to the patient’s procedure. Patient services of the Company are primarily non-emergency, which allows the surgical facilities to control the procedures for which third-party reimbursement is sought and obtained. The Company does not require collateral from self-pay patients.
The Company's collection policies and procedures are based on the type of payor, size of claim and estimated collection percentage for each patient account. The operating systems used to manage patient accounts provide for an aging schedule in 30-day increments, by payor, physician and patient. The Company analyzes accounts receivable at each of its surgical facilities to ensure the proper collection and aged category. The operating systems generate reports that assist in the collection efforts by prioritizing patient accounts. Collection efforts include direct contact with insurance carriers or patients, written correspondence and the use of legal or collection agency assistance, as required.
The receivables related to the Company's optical products purchasing organization are recognized separately from patient accounts receivable, as discussed above, and are included in other current assets in the condensed consolidated balance sheets.
Goodwill
Goodwill
Goodwill represents the fair value of the consideration provided in an acquisition over the fair value of net assets acquired and is not amortized. Additions to goodwill include amounts resulting from new business combinations and incremental ownership purchases in the Company's subsidiaries.
Derivative Instruments and Hedging Activities
Derivative Instruments and Hedging Activities
In accordance with Accounting Standards Codification 815, Derivatives and Hedging, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the fair value measurement guidance issued by the FASB in Accounting Standards Update ("ASU") 2011-04, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. During 2019, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.
For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in accumulated other comprehensive income and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings, as documented at hedge inception in accordance with the Company’s accounting policy election. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt.
Non-Controlling Interests—Redeemable
Non-Controlling Interests—Redeemable
Each partnership and limited liability company through which the Company owns and operates its surgical facilities is governed by a partnership or operating agreement, respectively. In certain circumstances, the applicable partnership or operating agreements for the Company's surgical facilities provide that the facilities will purchase all of the physician limited partners’ or physician minority members’, as applicable, ownership if certain adverse regulatory events occur, such as it becoming illegal for the physician(s) to own an interest in a surgical facility, refer patients to a surgical facility or receive cash distributions from a surgical facility. The non-controlling interests—redeemable are reported outside of stockholders' equity in the condensed consolidated balance sheets.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In February 2016, the FASB issued ASU 2016-02, "Leases," (the "Lease Accounting Standard"). The core principal of the Lease Accounting Standard is to increase transparency and comparability among organizations by requiring the recognition of right-of-use lease assets and liabilities on the balance sheet and disclosing key information. The most prominent among the changes from this ASU is the recognition of right-of-use assets and lease liabilities by lessees for those leases classified as operating leases. The Company’s accounting for finance leases remained substantially unchanged from its prior accounting for capital leases. The disclosure objective is to enable users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases.
The Company adopted the Lease Accounting Standard effective January 1, 2019, using a modified retrospective transition approach. Under this approach, the Company elected to recognize and measure leases under the new standard in the period of adoption, with a cumulative-effect adjustment recorded to equity on its condensed consolidated balance sheets, along with the application of certain available practical expedients including an exclusion for short-term leases and accounting for leases at the portfolio level where appropriate. The cumulative effect of the accounting change recognized upon adoption was $18.0 million reflected as an adjustment to retained deficit in our condensed consolidated balance sheets.
The Company has implemented internal controls and key system functionality to establish governance and oversight over the implementation, and to ensure the Company’s financial statements and related footnotes are complete and accurate and are adequately reviewed by members of management. The newly implemented internal control changes related to leases include new systems and software implementation, updated accounting and disclosure policies, and redesigned financial reporting internal controls over governance, oversight and reviews. Additionally, the Company has expanded data gathering procedures to comply with the additional disclosure requirements and ongoing contract review requirements.
Leases
On January 1, 2019, the Company adopted the Lease Accounting Standard using the modified retrospective transition approach by applying the new standard to all leases existing at that date. Results and disclosure requirements for reporting periods beginning after January 1, 2019 are presented under the new guidance, while prior period amounts have not been adjusted.
The Company elected the package of practical expedients permitted under the transition guidance, which allowed the Company to carryforward its historical lease identification, lease classification and initial direct costs for any leases that existed prior to January 1, 2019. The Company also elected the practical expedient to use hindsight to determine the lease term for its leases at transition and the accounting policy practical expedient to exclude leases with an initial term of twelve months or less from the balance sheet. Additionally, for certain leases, the Company applied a portfolio approach to effectively account for the operating lease right-of-use assets and liabilities.
The Company determines if an arrangement is a lease at inception. Right-of-use assets and liabilities are recognized at commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed and determinable at the time of commencement. Variable components of lease payments fluctuating with a future index or rate, as well as those related to common area maintenance costs, are not included in determining lease payments and are expensed as incurred. As most leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is a hypothetical rate based on the Company's understanding of what its credit rating would be. The right-of-use asset also includes any lease payments made prior to commencement and is recorded net of any lease incentives received. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise such options.
The Company's operating leases are primarily for real estate, including medical office buildings, and corporate and other administrative offices. The Company's finance leases are primarily for medical equipment and information technology and telecommunications assets. Real estate lease agreements typically have initial terms of ten years and may include one or more options to renew. Certain leases also include options to purchase the leased property. The useful life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. The majority of the Company's medical equipment leases have a bargain purchase option that is reasonably certain of exercise, so these assets are depreciated over their useful life, typically ranging from five to seven years.
Earnings Per Share
Earnings Per Share
Basic and diluted earnings per share are calculated in accordance with Accounting Standards Codification 260, Earnings Per Share, based on the weighted-average number of shares outstanding in each period and dilutive stock options, unvested shares and warrants, to the extent such securities exist and have a dilutive effect on earnings per share. The Company computes basic and diluted earnings per share using the two-class method. The two-class method of computing earnings per share is an earnings allocation method that determines earnings per share for common shares and participating securities according to their participation rights in dividends and undistributed earnings.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Carrying Amounts and Fair Values of Long-Term Debt
A summary of the carrying amounts and estimated fair values of the Company's long-term debt follows (in millions):
 
 
Carrying Amount
 
Fair Value
 
 
June 30,
2019
 
December 31,
2018
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
 
 
 
 
Term Loan
 
$
1,440.8

 
$
1,447.9

 
$
1,386.8

 
$
1,382.8

Senior Unsecured Notes due 2021
 
$
—

 
$
406.7

 
$
—

 
$
407.2

Senior Unsecured Notes due 2025
 
$
370.0

 
$
370.0

 
$
324.7

 
$
320.5

Senior Unsecured Notes due 2027
 
$
430.0

 
$
—

 
$
427.9

 
$
—
Schedule of Revenues by Service Type
A summary of revenues by service type as a percentage of total revenues follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Patient service revenues:
 
 
 
 
 
 
 
   Surgical facilities revenues
94.1
%
 
92.6
%
 
94.0
%
 
93.0
%
   Ancillary services revenues
4.6
%
 
4.9
%
 
4.7
%
 
4.9
%
 
98.7
%
 
97.5
%
 
98.7
%
 
97.9
%
Other service revenues:
 
 
 
 
 
 
 
   Optical services revenues
0.2
%
 
0.6
%
 
0.2
%
 
0.7
%
   Other revenues
1.1
%
 
1.9
%
 
1.1
%
 
1.4
%
 
1.3
%
 
2.5
%
 
1.3
%
 
2.1
%
Total revenues
100.0
%
 
100.0
%
 
100.0
%
 
100.0
%
Schedule of Revenue Sources for Patient Service Revenues
The following table sets forth patient service revenues by type of payor and as a percentage of total patient service revenues for the Company's consolidated surgical facilities (dollars in millions):
 
 
Three Months Ended June 30,
 
 
2019
 
2018
 
 
Amount
 
%
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
Private insurance
 
$
230.5

 
52.4
%
 
$
227.7

 
53.5
%
Government
 
178.1

 
40.5
%
 
163.9

 
38.6
%
Self-pay
 
9.5

 
2.2
%
 
13.1

 
3.1
%
Other (1)
 
21.4

 
4.9
%
 
20.6

 
4.8
%
Total patient service revenues
 
439.5

 
100.0
%
 
425.3

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
1.0

 
 
 
2.8

 
 
Other revenues
 
4.9

 
 
 
8.5

 
 
Total revenues
 
$
445.4

 
 
 
$
436.6

 
 
 
 
Six Months Ended June 30,
 
 
2019
 
2018
 
 
Amount
 
%
 
Amount
 
%
Patient service revenues:
 
 
 
 
 
 
 
 
Private insurance
 
$
445.8

 
52.4
%
 
$
444.2

 
53.5
%
Government
 
343.0

 
40.3
%
 
321.0

 
38.7
%
Self-pay
 
20.3

 
2.4
%
 
25.9

 
3.1
%
Other (1)
 
41.2

 
4.9
%
 
38.9

 
4.7
%
Total patient service revenues
 
850.3

 
100.0
%
 
830.0

 
100.0
%
Other service revenues:
 
 
 
 
 
 
 
 
Optical services revenues
 
2.1

 
 
 
5.8

 
 
Other revenues
 
9.8

 
 
 
12.1

 
 
Total revenues
 
$
862.2

 
 
 
$
847.9

 
 
(1)
Other is comprised of anesthesia service agreements, auto liability, letters of protection and other payor types.
Schedule of Rollforward of Goodwill
A summary of activity related to goodwill for the six months ended June 30, 2019 is as follows (in millions):
Balance at December 31, 2018
 
$
3,382.8

Acquisitions, including post acquisition adjustments
 
19.5

Balance at June 30, 2019
 
$
3,402.3
Schedule of Rollforward of Noncontrolling Interest - Redeemable
A summary of activity related to the non-controlling interests—redeemable is as follows (in millions):
Balance at December 31, 2018
 
$
326.6

Net income attributable to non-controlling interests—redeemable
 
16.8

Acquisition and disposal of shares of non-controlling interests, net—redeemable (1)
 
(7.7
)
Distributions to non-controlling interest—redeemable holders
 
(19.7
)
Balance at June 30, 2019
 
$
316.0

(1)
Includes post acquisition date adjustments.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.2
Acquisitions (Tables)
 6 Months Ended
Jun. 30, 2019
Business Combinations [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed
The aggregate amounts preliminarily recognized for each major class of assets acquired and liabilities assumed for the acquisitions are as follows (in millions):
Cash consideration
 
$
13.4

Fair value of non-controlling interests
 
8.3

Aggregate acquisition date fair value
 
$
21.7

Net assets acquired:
 
 
Current Assets
 
$
1.4

Property and equipment
 
1.0

Goodwill
 
19.9

Current liabilities
 
(0.5
)
Long-term debt, less current maturities
 
(0.1
)
Aggregate acquisition date fair value
 
$
21.7
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Debt (Tables)
 6 Months Ended
Jun. 30, 2019
Debt Disclosure [Abstract]  
Summary of Long-term Debt
A summary of long-term debt is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Term Loan (1)
 
$
1,440.8

 
$
1,447.9

Senior Unsecured Notes due 2021 (2)

—

 
406.7

Senior Unsecured Notes due 2025
 
370.0

 
370.0

Senior Unsecured Notes due 2027
 
430.0

 
—

Notes payable and secured loans
 
75.9

 
79.4

Finance lease obligations (3)
 
149.2

 
25.4

Less: unamortized debt issuance costs
 
(11.2
)
 
(2.9
)
Total debt
 
2,454.7

 
2,326.5

Less: Current maturities
 
57.3

 
55.6

Total long-term debt
 
$
2,397.4

 
$
2,270.9


(1)
Includes unamortized fair value discount of $5.3 million and $5.5 million as of June 30, 2019 and December 31, 2018, respectively.
(2)
Includes unamortized fair value premium of $6.7 million as of December 31, 2018. The premium was written off upon redemption as discussed below.
(3)
In connection with the adoption of the Lease Accounting Standard, the Company's capital lease obligations that existed as of December 31, 2018 were derecognized and included as a component of the finance lease obligations included in the table shown above. See Note 4. "Leases" for further discussion on the adoption of the Lease Accounting Standard. The increase in finance lease obligations upon adoption of the Lease Accounting Standard is due to the inclusion of certain financing obligations that were previously recognized as a component of other current and long-term liabilities as discussed further in Note 8. "Other Assets and Liabilities."
Summary of Debt Instrument Redemption
The Company may redeem the 2027 Unsecured Notes, in whole or in part, at any time on or after April 15, 2022, at the redemption prices set forth below (expressed as a percentage of the principal amount of notes to be redeemed), plus accrued and unpaid interest, if any, to, but excluding, the date of redemption:
April 15, 2022 to April 14, 2023
105.000
%
April 15, 2023 to April 14, 2024
102.500
%
April 15, 2024 and thereafter
100.000
%
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.2
Leases (Tables)
 6 Months Ended
Jun. 30, 2019
Leases [Abstract]  
Schedule of Components of Right-of-use Assets and Liabilities Related to Leases
The following table presents the components of the Company's right-of-use assets and liabilities related to leases and their classification in the condensed consolidated balance sheets at June 30, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Balance Sheets
 
June 30, 2019
Assets:
 
 
 
 
Operating lease assets
 
Other long-term assets
 
$
285.0

Finance lease assets
 
Property and equipment, net of accumulated depreciation
 
146.1

Total leased assets
 
 
 
$
431.1

 
 
 
 
 
Liabilities:
 
 
 
 
Operating lease liabilities:
 
 
 
 
Current
 
Other current liabilities
 
$
34.8

Long-term
 
Other long-term liabilities
 
255.1

Total operating lease liabilities
 
 
 
289.9

Finance lease liabilities:
 
 
 
 
Current
 
Current maturities of long-term debt
 
13.1

Long-term
 
Long-term debt, less current maturities
 
136.1

Total finance lease liabilities
 
 
 
149.2

Total lease liabilities
 

 
$
439.1
Schedule of Lease Expense and Cash Flow Information
The weighted-average lease terms and discount rates and cash flow information for operating and finance leases are presented in the following table (dollars in millions):
 
 
June 30, 2019
Weighted-average remaining lease term (years)
 
 
Operating leases
 
8.5

Finance leases
 
13.1

Weighted-average discount rate
 
 
Operating leases
 
10.3
%
Finance leases
 
10.5
%
 
 
 
Cash paid for amounts included in the measurement of lease liabilities:
 
 
Operating cash outflows from operating leases
 
$
32.8

Operating cash outflows from finance leases
 
$
7.3

Financing cash outflows from finance leases
 
$
5.2

 
 
 
Right-of-use assets obtained in exchange for lease obligations:
 
 
Operating leases
 
$
5.0

Finance leases
 
$
5.0


The following table presents the components of the Company's lease expense and their classification in the condensed consolidated statement of operations for the six months ended June 30, 2019 (in millions):
Component of Lease Balances
 
Classification in Condensed Consolidated Statement of Operations
 
June 30, 2019
 
 
 
 
 
Operating lease costs
 
Lease expense and general and administrative expenses
 
$
34.4

Finance lease costs
 
 
 
 
Amortization of leased assets
 
Depreciation and amortization
 
9.3

Interest on lease liabilities
 
Interest expense, net
 
7.3

Total finance lease costs
 
 
 
16.6

Variable and short-term lease costs
 
Lease expense and general and administrative expenses
 
6.0

Total lease costs
 
 
 
$
57.0
Maturity of Operating Leases
Future maturities of lease liabilities at June 30, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
35.4

 
$
15.2

2020
 
59.7

 
26.3

2021
 
55.1

 
24.4

2022
 
49.9

 
21.4

2023
 
46.6

 
19.1

Thereafter
 
195.8

 
187.6

Total lease payments
 
442.5

 
294.0

Less: imputed interest
 
(152.6
)
 
(144.8
)
Total lease obligations
 
$
289.9

 
$
149.2
Maturity of Finance Leases
Future maturities of lease liabilities at June 30, 2019 are presented in the following table (in millions):
 
 
Operating Leases
 
Finance Leases
 
 
 
 
 
2019
 
$
35.4

 
$
15.2

2020
 
59.7

 
26.3

2021
 
55.1

 
24.4

2022
 
49.9

 
21.4

2023
 
46.6

 
19.1

Thereafter
 
195.8

 
187.6

Total lease payments
 
442.5

 
294.0

Less: imputed interest
 
(152.6
)
 
(144.8
)
Total lease obligations
 
$
289.9

 
$
149.2
Maturity of Leases Prior to Adoption of 842
Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. As of December 31, 2018, the current portion of the financing obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portion of the finance obligations was $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
Maturity of Leases Prior to Adoption of 842
Future maturities of lease liabilities at December 31, 2018, prior to the adoption of the Lease Accounting Standard, are presented in the following table (in millions):
 
 
Operating Leases (1)
 
Capital Leases
 
 
 
 
 
2019
 
$
81.5

 
$
8.8

2020
 
75.6

 
6.7

2021
 
66.7

 
4.7

2022
 
61.3

 
2.9

2023
 
57.2

 
1.5

Thereafter
 
470.2

 
4.3

Total lease payments
 
$
812.5

 
28.9

Less: imputed interest
 
 
 
(3.5
)
Capital lease obligations
 
 
 
$
25.4

(1)
Includes financing obligations payable to the lessors of certain land, buildings and improvements that arose due to the Company's continued involvement with the leased assets under the sale-leaseback guidance in effect prior to the adoption of the Lease Accounting Standard. As of December 31, 2018, the current portion of the financing obligations was $7.0 million and was included in other current liabilities in the consolidated balance sheets. The long-term portion of the finance obligations was $149.8 million and was included as other long-term liabilities in the consolidated balance sheets.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.2
Redeemable Preferred Stock (Tables)
 6 Months Ended
Jun. 30, 2019
Temporary Equity Disclosure [Abstract]  
Activity Related to Redeemable Preferred Stock
A summary of activity related to the redeemable preferred stock follows (in millions):
Balance at December 31, 2018
 
$
359.3

Dividends accrued (there were no cash dividends declared)
 
17.3

Balance at June 30, 2019
 
$
376.6
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.2
Derivatives and Hedging Activities (Tables)
 6 Months Ended
Jun. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Effect of Interest Rate Swaps
The following table presents the pre-tax effect of the interest rate swaps on the Company's accumulated other comprehensive income ("OCI") and statement of operations for the three and six months ended June 30, 2019 (dollars in millions):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2019
 
2018 (1)
 
2019
 
2018 (1)
Derivatives in Cash Flow Hedging Relationships
 
 
 
 
 
 
 
 
Loss recognized in OCI (effective portion)
 
$
18.3

 
$
—

 
$
31.1

 
$
—

Loss reclassified from accumulated OCI to interest expense (effective portion)
 
$
1.5

 
$
—

 
$
2.8

 
$
—

(1)
There were no derivatives outstanding for the comparative periods in 2018.
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.2
Earnings Per Share (Tables)
 6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts, shares in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Numerator:
 
 
 
 
 
 
 
Net loss attributable to Surgery Partners, Inc.
$
(19.8
)
 
$
(19.5
)
 
$
(39.9
)
 
$
(37.0
)
Less: amounts allocated to participating securities (1)
(8.8
)
 
(7.9
)
 
(17.3
)
 
(15.7
)
Net loss attributable to common stockholders
$
(28.6
)
 
$
(27.4
)
 
$
(57.2
)
 
$
(52.7
)
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding- basic
48,291

 
48,016

 
48,241

 
48,012

Effect of dilutive securities (2)
—

 
—

 
—

 
—

Weighted average shares outstanding- diluted
48,291

 
48,016

 
48,241

 
48,012

 
 
 
 
 
 
 
 
Loss per share:
 
 
 
 
 
 
 
Basic
$
(0.59
)
 
$
(0.57
)
 
$
(1.19
)
 
$
(1.10
)
Diluted (2)
$
(0.59
)
 
$
(0.57
)
 
$
(1.19
)
 
$
(1.10
)
 
 
 
 
 
 
 
 
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
 
 
 
 
 
 
 
Stock options
—

 
161

 
—

 
144

Restricted shares
25

 
86

 
27

 
83

Convertible preferred stock
N/A

 
N/A

 
N/A

 
N/A

(1)
Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.
(2)
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.2
Other Assets and Liabilities (Tables)
 6 Months Ended
Jun. 30, 2019
Balance Sheet Related Disclosures [Abstract]  
Schedule of Other Long-term Assets
A summary of other long-term assets is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease assets
 
$
285.0

 
$
—

Other
 
28.0

 
36.9

Total
 
$
313.0

 
$
36.9
Summary of Other Current Liabilities
A summary of other current liabilities is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Accrued legal settlement
 
$
42.0

 
$
42.3

Right-of-use operating lease liabilities
 
34.8

 
—

Interest payable
 
22.4

 
20.8

Amounts due to patients and payors
 
17.5

 
20.0

Accrued expenses and other
 
77.2

 
72.1

Total
 
$
193.9

 
$
155.2
Summary of Other Long-term Liabilities
A summary of other long-term liabilities is as follows (in millions):
 
 
June 30,
2019
 
December 31,
2018
 
 
 
 
 
Right-of-use operating lease liabilities
 
$
255.1

 
$
—

Facility lease obligations
 
—

 
149.8

Other
 
132.0

 
121.5

Total
 
$
387.1

 
$
271.3
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.2
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
Schedule of Segment Revenue and Operating Income
The following tables present financial information for each reportable segment (in millions):

Three Months Ended June 30,
 
Six Months Ended June 30,

2019
 
2018
 
2019
 
2018
Revenues:
 
 
 
 
 
 
 
Surgical facility services
$
424.0

 
$
413.0

 
$
819.8

 
$
801.3

Ancillary services
20.4

 
20.8

 
40.3

 
40.8

Optical services
1.0

 
2.8

 
2.1

 
5.8

Total
$
445.4

 
$
436.6

 
$
862.2

 
$
847.9

 
 
 
 
 
 
 
 
Adjusted EBITDA:
 
 
 
 
 
 
 
Surgical facility services
$
78.4

 
$
75.5

 
$
146.8

 
$
142.0

Ancillary services
1.4

 
1.0

 
2.6

 
2.1

Optical services
0.4

 
0.7

 
0.9

 
1.5

All other
(19.0
)
 
(21.8
)
 
(38.3
)
 
(43.1
)
Total
$
61.2

 
$
55.4

 
$
112.0

 
$
102.5

 
 
 
 
 
 
 
 
Adjusted EBITDA:
$
61.2

 
$
55.4

 
$
112.0

 
$
102.5

Net income attributable to non-controlling interests
27.9

 
23.8

 
51.5

 
46.4

Depreciation and amortization
(19.1
)
 
(16.7
)
 
(37.9
)
 
(32.4
)
Interest expense, net
(46.4
)
 
(35.9
)
 
(88.4
)
 
(70.2
)
Equity-based compensation expense
(3.0
)
 
(2.8
)
 
(4.9
)
 
(4.8
)
Contingent acquisition compensation expense
—

 
(0.5
)
 
—

 
(1.0
)
Transaction, integration and acquisition costs (1)
(8.0
)
 
(12.5
)
 
(11.5
)
 
(18.0
)
Reserve adjustments (2)
—

 
—

 
—

 
(4.8
)
Loss on debt extinguishment
(11.7
)
 
—

 
(11.7
)
 
—

Gain (loss) on disposals and deconsolidations, net
8.2

 
(3.2
)
 
7.6

 
(3.2
)
Tax receivable agreement expense
—

 
—

 
(2.4
)
 
—

Income before income taxes
$
9.1

 
$
7.6

 
$
14.3

 
$
14.5


(1)
For the three months ended June 30, 2019 and 2018, this amount includes transaction and integration costs of $6.2 million and $11.7 million, respectively, and acquisition costs of $1.2 million and $0.8 million, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $0.6 million for the three months ended June 30, 2019, with no comparable costs in the 2018 period. For the six months ended June 30, 2019 and 2018, this amount includes transaction and integration costs of $8.2 million and $16.7 million, respectively, and acquisition costs of $1.5 million and $1.3 million, respectively. This amount further includes start-up costs related to a de novo surgical hospital of $1.8 million for the six months ended June 30, 2019, with no comparable costs in the 2018 period.
(2)
This amount represents adjustments to revenue in connection with applying consistent policies across the combined company as a result of the integration of Surgery Partners and NSH Holdco, Inc.
Reconciliation of Assets from Segment to Consolidated
 
 
June 30,
2019
 
December 31,
2018
Assets:
 
 
 
 
Surgical facility services
 
$
4,445.5

 
$
4,204.3

Ancillary services
 
80.1

 
52.7

Optical services
 
21.8

 
20.1

All other
 
343.5

 
399.2

Total assets
 
$
4,890.9

 
$
4,676.3
Schedule of Financial Information by Reportable Segment
 
 
Six Months Ended June 30,
 
 
2019
 
2018
Cash purchases of property and equipment, net:
 
 
 
 
Surgical facility services
 
$
25.3

 
$
13.2

Ancillary services
 
0.3

 
0.3

All other
 
6.2

 
2.4

Total cash purchases of property and equipment, net
 
$
31.8

 
$
15.9
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Organization (Details)
Jun. 30, 2019
surgical_facility
state
Products And Services [Line Items]  
Number of surgical facilities owned 128
Number of states in which entity operates | state 31
Number of surgical facilities owned, majority interest 85
Number of surgical facilities owned, consolidated 107
Facilities, Ambulatory Surgery Centers  
Products And Services [Line Items]  
Number of surgical facilities owned 113
Facilities, Surgical Hospitals  
Products And Services [Line Items]  
Number of surgical facilities owned 15
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Variable Interest Entities (Details)
$ in Millions
Jun. 30, 2019
Anesthesia_Practice
Jun. 30, 2019
surgical_facility
Jun. 30, 2019
physician_practice
Jun. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Variable Interest Entity [Line Items]          
Number of facilities included in VIE 3 4 3    
Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure          
Variable Interest Entity [Line Items]          
Total assets related to VIE       $ 24.8 $ 11.2
Total liabilities related to VIE       $ 17.2 $ 3.6
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) - Senior Notes - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Senior Unsecured Notes due 2021    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt $ 0.0 $ 406.7
Senior Unsecured Notes due 2021 | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 0.0 406.7
Senior Unsecured Notes due 2021 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 0.0 407.2
Senior Unsecured Notes due 2025    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 370.0 370.0
Senior Unsecured Notes due 2025 | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 370.0 370.0
Senior Unsecured Notes due 2025 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 324.7 320.5
Senior Unsecured Notes due 2027    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 430.0 0.0
Senior Unsecured Notes due 2027 | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 430.0  
Senior Unsecured Notes due 2027 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 427.9  
Revolving Credit Facility | Term Loan | Carrying Amount    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt 1,440.8 1,447.9
Revolving Credit Facility | Term Loan | Fair Value | Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt $ 1,386.8 $ 1,382.8
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Interest rate swap agreement $ 50.7 $ 22.4
Fair Value, Inputs, Level 1    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Assets of SERP $ 1.0 $ 1.4
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) - Revenue Source - Revenue
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenue from External Customer [Line Items]        
Service revenues as a percentage of total revenues 100.00% 100.00% 100.00% 100.00%
Healthcare Organization, Patient Service        
Revenue from External Customer [Line Items]        
Service revenues as a percentage of total revenues 98.70% 97.50% 98.70% 97.90%
Surgical Facility Services        
Revenue from External Customer [Line Items]        
Service revenues as a percentage of total revenues 94.10% 92.60% 94.00% 93.00%
Ancillary Services        
Revenue from External Customer [Line Items]        
Service revenues as a percentage of total revenues 4.60% 4.90% 4.70% 4.90%
Healthcare Organization, Other Service        
Revenue from External Customer [Line Items]        
Service revenues as a percentage of total revenues 1.30% 2.50% 1.30% 2.10%
Optical Services        
Revenue from External Customer [Line Items]        
Service revenues as a percentage of total revenues 0.20% 0.60% 0.20% 0.70%
Other        
Revenue from External Customer [Line Items]        
Service revenues as a percentage of total revenues 1.10% 1.90% 1.10% 1.40%
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Total revenues $ 445.4 $ 436.6 $ 862.2 $ 847.9
Healthcare Organization, Patient Service        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Total revenues $ 439.5 $ 425.3 $ 850.3 $ 830.0
Healthcare Organization, Patient Service | Customer | Revenue        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Service revenues as a percentage of total revenues 100.00% 100.00% 100.00% 100.00%
Healthcare Organization, Patient Service | Private insurance        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Total revenues $ 230.5 $ 227.7 $ 445.8 $ 444.2
Healthcare Organization, Patient Service | Private insurance | Customer | Revenue        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Service revenues as a percentage of total revenues 52.40% 53.50% 52.40% 53.50%
Healthcare Organization, Patient Service | Government        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Total revenues $ 178.1 $ 163.9 $ 343.0 $ 321.0
Healthcare Organization, Patient Service | Government | Customer | Revenue        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Service revenues as a percentage of total revenues 40.50% 38.60% 40.30% 38.70%
Healthcare Organization, Patient Service | Self-pay        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Total revenues $ 9.5 $ 13.1 $ 20.3 $ 25.9
Healthcare Organization, Patient Service | Self-pay | Customer | Revenue        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Service revenues as a percentage of total revenues 2.20% 3.10% 2.40% 3.10%
Healthcare Organization, Patient Service | Other        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Total revenues $ 21.4 $ 20.6 $ 41.2 $ 38.9
Healthcare Organization, Patient Service | Other | Customer | Revenue        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Service revenues as a percentage of total revenues 4.90% 4.80% 4.90% 4.70%
Optical Services        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Total revenues $ 1.0 $ 2.8 $ 2.1 $ 5.8
Other        
Health Care Organization, Receivable and Revenue Disclosures [Line Items]        
Total revenues $ 4.9 $ 8.5 $ 9.8 $ 12.1
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Restricted invested assets included in other long-term assets $ 0.3 $ 0.3
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Third-Party Medicaid settlement liability $ 7.5 $ 4.8
Optical products receivable $ 10.0 $ 8.5
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2019
USD ($)
Goodwill [Roll Forward]  
Goodwill, beginning of period $ 3,382.8
Acquisitions, including post acquisition adjustments 19.5
Goodwill, end of period $ 3,402.3
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2019
USD ($)
Non-Controlling Interests - Redeemable [Roll Forward]  
Beginning balance $ 326.6
Net income attributable to non-controlling interests—redeemable 16.8
Acquisition and disposal of shares of non-controlling interests, net—redeemable (7.7)
Distributions to non-controlling interest—redeemable holders (19.7)
Ending balance $ 316.0
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.19.2
Organization and Summary of Accounting Policies - Recent Accounting Pronouncements (Details)
$ in Millions
Jan. 01, 2019
USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Cumulative effect of accounting change, adjustment to retained deficit $ 18.0
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.19.2
Acquisitions - Additional Information (Details)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2019
USD ($)
surgical_facility
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
surgical_facility
physician_practice
Jun. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Business Acquisition [Line Items]          
Payments for acquisitions, net of cash acquired     $ 13.2 $ 47.9  
Goodwill allocated $ 3,402.3   3,402.3   $ 3,382.8
Cash investments to acquire non-controlling interests     15.2 0.0  
Pretax gain recognized on sale 8.2 $ (3.2) $ 7.6 $ (3.2)  
Surgical Facility          
Business Acquisition [Line Items]          
Number of businesses acquired | surgical_facility     1    
Physician Practice          
Business Acquisition [Line Items]          
Number of businesses acquired | physician_practice     1,000    
Surgical Facility and Physician Practice          
Business Acquisition [Line Items]          
Payments for acquisitions, net of cash acquired     $ 13.2    
Goodwill allocated 19.9   19.9    
Surgical Facility Services | Surgical Facility and Physician Practice          
Business Acquisition [Line Items]          
Goodwill allocated 11.4   11.4    
Ancillary Services | Surgical Facility and Physician Practice          
Business Acquisition [Line Items]          
Goodwill allocated $ 8.5   $ 8.5    
Other Acquisitions, Noncontrolling Interest          
Business Acquisition [Line Items]          
Number of non-controlling interests acquired | surgical_facility 4   4    
Cash investments to acquire non-controlling interests     $ 14.0    
Disposed of by Sale          
Business Acquisition [Line Items]          
Pretax gain recognized on sale     $ 10.9    
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.19.2
Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Net assets acquired:    
Goodwill $ 3,402.3 $ 3,382.8
Surgical Facility and Physician Practice    
Business Acquisition [Line Items]    
Cash consideration 13.4  
Fair value of non-controlling interests 8.3  
Acquisition date fair value 21.7  
Net assets acquired:    
Current Assets 1.4  
Property and equipment 1.0  
Goodwill 19.9  
Current liabilities (0.5)  
Long-term debt, less current maturities (0.1)  
Aggregate acquisition date fair value $ 21.7  
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Debt - Summary of Long-Term Debt (Details) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Debt Instrument [Line Items]    
Total lease obligations $ 149.2 $ 25.4
Less: unamortized debt issuance costs (11.2) (2.9)
Total debt 2,454.7 2,326.5
Less: Current maturities 57.3 55.6
Total long-term debt 2,397.4 2,270.9
Unamortized fair value premium   6.7
Secured Debt | Term Loan    
Debt Instrument [Line Items]    
Long-term debt 1,440.8 1,447.9
Unamortized fair value discount (5.3) (5.5)
Senior Notes | Senior Unsecured Notes due 2021    
Debt Instrument [Line Items]    
Long-term debt 0.0 406.7
Senior Notes | Senior Unsecured Notes due 2025    
Debt Instrument [Line Items]    
Long-term debt 370.0 370.0
Senior Notes | Senior Unsecured Notes due 2027    
Debt Instrument [Line Items]    
Long-term debt 430.0 0.0
Notes payable and secured loans    
Debt Instrument [Line Items]    
Long-term debt $ 75.9 $ 79.4
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Debt - Senior Unsecured Notes due 2027 (Details) - Senior Notes - Senior Unsecured Notes, Due 2027 - USD ($)
Apr. 11, 2019
Jun. 30, 2019
Debt Instrument [Line Items]    
Face value of debt issued $ 430,000,000.0  
Stated interest rate 10.00%  
Percentage of debt principal redeemable 40.00%  
Debt issuance costs   $ 8,800,000
Redemption Condition One    
Debt Instrument [Line Items]    
Redemption price of debt 110.00%  
Redemption Condition Two    
Debt Instrument [Line Items]    
Redemption price of debt 100.00%  
Redemption Condition Six    
Debt Instrument [Line Items]    
Redemption price of debt 101.00%  
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Debt - Debt Redemption Schedule (Details) - Senior Notes - Senior Unsecured Notes, Due 2027
Apr. 11, 2019
April 15, 2022 to April 14, 2023  
Debt Instrument [Line Items]  
Redemption price of debt 105.00%
April 15, 2023 to April 14, 2024  
Debt Instrument [Line Items]  
Redemption price of debt 102.50%
April 15, 2024 and thereafter  
Debt Instrument [Line Items]  
Redemption price of debt 100.00%
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Debt - Senior Unsecured Notes due 2021 (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Apr. 11, 2019
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Debt Instrument [Line Items]          
Loss on debt extinguishment   $ 11.7 $ 0.0 $ 11.7 $ 0.0
Senior Notes | Senior Unsecured Notes, Due 2021          
Debt Instrument [Line Items]          
Redemption price of debt 104.438%        
Loss on debt extinguishment   $ 11.7   $ 11.7  
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Debt - Revolver (Details) - Secured Debt - 2017 Revolver Loan, Maturing 2022 - USD ($)
Jun. 30, 2019
Apr. 11, 2019
Dec. 31, 2018
Revolving Credit Facility      
Debt Instrument [Line Items]      
Amount of line of credit outstanding $ 0 $ 45,000,000 $ 0
Availability on line of credit instrument 115,900,000    
Letter of Credit      
Debt Instrument [Line Items]      
Availability on line of credit instrument $ 4,100,000    
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.19.2
Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2019
USD ($)
option_to_renew
Dec. 31, 2018
USD ($)
Lessee, Lease, Description [Line Items]    
Initial term of operating leases 10 years  
Number of options to renew operating leases | option_to_renew 1  
Assets:    
Operating lease assets $ 285.0 $ 0.0
Finance lease assets 146.1  
Total leased assets 431.1  
Operating lease liabilities:    
Current 34.8 0.0
Long-term 255.1 0.0
Total operating lease liabilities 289.9  
Finance lease liabilities:    
Current 13.1 7.0
Long-term 136.1 149.8
Total finance lease liabilities 149.2 $ 25.4
Total lease liabilities $ 439.1  
Minimum    
Lessee, Lease, Description [Line Items]    
Typical term of finance leases 5 years  
Maximum    
Lessee, Lease, Description [Line Items]    
Typical term of finance leases 7 years  
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.19.2
Leases - Lease Expense and Cash Flow Information (Details)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Lessee, Lease, Description [Line Items]    
Operating lease costs $ 34.4  
Finance lease costs    
Amortization of leased assets 9.3  
Interest on lease liabilities 7.3  
Total finance lease costs 16.6  
Variable and short-term lease costs 6.0  
Total lease costs $ 57.0  
Weighted-average remaining lease term, operating leases 8 years 5 months 20 days 8 years 5 months 20 days
Weighted-average remaining lease term, finance leases 13 years 28 days 13 years 28 days
Weighted-average discount rate, operating leases 10.30% 10.30%
Weighted-average discount rate, finance leases 10.50% 10.50%
Operating cash outflows from operating leases   $ 32.8
Operating cash outflows from finance leases   7.3
Financing cash outflows from finance leases   5.2
Right-of-use assets obtained in exchange for operating leases   5.0
Right-of-use assets obtained in exchange for finance leases   5.0
Physician Investors    
Lessee, Lease, Description [Line Items]    
Operating lease costs   $ 10.2
Noncontrolling Interest    
Finance lease costs    
Rent paid under finance lease agreement, allocated to principal and interest $ 3.2  
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.19.2
Leases - Maturities of Lease Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Operating Leases    
2019 $ 35.4  
2020 59.7  
2021 55.1  
2022 49.9  
2023 46.6  
Thereafter 195.8  
Total lease payments 442.5  
Less: imputed interest (152.6)  
Total lease obligations 289.9  
Finance Leases    
2019 15.2  
2020 26.3  
2021 24.4  
2022 21.4  
2023 19.1  
Thereafter 187.6  
Total lease payments 294.0  
Less: imputed interest (144.8)  
Total lease obligations $ 149.2 $ 25.4
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.19.2
Leases - Maturities of Leases Prior to Adoption of 842 (Details) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Operating Leases (1)    
2019   $ 81.5
2020   75.6
2021   66.7
2022   61.3
2023   57.2
Thereafter   470.2
Total lease payments   812.5
Capital Leases    
2019   8.8
2020   6.7
2021   4.7
2022   2.9
2023   1.5
Thereafter   4.3
Total lease payments   28.9
Less: imputed interest   (3.5)
Capital lease obligations   25.4
Current portion of finance lease $ 13.1 7.0
Noncurrent portion of finance lease $ 136.1 $ 149.8
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.19.2
Redeemable Preferred Stock - Additional Information (Details) - Series A Preferred Stock - USD ($)
 6 Months Ended
Aug. 31, 2017
Jun. 30, 2019
Dec. 31, 2018
Temporary Equity [Line Items]      
Dividends payable   $ 0 $ 0
Cumulative preferred dividends   $ 51,000,000  
Preferred dividends payable (in USD per share)   $ 164.64  
Majority Shareholder      
Temporary Equity [Line Items]      
Stock issued during period (shares) 310,000    
Purchase price per share (in USD per share) $ 1,000    
Proceeds from issuance of preferred shares $ 310,000,000    
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.19.2
Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details)
$ in Millions
 6 Months Ended
Jun. 30, 2019
USD ($)
Increase (Decrease) in Temporary Equity [Roll Forward]  
Beginning balance $ 359.3
Ending balance 376.6
Series A Preferred Stock  
Increase (Decrease) in Temporary Equity [Roll Forward]  
Beginning balance 359.3
Dividends accrued (there were no cash dividends declared) 17.3
Ending balance $ 376.6
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.19.2
Derivatives and Hedging Activities (Details)
 3 Months Ended 6 Months Ended
Jun. 30, 2019
USD ($)
swap
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
swap
Jun. 30, 2018
USD ($)
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]        
Estimated reduction to interest expense     $ 11,600,000  
Number of interest rate swaps | swap 4   4  
Derivative notional amount   $ 0   $ 0
Loss recognized in OCI (effective portion) $ 18,300,000 0 $ 31,100,000 0
Loss reclassified from accumulated OCI to interest expense (effective portion) 1,500,000 $ 0 2,800,000 $ 0
Interest Rate Swap One        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]        
Derivative notional amount $ 1,200,000,000   $ 1,200,000,000  
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.19.2
Earnings Per Share (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 15, 2017
Numerator:          
Net loss attributable to Surgery Partners, Inc. $ (19,800,000) $ (19,500,000) $ (39,900,000) $ (37,000,000)  
Less: amounts allocated to participating securities (8,800,000) (7,900,000) (17,300,000) (15,700,000)  
Net loss attributable to common stockholders $ (28,600,000) $ (27,400,000) $ (57,200,000) $ (52,700,000)  
Denominator:          
Weighted average shares outstanding- basic (shares) 48,291,000 48,016,000 48,241,000 48,012,000  
Effect of dilutive securities (shares) 0 0 0 0  
Weighted average shares outstanding- diluted (shares) [1] 48,291,000 48,016,000 48,241,000 48,012,000  
Loss per share:          
Basic (in USD per share) $ (0.59) $ (0.57) $ (1.19) $ (1.10)  
Diluted (in USD per share) [1] $ (0.59) $ (0.57) $ (1.19) $ (1.10)  
Authorized share repurchase amount         $ 50,000,000.0
Stock repurchased (shares)     0 156,818  
Average repurchase cost (in USD per share)       $ 12.64  
Remaining repurchase authorization available $ 46,000,000   $ 46,000,000    
Stock options          
Loss per share:          
Antidilutive securities excluded from computation of (loss) per share (shares) 0 161,000 0 144,000  
Restricted shares          
Loss per share:          
Antidilutive securities excluded from computation of (loss) per share (shares) 25,000 86,000 27,000 83,000  
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in those periods.
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.19.2
Other Assets and Liabilities - Other Long-term Assets (Details) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]    
Right-of-use operating lease assets $ 285.0 $ 0.0
Other 28.0 36.9
Total $ 313.0 $ 36.9
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.19.2
Other Assets and Liabilities - Other Current Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]    
Accrued legal settlement $ 42.0 $ 42.3
Right-of-use operating lease liabilities 34.8 0.0
Interest payable 22.4 20.8
Amounts due to patients and payors 17.5 20.0
Accrued expenses and other 77.2 72.1
Total $ 193.9 $ 155.2
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.19.2
Other Assets and Liabilities - Other Long-Term Liabilities (Details) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Balance Sheet Related Disclosures [Abstract]    
Right-of-use operating lease liabilities $ 255.1 $ 0.0
Facility lease obligations 0.0 149.8
Other 132.0 121.5
Total $ 387.1 $ 271.3
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.19.2
Commitments and Contingencies (Details) - USD ($)
$ in Millions
 6 Months Ended 12 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Guarantor Obligations [Line Items]    
Professional, general and workers' compensation insurance reserve $ 19.4 $ 18.2
Expected insurance recoveries $ 12.0 12.0
Litigation related charge   46.0
Federal effective tax rate 24.00%  
Long-term tax receivable agreement liability $ 68.2 64.6
Net long-term tax receivable agreement liability 53.9 48.5
Current portion of tax liability $ 8.0 $ 7.6
Materially More Restrictive | LIBOR    
Guarantor Obligations [Line Items]    
Debt instrument, basis spread on variable rate 5.00%  
Not Materially More Restrictive | LIBOR    
Guarantor Obligations [Line Items]    
Debt instrument, basis spread on variable rate 3.00%  
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.19.2
Segment Reporting - Revenues and Operating Income by Reportable Segment (Details)
 3 Months Ended 6 Months Ended
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
segment
Jun. 30, 2018
USD ($)
Segment Reporting [Abstract]        
Number of operating segments | segment     3  
Segment Reporting Information [Line Items]        
Revenues $ 445,400,000 $ 436,600,000 $ 862,200,000 $ 847,900,000
Adjusted EBITDA 61,200,000 55,400,000 112,000,000 102,500,000
Net income attributable to non-controlling interests 27,900,000 23,800,000 51,500,000 46,400,000
Depreciation and amortization (19,100,000) (16,700,000) (37,900,000) (32,400,000)
Interest expense, net (46,400,000) (35,900,000) (88,400,000) (70,200,000)
Equity-based compensation expense (3,000,000) (2,800,000) (4,900,000) (4,800,000)
Contingent acquisition compensation expense 0 (500,000) 0 (1,000,000)
Transaction, integration and practice acquisition costs (8,000,000) (12,500,000) (11,500,000) (18,000,000)
Reserve adjustments 0 0 0 (4,800,000)
Loss on debt extinguishment (11,700,000) 0 (11,700,000) 0
Gain (loss) on disposals and deconsolidations, net 8,200,000 (3,200,000) 7,600,000 (3,200,000)
Tax receivable agreement expense 0 0 (2,400,000) 0
Income before income taxes 9,100,000 7,600,000 14,300,000 14,500,000
Transaction and integration costs 6,200,000 11,700,000 8,200,000 16,700,000
Acquisition costs 1,200,000 800,000 1,500,000 1,300,000
Start-up costs related to de novo surgical hospital 600,000 0    
Operating Segments | Surgical Facility Services        
Segment Reporting Information [Line Items]        
Revenues 424,000,000 413,000,000 819,800,000 801,300,000
Adjusted EBITDA 78,400,000 75,500,000 146,800,000 142,000,000
Operating Segments | Ancillary Services        
Segment Reporting Information [Line Items]        
Revenues 20,400,000 20,800,000 40,300,000 40,800,000
Adjusted EBITDA 1,400,000 1,000,000 2,600,000 2,100,000
Operating Segments | Optical Services        
Segment Reporting Information [Line Items]        
Revenues 1,000,000 2,800,000 2,100,000 5,800,000
Adjusted EBITDA 400,000 700,000 900,000 1,500,000
All Other        
Segment Reporting Information [Line Items]        
Adjusted EBITDA $ (19,000,000) $ (21,800,000) $ (38,300,000) $ (43,100,000)
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.19.2
Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Segment Reporting Information [Line Items]      
Assets $ 4,890.9   $ 4,676.3
Purchases of property and equipment, net 31.8 $ 15.9  
Operating Segments | Surgical Facility Services      
Segment Reporting Information [Line Items]      
Assets 4,445.5   4,204.3
Purchases of property and equipment, net 25.3 13.2  
Operating Segments | Ancillary Services      
Segment Reporting Information [Line Items]      
Assets 80.1   52.7
Purchases of property and equipment, net 0.3 0.3  
Operating Segments | Optical Services      
Segment Reporting Information [Line Items]      
Assets 21.8   20.1
All Other      
Segment Reporting Information [Line Items]      
Assets 343.5   $ 399.2
Purchases of property and equipment, net $ 6.2 $ 2.4  
XML 71 R9999.htm IDEA: XBRL DOCUMENT v3.19.2
Label Element Value
Retained Earnings [Member]  
Cumulative Effect of New Accounting Principle in Period of Adoption us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption $ 18,000,000
EXCEL 72 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 74 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 75 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 238 383 1 true 62 0 false 11 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.surgerypartners.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.surgerypartners.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001001 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.surgerypartners.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 1004000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeLoss Condensed Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 1005000 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1006000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.surgerypartners.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101100 - Disclosure - Organization and Summary of Accounting Policies Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPolicies Organization and Summary of Accounting Policies Notes 8 false false R9.htm 2102100 - Disclosure - Acquisitions Sheet http://www.surgerypartners.com/role/Acquisitions Acquisitions Notes 9 false false R10.htm 2103100 - Disclosure - Long-Term Debt Sheet http://www.surgerypartners.com/role/LongTermDebt Long-Term Debt Notes 10 false false R11.htm 2104100 - Disclosure - Leases Sheet http://www.surgerypartners.com/role/Leases Leases Notes 11 false false R12.htm 2105100 - Disclosure - Redeemable Preferred Stock Sheet http://www.surgerypartners.com/role/RedeemablePreferredStock Redeemable Preferred Stock Notes 12 false false R13.htm 2106100 - Disclosure - Derivatives and Hedging Activities Sheet http://www.surgerypartners.com/role/DerivativesAndHedgingActivities Derivatives and Hedging Activities Notes 13 false false R14.htm 2107100 - Disclosure - Earnings Per Share Sheet http://www.surgerypartners.com/role/EarningsPerShare Earnings Per Share Notes 14 false false R15.htm 2108100 - Disclosure - Other Assets and Liabilities Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilities Other Assets and Liabilities Notes 15 false false R16.htm 2109100 - Disclosure - Commitments and Contingencies Sheet http://www.surgerypartners.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 16 false false R17.htm 2110100 - Disclosure - Segment Reporting Sheet http://www.surgerypartners.com/role/SegmentReporting Segment Reporting Notes 17 false false R18.htm 2201201 - Disclosure - Organization and Summary of Accounting Policies (Policies) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesPolicies Organization and Summary of Accounting Policies (Policies) Policies http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPolicies 18 false false R19.htm 2301302 - Disclosure - Organization and Summary of Accounting Policies (Tables) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesTables Organization and Summary of Accounting Policies (Tables) Tables http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPolicies 19 false false R20.htm 2302301 - Disclosure - Acquisitions (Tables) Sheet http://www.surgerypartners.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.surgerypartners.com/role/Acquisitions 20 false false R21.htm 2303301 - Disclosure - Long-Term Debt (Tables) Sheet http://www.surgerypartners.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.surgerypartners.com/role/LongTermDebt 21 false false R22.htm 2304301 - Disclosure - Leases (Tables) Sheet http://www.surgerypartners.com/role/LeasesTables Leases (Tables) Tables http://www.surgerypartners.com/role/Leases 22 false false R23.htm 2305301 - Disclosure - Redeemable Preferred Stock (Tables) Sheet http://www.surgerypartners.com/role/RedeemablePreferredStockTables Redeemable Preferred Stock (Tables) Tables http://www.surgerypartners.com/role/RedeemablePreferredStock 23 false false R24.htm 2306301 - Disclosure - Derivatives and Hedging Activities (Tables) Sheet http://www.surgerypartners.com/role/DerivativesAndHedgingActivitiesTables Derivatives and Hedging Activities (Tables) Tables http://www.surgerypartners.com/role/DerivativesAndHedgingActivities 24 false false R25.htm 2307301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.surgerypartners.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.surgerypartners.com/role/EarningsPerShare 25 false false R26.htm 2308301 - Disclosure - Other Assets and Liabilities (Tables) Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilitiesTables Other Assets and Liabilities (Tables) Tables http://www.surgerypartners.com/role/OtherAssetsAndLiabilities 26 false false R27.htm 2310301 - Disclosure - Segment Reporting (Tables) Sheet http://www.surgerypartners.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.surgerypartners.com/role/SegmentReporting 27 false false R28.htm 2401403 - Disclosure - Organization and Summary of Accounting Policies - Organization (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesOrganizationDetails Organization and Summary of Accounting Policies - Organization (Details) Details 28 false false R29.htm 2401404 - Disclosure - Organization and Summary of Accounting Policies - Variable Interest Entities (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesVariableInterestEntitiesDetails Organization and Summary of Accounting Policies - Variable Interest Entities (Details) Details 29 false false R30.htm 2401405 - Disclosure - Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesCarryingAmountAndFairValueOfLongTermDebtDetails Organization and Summary of Accounting Policies - Carrying Amount and Fair Value of Long-Term Debt (Details) Details 30 false false R31.htm 2401406 - Disclosure - Organization and Summary of Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesFairValueOfFinancialInstrumentsNarrativeDetails Organization and Summary of Accounting Policies - Fair Value of Financial Instruments, Narrative (Details) Details 31 false false R32.htm 2401407 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesScheduleOfRevenuesByServiceTypeDetails Organization and Summary of Accounting Policies - Schedule of Revenues by Service Type (Details) Details 32 false false R33.htm 2401408 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesScheduleOfRevenuesBySourcesDetails Organization and Summary of Accounting Policies - Schedule of Revenues by Sources (Details) Details 33 false false R34.htm 2401409 - Disclosure - Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesCashCashEquivalentsAndRestrictedCashDetails Organization and Summary of Accounting Policies - Cash, Cash Equivalents and Restricted Cash (Details) Details 34 false false R35.htm 2401410 - Disclosure - Organization and Summary of Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesAccountsReceivableAndAllowancesForContractualAdjustmentsAndDoubtfulAccountsDetails Organization and Summary of Accounting Policies - Accounts Receivable and Allowances for Contractual Adjustments and Doubtful Accounts (Details) Details 35 false false R36.htm 2401411 - Disclosure - Organization and Summary of Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesRollforwardOfGoodwillAndInformationOnImpairmentsDetails Organization and Summary of Accounting Policies - Rollforward of Goodwill and Information on Impairments (Details) Details 36 false false R37.htm 2401412 - Disclosure - Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesScheduleOfNonControllingInterestsRedeemableDetails Organization and Summary of Accounting Policies - Schedule of Non-Controlling Interests - Redeemable (Details) Details 37 false false R38.htm 2401413 - Disclosure - Organization and Summary of Accounting Policies - Recent Accounting Pronouncements (Details) Sheet http://www.surgerypartners.com/role/OrganizationAndSummaryOfAccountingPoliciesRecentAccountingPronouncementsDetails Organization and Summary of Accounting Policies - Recent Accounting Pronouncements (Details) Details 38 false false R39.htm 2402402 - Disclosure - Acquisitions - Additional Information (Details) Sheet http://www.surgerypartners.com/role/AcquisitionsAdditionalInformationDetails Acquisitions - Additional Information (Details) Details 39 false false R40.htm 2402403 - Disclosure - Acquisitions - Assets Acquired and Liabilities Assumed (Details) Sheet http://www.surgerypartners.com/role/AcquisitionsAssetsAcquiredAndLiabilitiesAssumedDetails Acquisitions - Assets Acquired and Liabilities Assumed (Details) Details 40 false false R41.htm 2403402 - Disclosure - Long-Term Debt - Summary of Long-Term Debt (Details) Sheet http://www.surgerypartners.com/role/LongTermDebtSummaryOfLongTermDebtDetails Long-Term Debt - Summary of Long-Term Debt (Details) Details 41 false false R42.htm 2403403 - Disclosure - Long-Term Debt - Senior Unsecured Notes due 2027 (Details) Notes http://www.surgerypartners.com/role/LongTermDebtSeniorUnsecuredNotesDue2027Details Long-Term Debt - Senior Unsecured Notes due 2027 (Details) Details 42 false false R43.htm 2403404 - Disclosure - Long-Term Debt - Debt Redemption Schedule (Details) Sheet http://www.surgerypartners.com/role/LongTermDebtDebtRedemptionScheduleDetails Long-Term Debt - Debt Redemption Schedule (Details) Details 43 false false R44.htm 2403405 - Disclosure - Long-Term Debt - Senior Unsecured Notes due 2021 (Details) Notes http://www.surgerypartners.com/role/LongTermDebtSeniorUnsecuredNotesDue2021Details Long-Term Debt - Senior Unsecured Notes due 2021 (Details) Details 44 false false R45.htm 2403406 - Disclosure - Long-Term Debt - Revolver (Details) Sheet http://www.surgerypartners.com/role/LongTermDebtRevolverDetails Long-Term Debt - Revolver (Details) Details 45 false false R46.htm 2404402 - Disclosure - Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details) Sheet http://www.surgerypartners.com/role/LeasesComponentsOfRightOfUsAssetsAndLiabilitiesRelatedToLeasesDetails Leases - Components of Right-of-us Assets and Liabilities Related to Leases (Details) Details 46 false false R47.htm 2404403 - Disclosure - Leases - Lease Expense and Cash Flow Information (Details) Sheet http://www.surgerypartners.com/role/LeasesLeaseExpenseAndCashFlowInformationDetails Leases - Lease Expense and Cash Flow Information (Details) Details 47 false false R48.htm 2404404 - Disclosure - Leases - Maturities of Lease Liabilities (Details) Sheet http://www.surgerypartners.com/role/LeasesMaturitiesOfLeaseLiabilitiesDetails Leases - Maturities of Lease Liabilities (Details) Details 48 false false R49.htm 2404405 - Disclosure - Leases - Maturities of Leases Prior to Adoption of 842 (Details) Sheet http://www.surgerypartners.com/role/LeasesMaturitiesOfLeasesPriorToAdoptionOf842Details Leases - Maturities of Leases Prior to Adoption of 842 (Details) Details 49 false false R50.htm 2405402 - Disclosure - Redeemable Preferred Stock - Additional Information (Details) Sheet http://www.surgerypartners.com/role/RedeemablePreferredStockAdditionalInformationDetails Redeemable Preferred Stock - Additional Information (Details) Details 50 false false R51.htm 2405403 - Disclosure - Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) Sheet http://www.surgerypartners.com/role/RedeemablePreferredStockRedeemablePreferredStockActivityDetails Redeemable Preferred Stock - Redeemable Preferred Stock Activity (Details) Details 51 false false R52.htm 2406402 - Disclosure - Derivatives and Hedging Activities (Details) Sheet http://www.surgerypartners.com/role/DerivativesAndHedgingActivitiesDetails Derivatives and Hedging Activities (Details) Details http://www.surgerypartners.com/role/DerivativesAndHedgingActivitiesTables 52 false false R53.htm 2407402 - Disclosure - Earnings Per Share (Details) Sheet http://www.surgerypartners.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.surgerypartners.com/role/EarningsPerShareTables 53 false false R54.htm 2408402 - Disclosure - Other Assets and Liabilities - Other Long-term Assets (Details) Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilitiesOtherLongTermAssetsDetails Other Assets and Liabilities - Other Long-term Assets (Details) Details 54 false false R55.htm 2408403 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details) Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilitiesOtherCurrentLiabilitiesDetails Other Assets and Liabilities - Other Current Liabilities (Details) Details 55 false false R56.htm 2408404 - Disclosure - Other Assets and Liabilities - Other Long-Term Liabilities (Details) Sheet http://www.surgerypartners.com/role/OtherAssetsAndLiabilitiesOtherLongTermLiabilitiesDetails Other Assets and Liabilities - Other Long-Term Liabilities (Details) Details 56 false false R57.htm 2409401 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.surgerypartners.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) Details http://www.surgerypartners.com/role/CommitmentsAndContingencies 57 false false R58.htm 2410402 - Disclosure - Segment Reporting - Revenues and Operating Income by Reportable Segment (Details) Sheet http://www.surgerypartners.com/role/SegmentReportingRevenuesAndOperatingIncomeByReportableSegmentDetails Segment Reporting - Revenues and Operating Income by Reportable Segment (Details) Details 58 false false R59.htm 2410403 - Disclosure - Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details) Sheet http://www.surgerypartners.com/role/SegmentReportingAssetsAndCashPurchasesOfPropertyAndEquipmentByOperatingSegmentDetails Segment Reporting - Assets and Cash Purchases of Property and Equipment by Operating Segment (Details) Details 59 false false R9999.htm Uncategorized Items - sgry-20190630.xml Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - sgry-20190630.xml Cover 60 false false All Reports Book All Reports sgry-20190630.xml sgry-20190630.xsd sgry-20190630_cal.xml sgry-20190630_def.xml sgry-20190630_lab.xml sgry-20190630_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2019-01-31 true true ZIP 77 0001638833-19-000061-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001638833-19-000061-xbrl.zip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�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